这是一篇来自已证抗体库的有关人类 beta连环蛋白 (beta-catenin) 的综述,是根据679篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合beta连环蛋白 抗体。
beta连环蛋白 同义词: CTNNB; EVR7; MRD19; NEDSDV; armadillo

赛默飞世尔
domestic rabbit 多克隆(CAT-15)
赛默飞世尔beta连环蛋白抗体(Thermo Fisher, 71-2700)被用于. FASEB J (2019) ncbi
小鼠 单克隆(15B8)
  • 流式细胞仪; 人类; 图 2b
赛默飞世尔beta连环蛋白抗体(eBioscience, 50-2567-42)被用于被用于流式细胞仪在人类样本上 (图 2b). Cell Rep (2018) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:300; 表 1
赛默飞世尔beta连环蛋白抗体(生活技术, Cat-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:300 (表 1). Oncotarget (2017) ncbi
domestic rabbit 多克隆(CAT-15)
  • 免疫印迹; 小鼠; 图 4f
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71-2700)被用于被用于免疫印迹在小鼠样本上 (图 4f). J Clin Invest (2017) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 人类; 1:500; 图 5b
赛默飞世尔beta连环蛋白抗体(Invitrogen, 13-8400)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 5b). Br J Haematol (2017) ncbi
domestic rabbit 多克隆(CAT-15)
  • 免疫细胞化学; 大鼠; 1:100; 图 3b
  • 免疫印迹; 大鼠; 1:250; 图 3a
赛默飞世尔beta连环蛋白抗体(ThermoFisher Scientific, 71-2700)被用于被用于免疫细胞化学在大鼠样本上浓度为1:100 (图 3b) 和 被用于免疫印迹在大鼠样本上浓度为1:250 (图 3a). FASEB J (2017) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 人类; 图 3b
赛默飞世尔beta连环蛋白抗体(Invitrogen, 13-8400)被用于被用于免疫细胞化学在人类样本上 (图 3b). Front Physiol (2016) ncbi
domestic rabbit 多克隆(CAT-15)
  • 免疫细胞化学; 大鼠; 1:500; 表 1
  • 免疫印迹; 大鼠; 1:1000; 表 1
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71-2700)被用于被用于免疫细胞化学在大鼠样本上浓度为1:500 (表 1) 和 被用于免疫印迹在大鼠样本上浓度为1:1000 (表 1). Spermatogenesis (2016) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 人类; 图 1
赛默飞世尔beta连环蛋白抗体(Invitrogen, 138400)被用于被用于免疫细胞化学在人类样本上 (图 1). Gastroenterol Res Pract (2016) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 小鼠; 1:1000; 图 5a
赛默飞世尔beta连环蛋白抗体(Invitrogen, 13-8400)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). Cardiovasc Res (2016) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 大鼠; 1:100; 图 1
  • 免疫印迹; 大鼠; 1:500; 图 1
赛默飞世尔beta连环蛋白抗体(Invitrogen, 13-8400)被用于被用于免疫细胞化学在大鼠样本上浓度为1:100 (图 1) 和 被用于免疫印迹在大鼠样本上浓度为1:500 (图 1). Sci Rep (2016) ncbi
domestic rabbit 多克隆(CAT-15)
  • 免疫细胞化学; 小鼠; 图 5
赛默飞世尔beta连环蛋白抗体(生活技术, 71-2700)被用于被用于免疫细胞化学在小鼠样本上 (图 5). Stem Cell Reports (2016) ncbi
domestic rabbit 多克隆(CAT-15)
  • 免疫细胞化学; 大鼠; 1:100; 图 5
  • 免疫印迹; 大鼠; 1:250; 图 5
赛默飞世尔beta连环蛋白抗体(Invitrogen, Life Technologies, 71-2700)被用于被用于免疫细胞化学在大鼠样本上浓度为1:100 (图 5) 和 被用于免疫印迹在大鼠样本上浓度为1:250 (图 5). Sci Rep (2016) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化; 人类; 1:400; 表 4
赛默飞世尔beta连环蛋白抗体(Zymed, E247)被用于被用于免疫组化在人类样本上浓度为1:400 (表 4). Diagn Pathol (2016) ncbi
domestic rabbit 多克隆(CAT-15)
  • 免疫细胞化学; 人类; 图 1
赛默飞世尔beta连环蛋白抗体(生活技术, 71-2700)被用于被用于免疫细胞化学在人类样本上 (图 1). Thromb Res (2016) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 犬; 1:100; 图 1a
赛默飞世尔beta连环蛋白抗体(Invitrogen, CAT-5H10)被用于被用于免疫组化-石蜡切片在犬样本上浓度为1:100 (图 1a). Theriogenology (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 5a
赛默飞世尔beta连环蛋白抗体(Pierce, PA5-19469)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5a). Oncogene (2016) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 7
  • 免疫印迹; 小鼠; 图 8
赛默飞世尔beta连环蛋白抗体(Invitrogen, 138400)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 7) 和 被用于免疫印迹在小鼠样本上 (图 8). Histochem Cell Biol (2016) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 大鼠; 1:100; 图 3
  • 免疫印迹; 大鼠; 1:300; 图 3
赛默飞世尔beta连环蛋白抗体(Invitrogen, 138400)被用于被用于免疫细胞化学在大鼠样本上浓度为1:100 (图 3) 和 被用于免疫印迹在大鼠样本上浓度为1:300 (图 3). Endocrinology (2016) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 人类; 图 5
赛默飞世尔beta连环蛋白抗体(ZYMED, 13-8400)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2016) ncbi
domestic rabbit 多克隆(CAT-15)
  • 免疫沉淀; 人类; 图 s5
  • 免疫印迹; 人类; 图 4
  • 免疫印迹; 小鼠; 图 8
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71-2700)被用于被用于免疫沉淀在人类样本上 (图 s5), 被用于免疫印迹在人类样本上 (图 4) 和 被用于免疫印迹在小鼠样本上 (图 8). Sci Rep (2016) ncbi
domestic rabbit 多克隆(CAT-15)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 3
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71-2700)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 3). Biotechnol Bioeng (2016) ncbi
domestic rabbit 多克隆(CAT-15)
  • 免疫细胞化学; 大鼠; 图 1
  • 免疫印迹; 大鼠; 1:400; 图 2
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71-2700)被用于被用于免疫细胞化学在大鼠样本上 (图 1) 和 被用于免疫印迹在大鼠样本上浓度为1:400 (图 2). Cell Signal (2016) ncbi
小鼠 单克隆(CAT-5H10)
  • 其他; 人类; 图 st1
赛默飞世尔beta连环蛋白抗体(INVITROGEN, CAT-5H10)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:200; 图 4
赛默飞世尔beta连环蛋白抗体(Thermo Scientific, PA5-19469)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 4). Aging (Albany NY) (2016) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 人类; 1:50
  • 免疫印迹; 人类; 1:2000; 图 2a
赛默飞世尔beta连环蛋白抗体(Invitrogene, 138400)被用于被用于免疫细胞化学在人类样本上浓度为1:50 和 被用于免疫印迹在人类样本上浓度为1:2000 (图 2a). Exp Cell Res (2015) ncbi
domestic rabbit 多克隆
赛默飞世尔beta连环蛋白抗体(Thermo Scientific, PA5-16762)被用于. Biochem Biophys Res Commun (2015) ncbi
小鼠 单克隆(6F9)
  • 免疫细胞化学; 人类; 1:500
  • 免疫组化; 人类
赛默飞世尔beta连环蛋白抗体(Thermo Scientific, MA1-300)被用于被用于免疫细胞化学在人类样本上浓度为1:500 和 被用于免疫组化在人类样本上. Oncotarget (2015) ncbi
domestic rabbit 多克隆(CAT-15)
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71-2700)被用于. FASEB J (2015) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:300
赛默飞世尔beta连环蛋白抗体(Zymed/Invitrogen, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:300. Anticancer Res (2015) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 人类; 1:100; 图 1d
赛默飞世尔beta连环蛋白抗体(Zymed, CAT5-H10)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 1d). Nat Med (2015) ncbi
domestic rabbit 多克隆(CAT-15)
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71- 2700)被用于. Histol Histopathol (2015) ncbi
domestic rabbit 多克隆(CAT-15)
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71-2700)被用于. Andrology (2015) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化-石蜡切片; 人类; 1:50
赛默飞世尔beta连环蛋白抗体(Thermo scientific, MA5-14461)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50. PLoS ONE (2015) ncbi
domestic rabbit 多克隆(CAT-15)
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71-2700)被用于. Ann Biomed Eng (2015) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 大鼠; 1:500
赛默飞世尔beta连环蛋白抗体(Invitrogen, CAT-5H10)被用于被用于免疫组化在大鼠样本上浓度为1:500. Exp Mol Pathol (2015) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 小鼠; 1:100; 图 6
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 6). Front Neurosci (2015) ncbi
domestic rabbit 多克隆(CAT-15)
赛默飞世尔beta连环蛋白抗体(Invitrogen, 71-2700)被用于. Mol Biol Cell (2015) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 人类; 1:1000; 图 4
赛默飞世尔beta连环蛋白抗体(Invitrogen, 138400)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Cancer Biol Ther (2015) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:1000
赛默飞世尔beta连环蛋白抗体(Zymed Laboratories, 5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000. Exp Ther Med (2015) ncbi
小鼠 单克隆(15B8)
  • 免疫组化-石蜡切片; 人类; 1:500
赛默飞世尔beta连环蛋白抗体(Thermo Fisher Scientific Inc, 15B8)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500. Clin Exp Metastasis (2015) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 人类
赛默飞世尔beta连环蛋白抗体(Invitrogen, 13-8400)被用于被用于免疫印迹在人类样本上. Oncotarget (2014) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 人类
赛默飞世尔beta连环蛋白抗体(生活技术, 13-8400)被用于被用于免疫细胞化学在人类样本上. J Pharm Sci (2014) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 人类
赛默飞世尔beta连环蛋白抗体(Invitrogen, 13-8400)被用于被用于免疫印迹在人类样本上. Surgery (2014) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:1000
赛默飞世尔beta连环蛋白抗体(Zymed Laboratorys, 5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000. Chin J Cancer Res (2014) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 犬; 1:150
赛默飞世尔beta连环蛋白抗体(Zymed, CAT5H10)被用于被用于免疫组化-石蜡切片在犬样本上浓度为1:150. Pak J Biol Sci (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 人类; 1:2000
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化在人类样本上浓度为1:2000. Hum Pathol (2014) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 人类; 图 2
赛默飞世尔beta连环蛋白抗体(Invitrogen, 5H10)被用于被用于免疫组化在人类样本上 (图 2). J Urol (2014) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔beta连环蛋白抗体(Invitrogen, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. J Clin Pathol (2014) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 人类; 1:1500; 表 1
赛默飞世尔beta连环蛋白抗体(Invitrogen, CAT-5H10)被用于被用于免疫组化在人类样本上浓度为1:1500 (表 1). Int J Surg Pathol (2014) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:400; 表 4
赛默飞世尔beta连环蛋白抗体(Invitrogen, clone CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:400 (表 4). Pathol Int (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 1
赛默飞世尔beta连环蛋白抗体(Zymed, clone CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 1). Diagn Pathol (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 人类; 1:150; 图 2
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化在人类样本上浓度为1:150 (图 2). J Korean Med Sci (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 人类; 图 5
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于免疫印迹在人类样本上 (图 5). PLoS ONE (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 小鼠; 1:75; 图 2
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:75 (图 2). Urol Int (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 人类; 1:100; 表 1
赛默飞世尔beta连环蛋白抗体(Invitrogen, clone CAT-5H10)被用于被用于免疫组化在人类样本上浓度为1:100 (表 1). PLoS ONE (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 人类; 1:3000; 图 1
赛默飞世尔beta连环蛋白抗体(Invitrogen, 13-8400)被用于被用于免疫组化在人类样本上浓度为1:3000 (图 1). Hum Pathol (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 小鼠
  • 免疫印迹; 小鼠
赛默飞世尔beta连环蛋白抗体(Zymed Laboratories, clone 5H10)被用于被用于免疫细胞化学在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Dev Biol (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:250; 图 6
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:250 (图 6). Genes Chromosomes Cancer (2013) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 人类; 图 4
  • 免疫印迹; 人类; 图 3
赛默飞世尔beta连环蛋白抗体(Invitrogen, CAT-5H10)被用于被用于免疫细胞化学在人类样本上 (图 4) 和 被用于免疫印迹在人类样本上 (图 3). Infect Immun (2012) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 小鼠; 1:600
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化在小鼠样本上浓度为1:600. Environ Toxicol (2014) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 大鼠; 1:1000; 图 4
赛默飞世尔beta连环蛋白抗体(Zymed, 138400)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4). Neurochem Res (2012) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 人类; 图 2
赛默飞世尔beta连环蛋白抗体(Invitrogen, CAT-5H10)被用于被用于免疫组化在人类样本上 (图 2). Histopathology (2011) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化-石蜡切片; 人类; 1:1; 表 3
赛默飞世尔beta连环蛋白抗体(Thermo Fisher, E247)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1 (表 3). Hepatol Res (2011) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 人类; 图 5
赛默飞世尔beta连环蛋白抗体(Invitrogen, 13-8400)被用于被用于免疫印迹在人类样本上 (图 5). Surgery (2011) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 人类; 1:250; 图 2
赛默飞世尔beta连环蛋白抗体(Invitrogen, 13-8400)被用于被用于免疫印迹在人类样本上浓度为1:250 (图 2). Cell Adh Migr (2011) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 猕猴; 图 3
赛默飞世尔beta连环蛋白抗体(Invitrogen, 138400)被用于被用于免疫组化在猕猴样本上 (图 3). Neuroscience (2011) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 小鼠; 1:1000; 图 4
  • 免疫印迹; 小鼠; 1:1000; 图 4
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于免疫组化在小鼠样本上浓度为1:1000 (图 4) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). Development (2011) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 1
赛默飞世尔beta连环蛋白抗体(Zymed Laboratories, clone CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 1). J Cutan Pathol (2011) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 小鼠; 图 8
赛默飞世尔beta连环蛋白抗体(Invitrogen, CAT-5H10)被用于被用于免疫印迹在小鼠样本上 (图 8). Mol Cell Biol (2011) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 图 1
赛默飞世尔beta连环蛋白抗体(Neomarker, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1). Int J Surg Pathol (2010) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 人类; 图 s7
赛默飞世尔beta连环蛋白抗体(invitrogen, 13-8400)被用于被用于免疫印迹在人类样本上 (图 s7). Differentiation (2010) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Int J Gynecol Cancer (2009) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:300; 表 2
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:300 (表 2). J Comp Pathol (2009) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔beta连环蛋白抗体(Zymed, Cat-SH10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Int J Surg Pathol (2009) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔beta连环蛋白抗体(Zymed Laboratories, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. World J Gastroenterol (2008) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔beta连环蛋白抗体(Zymed Laboratories, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. APMIS (2008) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔beta连环蛋白抗体(Zymed, 5H10)被用于被用于免疫组化-石蜡切片在人类样本上. Virchows Arch (2008) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:1500; 图 2
赛默飞世尔beta连环蛋白抗体(Zymed, CAT 5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1500 (图 2). Eur Arch Otorhinolaryngol (2008) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 大鼠; 图 3
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于免疫细胞化学在大鼠样本上 (图 3). J Comp Neurol (2008) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 鸡; 1:100; 图 2H
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于免疫组化在鸡样本上浓度为1:100 (图 2H). Reprod Toxicol (2008) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 犬; 1:100
赛默飞世尔beta连环蛋白抗体(Zymed Laboratory, CAT-5H10)被用于被用于免疫组化在犬样本上浓度为1:100. Vet J (2008) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫细胞化学; 人类; 1:100
赛默飞世尔beta连环蛋白抗体(Zymed Laboratories, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫细胞化学在人类样本上浓度为1:100. Cancer Epidemiol Biomarkers Prev (2007) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 图 2
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2). Oral Dis (2007) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
赛默飞世尔beta连环蛋白抗体(Zymed, a CAT 5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2). Pathol Res Pract (2007) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 图 4
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4). APMIS (2007) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫印迹; 小鼠; 1:1000
赛默飞世尔beta连环蛋白抗体(Zymed, 5H10)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Cancer Res (2007) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 小鼠; 1:400
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:400. Dev Cell (2007) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 人类; 1:250
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化在人类样本上浓度为1:250. Mod Pathol (2006) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 犬
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于免疫细胞化学在犬样本上. Proc Natl Acad Sci U S A (2006) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化; 人类; 1:400; 图 1
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化在人类样本上浓度为1:400 (图 1). Am J Clin Pathol (2006) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 1
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 1). Arch Androl (2005) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-冰冻切片; 人类
赛默飞世尔beta连环蛋白抗体(Zymed, 5H10)被用于被用于免疫组化-冰冻切片在人类样本上. Heart Rhythm (2004) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 小鼠
赛默飞世尔beta连环蛋白抗体(Zymed, 5H10)被用于被用于免疫组化-石蜡切片在小鼠样本上. J Cell Biochem (2005) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 小鼠; 图 3
  • 免疫印迹; 小鼠; 图 4A-B
赛默飞世尔beta连环蛋白抗体(ZYMED, CAT-5H10)被用于被用于免疫细胞化学在小鼠样本上 (图 3) 和 被用于免疫印迹在小鼠样本上 (图 4A-B). J Cell Biochem (2005) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 图 2
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2). J Clin Pathol (2005) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:250
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:250. Virchows Arch (2005) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-冰冻切片; 人类; 1:2000
  • 免疫组化-石蜡切片; 人类; 1:2000
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:2000 和 被用于免疫组化-石蜡切片在人类样本上浓度为1:2000. J Pathol (2004) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上. Am J Dermatopathol (2004) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:250; 表 1
赛默飞世尔beta连环蛋白抗体(ZYMED, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:250 (表 1). Gynecol Oncol (2004) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:750; 图 3
赛默飞世尔beta连环蛋白抗体(Zymed, 5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:750 (图 3). Hum Pathol (2004) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Cancer Cell (2004) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 1
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 1). J Clin Gastroenterol (2004) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上. Dig Dis Sci (2003) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 小鼠; 1:100
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100. J Cell Sci (2003) ncbi
小鼠 单克隆(CAT-5H10)
  • EMSA; 人类; 图 1
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于EMSA在人类样本上 (图 1). Gastroenterology (2003) ncbi
小鼠 单克隆(CAT-5H10)
  • 酶联免疫吸附测定; 人类; 1:400
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于酶联免疫吸附测定在人类样本上浓度为1:400. J Biol Chem (2002) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 鸡; 5 ug/ml; 图 5
赛默飞世尔beta连环蛋白抗体(生活技术, CAT-5H10)被用于被用于免疫细胞化学在鸡样本上浓度为5 ug/ml (图 5). J Neurosci (2002) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 表 1
赛默飞世尔beta连环蛋白抗体(Zymed, clone CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上 (表 1). J Mammary Gland Biol Neoplasia (2001) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上. J Clin Pathol (2001) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 1:250
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:250. Cancer (2001) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫沉淀; 人类
  • 免疫印迹; 人类
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫沉淀在人类样本上 和 被用于免疫印迹在人类样本上. Cancer Res (2001) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类
赛默飞世尔beta连环蛋白抗体(Zymed, 5H10)被用于被用于免疫组化-石蜡切片在人类样本上. Arch Pathol Lab Med (2000) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 牛; 1:100
赛默飞世尔beta连环蛋白抗体(Zymed, 13?C8400)被用于被用于免疫细胞化学在牛样本上浓度为1:100. Am J Physiol Cell Physiol (2000) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫细胞化学; 人类
赛默飞世尔beta连环蛋白抗体(Zymed, 13-8400)被用于被用于免疫细胞化学在人类样本上. Infect Immun (2000) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫沉淀; 人类; 图 7
赛默飞世尔beta连环蛋白抗体(Zymed, CAT-5H10)被用于被用于免疫沉淀在人类样本上 (图 7). J Biol Chem (2000) ncbi
小鼠 单克隆(CAT-5H10)
  • 免疫组化-石蜡切片; 人类; 图 3
赛默飞世尔beta连环蛋白抗体(Zymed, 5H10)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3). Cancer (1999) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(E247)
  • 免疫细胞化学; 人类; 1:200; 图 8a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 8a). Int J Mol Sci (2020) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化-石蜡切片; 人类; 1:4000; 图 1a, 2a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:4000 (图 1a, 2a). PLoS ONE (2020) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2). BMC Cancer (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 4a
  • 免疫印迹; 人类; 1:1000; 图 9a, 9b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab16051)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 4a) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 9a, 9b). Cancer Manag Res (2020) ncbi
小鼠 单克隆(12F7)
  • 免疫组化; 小鼠; 1:1000; 图 7j, e4j
  • 免疫印迹; 小鼠; 1:1000; 图 e2h
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab22656)被用于被用于免疫组化在小鼠样本上浓度为1:1000 (图 7j, e4j) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 e2h). EMBO Mol Med (2020) ncbi
小鼠 单克隆(15B8)
  • 免疫印迹; 人类; 1:4000; 图 6c, 6d
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab6302)被用于被用于免疫印迹在人类样本上浓度为1:4000 (图 6c, 6d). Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 6d, 6e
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, 16051)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6d, 6e). Clin Transl Gastroenterol (2020) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 人类; 图 6a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹在人类样本上 (图 6a). Braz J Med Biol Res (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化基因敲除验证; 小鼠; 1:1000; 图 2b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, Ab2365)被用于被用于免疫组化基因敲除验证在小鼠样本上浓度为1:1000 (图 2b). Arthritis Res Ther (2019) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 小鼠; 图 7s1a
  • 免疫组化; 人类; 图 7g
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹在小鼠样本上 (图 7s1a) 和 被用于免疫组化在人类样本上 (图 7g). elife (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 4d
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab27798)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4d). elife (2019) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 小鼠; 63 ng/ml; 图 4c
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, E247)被用于被用于免疫印迹在小鼠样本上浓度为63 ng/ml (图 4c). Science (2019) ncbi
小鼠 单克隆(12F7)
  • 免疫印迹; 人类; 2 ug/ml; 图 3b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab22656)被用于被用于免疫印迹在人类样本上浓度为2 ug/ml (图 3b). Cancer Cell Int (2019) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 人类; 图 3c
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹在人类样本上 (图 3c). Cell Death Dis (2019) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 人类; 1:2000; 图 3e, 3f
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3e, 3f). Biosci Rep (2019) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 大鼠; 图 6b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹在大鼠样本上 (图 6b). Braz J Med Biol Res (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化基因敲除验证; 小鼠; 图 4g
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab15180)被用于被用于免疫组化基因敲除验证在小鼠样本上 (图 4g). Kidney Int (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2c
  • 免疫组化-石蜡切片; 小鼠; 图 2e
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab27798)被用于被用于免疫印迹在人类样本上 (图 2c) 和 被用于免疫组化-石蜡切片在小鼠样本上 (图 2e). J Mol Cell Cardiol (2019) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 人类; 图 3a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹在人类样本上 (图 3a). Cancer Res (2019) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化; 小鼠; 1:400; 图 7c
  • 免疫印迹; 小鼠; 1:4000; 图 7c
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化在小鼠样本上浓度为1:400 (图 7c) 和 被用于免疫印迹在小鼠样本上浓度为1:4000 (图 7c). Cell Mol Gastroenterol Hepatol (2019) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化-冰冻切片; 小鼠; 图 4j
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 4j). Nat Commun (2018) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹基因敲除验证; 小鼠; 1:100; 图 s3, s6
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:100 (图 s3, s6). Hepatology (2019) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 人类; 1:5000; 图 4b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 4b). Biosci Rep (2018) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 小鼠; 图 3b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab2365)被用于被用于免疫细胞化学在小鼠样本上 (图 3b). Biochim Biophys Acta Mol Basis Dis (2018) ncbi
  • 免疫细胞化学; 人类; 图 4a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab59430)被用于被用于免疫细胞化学在人类样本上 (图 4a). Dev Cell (2017) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化; 人类; 图 6i
  • 免疫印迹; 人类; 图 5j
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化在人类样本上 (图 6i) 和 被用于免疫印迹在人类样本上 (图 5j). J Biol Chem (2017) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 9d
  • 免疫印迹; 人类; 1:5000; 图 3a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 9d) 和 被用于免疫印迹在人类样本上浓度为1:5000 (图 3a). Oncotarget (2017) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化; 人类; 1:100; 图 5f
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化在人类样本上浓度为1:100 (图 5f). Stem Cell Res Ther (2017) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化-冰冻切片; 小鼠; 1:250; 图 1a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:250 (图 1a). Hum Mol Genet (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:500; 图 5h
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab16051)被用于被用于免疫组化在小鼠样本上浓度为1:500 (图 5h). J Clin Invest (2017) ncbi
小鼠 单克隆(12F7)
  • 免疫沉淀; 大鼠; 图 5
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab22656)被用于被用于免疫沉淀在大鼠样本上 (图 5). Am J Transl Res (2016) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 大鼠; 图 4b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹在大鼠样本上 (图 4b). Am J Transl Res (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 3a
  • 免疫细胞化学; 小鼠; 图 3a
  • 免疫印迹; 小鼠; 图 5a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab16051)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 3a), 被用于免疫细胞化学在小鼠样本上 (图 3a) 和 被用于免疫印迹在小鼠样本上 (图 5a). Hum Mol Genet (2017) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化-石蜡切片; 大鼠; 1:200; 图 8a
  • 免疫印迹; 大鼠; 1:3000; 图 8g
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:200 (图 8a) 和 被用于免疫印迹在大鼠样本上浓度为1:3000 (图 8g). Toxicol Lett (2017) ncbi
小鼠 单克隆(15B8)
  • 免疫细胞化学; 人类; 1:100; 图 3d
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab6301)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 3d). Clin Sci (Lond) (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 4a
  • 免疫沉淀; 小鼠; 1:200; 表 1
  • 免疫印迹; 小鼠; 1:1000; 图 4d
艾博抗(上海)贸易有限公司beta连环蛋白抗体(abcam, ab16051)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 4a), 被用于免疫沉淀在小鼠样本上浓度为1:200 (表 1) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4d). Histochem Cell Biol (2016) ncbi
domestic rabbit 单克隆(E247)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 3b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 3b). Am J Pathol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab27798)被用于被用于免疫印迹在小鼠样本上 (图 5). Stem Cell Reports (2016) ncbi
  • 免疫印迹; 小鼠; 图 5
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab59430)被用于被用于免疫印迹在小鼠样本上 (图 5). Stem Cell Reports (2016) ncbi
domestic rabbit 多克隆
  • 免疫沉淀; 小鼠; 图 5
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab2365)被用于被用于免疫沉淀在小鼠样本上 (图 5). Stem Cell Reports (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab16051)被用于被用于免疫印迹在小鼠样本上 (图 5). Stem Cell Reports (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 图 s6a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab16051)被用于被用于免疫组化在人类样本上 (图 s6a). Nat Biotechnol (2016) ncbi
domestic rabbit 单克隆(E247)
  • 免疫细胞化学; 小鼠; 图 s1a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(abcam, ab32572)被用于被用于免疫细胞化学在小鼠样本上 (图 s1a). Eur J Cell Biol (2016) ncbi
domestic rabbit 单克隆(E247)
  • 核糖核酸免疫沉淀; 人类; 图 3f
  • EMSA; 人类; 图 3c
  • 免疫沉淀; 人类; 图 3h
  • 免疫细胞化学; 人类
  • 免疫组化; 人类; 图 3e
  • 免疫印迹; 人类; 图 3b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于核糖核酸免疫沉淀在人类样本上 (图 3f), 被用于EMSA在人类样本上 (图 3c), 被用于免疫沉淀在人类样本上 (图 3h), 被用于免疫细胞化学在人类样本上, 被用于免疫组化在人类样本上 (图 3e) 和 被用于免疫印迹在人类样本上 (图 3b). Nat Struct Mol Biol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:2500; 图 6
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab16051)被用于被用于免疫印迹在人类样本上浓度为1:2500 (图 6). PLoS ONE (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-冰冻切片; 小鼠; 图 3
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab16051)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 3). elife (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:100; 图 6b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab16051)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 6b). J Orthop Res (2016) ncbi
小鼠 单克隆(15B8)
  • 免疫组化; 斑马鱼; 1:400; 图 5
艾博抗(上海)贸易有限公司beta连环蛋白抗体(abcam, ab6301)被用于被用于免疫组化在斑马鱼样本上浓度为1:400 (图 5). PLoS ONE (2016) ncbi
小鼠 单克隆(15B8)
  • 免疫组化; 斑马鱼; 1:200; 图 1
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab6301)被用于被用于免疫组化在斑马鱼样本上浓度为1:200 (图 1). Int J Mol Sci (2016) ncbi
小鼠 单克隆(12F7)
  • 免疫细胞化学; 人类; 图 s7a
艾博抗(上海)贸易有限公司beta连环蛋白抗体(abcam, ab22656)被用于被用于免疫细胞化学在人类样本上 (图 s7a). Oncogene (2016) ncbi
小鼠 单克隆(15B8)
  • 免疫组化-自由浮动切片; 鸡; 1:1000; 图 5
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, 6301)被用于被用于免疫组化-自由浮动切片在鸡样本上浓度为1:1000 (图 5). J Cell Biol (2015) ncbi
小鼠 单克隆(12F7)
  • 免疫印迹; 大鼠; 1:1000; 图 5b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab22656)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5b). Int J Mol Med (2015) ncbi
小鼠 单克隆(12F7)
  • 免疫细胞化学; 人类; 1:400; 图 5
  • 免疫印迹; 人类; 1:400; 图 4
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab22656)被用于被用于免疫细胞化学在人类样本上浓度为1:400 (图 5) 和 被用于免疫印迹在人类样本上浓度为1:400 (图 4). Int J Med Sci (2015) ncbi
小鼠 单克隆(15B8)
  • 免疫组化; 人类
  • 免疫印迹; 人类
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab6301)被用于被用于免疫组化在人类样本上 和 被用于免疫印迹在人类样本上. J Clin Pathol (2015) ncbi
小鼠 单克隆(15B8)
  • 免疫细胞化学; 人类; 1:100
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab6301)被用于被用于免疫细胞化学在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上浓度为1:1000. Biochem Biophys Res Commun (2015) ncbi
小鼠 单克隆(12F7)
  • 免疫组化-石蜡切片; 人类; 图 2a
  • 免疫印迹; 人类; 图 S1
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab22656)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2a) 和 被用于免疫印迹在人类样本上 (图 S1). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 大鼠; 1:20,000; 图 1b
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫印迹在大鼠样本上浓度为1:20,000 (图 1b). Int J Neuropsychopharmacol (2015) ncbi
domestic rabbit 单克隆(E247)
  • 免疫细胞化学; 小鼠; 1:250; 图 4A
  • 免疫印迹; 小鼠; 1:5000; 图 3A
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab32572)被用于被用于免疫细胞化学在小鼠样本上浓度为1:250 (图 4A) 和 被用于免疫印迹在小鼠样本上浓度为1:5000 (图 3A). Biochimie (2015) ncbi
小鼠 单克隆(15B8)
  • 免疫细胞化学; 人类; 1:200
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab6301)被用于被用于免疫细胞化学在人类样本上浓度为1:200 和 被用于免疫印迹在人类样本上浓度为1:1000. J Biol Chem (2015) ncbi
小鼠 单克隆(12F7)
  • 免疫细胞化学; 人类; 1:500
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab22656)被用于被用于免疫细胞化学在人类样本上浓度为1:500. J Biol Chem (2013) ncbi
小鼠 单克隆(12F7)
  • 流式细胞仪; 人类
艾博抗(上海)贸易有限公司beta连环蛋白抗体(Abcam, ab22656)被用于被用于流式细胞仪在人类样本上. Cell Death Dis (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆(E-5)
  • 免疫细胞化学; 牛; 图 3b
  • 免疫印迹; 牛; 1:2000; 图 2c
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫细胞化学在牛样本上 (图 3b) 和 被用于免疫印迹在牛样本上浓度为1:2000 (图 2c). BMC Vet Res (2020) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 图 2b, s2b
  • 免疫细胞化学; 犬; 图 1d
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上 (图 2b, s2b) 和 被用于免疫细胞化学在犬样本上 (图 1d). iScience (2020) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 小鼠; 图 2e
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc7963)被用于被用于免疫印迹在小鼠样本上 (图 2e). Brain Behav (2020) ncbi
小鼠 单克隆(E-5)
  • 免疫组化-冰冻切片; 人类; 1:200; 图 4c
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, E-5)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:200 (图 4c). BMC Cancer (2019) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 图 6b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-7963)被用于被用于免疫印迹在人类样本上 (图 6b). Sci Adv (2019) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上 (图 2a). Theranostics (2019) ncbi
小鼠 单克隆(BC-22)
  • 免疫印迹; 人类; 图 5a
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology Inc, sc-57535)被用于被用于免疫印迹在人类样本上 (图 5a). Cancer Res (2019) ncbi
小鼠 单克隆(10H8)
  • 免疫印迹; 人类; 图 7f
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-65480)被用于被用于免疫印迹在人类样本上 (图 7f). Nat Commun (2017) ncbi
小鼠 单克隆(E-5)
  • 免疫细胞化学; 人类; 2 ug/ml; 图 s1
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, SC-7963)被用于被用于免疫细胞化学在人类样本上浓度为2 ug/ml (图 s1). Biol Open (2017) ncbi
小鼠 单克隆(E-5)
  • 免疫组化; 小鼠; 1:200; 图 8f
  • 免疫组化; 人类; 1:200; 图 2e
  • 免疫印迹; 人类; 图 1c
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, SC-7963)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 8f), 被用于免疫组化在人类样本上浓度为1:200 (图 2e) 和 被用于免疫印迹在人类样本上 (图 1c). Redox Biol (2017) ncbi
小鼠 单克隆(E-5)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 s3b
  • 免疫印迹基因敲除验证; 小鼠; 1:500; 图 5a
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 2d
  • 免疫细胞化学; 小鼠; 1:100
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 s3b), 被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:500 (图 5a), 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 2d) 和 被用于免疫细胞化学在小鼠样本上浓度为1:100. Arterioscler Thromb Vasc Biol (2017) ncbi
小鼠 单克隆
  • 免疫组化; 人类; 表 1
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, E-5)被用于被用于免疫组化在人类样本上 (表 1). Endocr Relat Cancer (2017) ncbi
小鼠 单克隆(E-5)
  • 免疫组化; 人类; 表 1
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, E-5)被用于被用于免疫组化在人类样本上 (表 1). Endocr Relat Cancer (2017) ncbi
小鼠 单克隆(10H8)
  • 免疫细胞化学; 人类; 图 4a
  • 免疫印迹; 人类; 1:1000; 图 3a
  • 免疫印迹; 小鼠; 1:1000; 图 7a
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-65480)被用于被用于免疫细胞化学在人类样本上 (图 4a), 被用于免疫印迹在人类样本上浓度为1:1000 (图 3a) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7a). Oncol Lett (2016) ncbi
小鼠 单克隆(15B8)
  • 免疫印迹; 仓鼠; 1:1000; 图 s2a
  • 免疫印迹; 鸡; 1:1000; 图 1b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-53483)被用于被用于免疫印迹在仓鼠样本上浓度为1:1000 (图 s2a) 和 被用于免疫印迹在鸡样本上浓度为1:1000 (图 1b). J Cell Biol (2016) ncbi
小鼠 单克隆(A-5)
  • 免疫印迹; 仓鼠; 1:3000; 图 s2a
  • 免疫沉淀; 鸡; 图 1c
  • 免疫组化; 鸡; 1:250; 图 4i
  • 免疫印迹; 鸡; 1:3000; 图 1b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-393501)被用于被用于免疫印迹在仓鼠样本上浓度为1:3000 (图 s2a), 被用于免疫沉淀在鸡样本上 (图 1c), 被用于免疫组化在鸡样本上浓度为1:250 (图 4i) 和 被用于免疫印迹在鸡样本上浓度为1:3000 (图 1b). J Cell Biol (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 小鼠; 1:800; 图 s2b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc7963)被用于被用于免疫印迹在小鼠样本上浓度为1:800 (图 s2b). Nature (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 大鼠; 1:500; 图 4b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在大鼠样本上浓度为1:500 (图 4b). Mol Pharm (2016) ncbi
小鼠 单克隆(12F7)
  • 免疫印迹; 人类; 1:200; 图 2d
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-59737)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 2d). Mol Hum Reprod (2016) ncbi
小鼠 单克隆(24E1)
  • 免疫印迹; 小鼠; 1:500; 图 5c
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-57534)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5c). Oncotarget (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上浓度为1:1000. Nat Med (2016) ncbi
小鼠 单克隆(6F9)
  • 免疫印迹; 人类; 1:2000; 图 5a
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-53484)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5a). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫组化基因敲除验证; 小鼠; 1:250; 图 1
  • 免疫印迹基因敲除验证; 小鼠; 1:500; 图 3
  • 免疫细胞化学; 小鼠; 1:100; 图 3
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫组化基因敲除验证在小鼠样本上浓度为1:250 (图 1), 被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:500 (图 3) 和 被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 3). Nat Commun (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 大鼠; 1:1000; 图 3
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, SC-7963)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3). Sci Rep (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫组化; 小鼠; 1:200; 图 3b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 3b). Reprod Biomed Online (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 1:1000; 图 3
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3). PLoS ONE (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 1
  • 免疫印迹; 人类; 1:100; 图 3
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, Sc-7963)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 1) 和 被用于免疫印迹在人类样本上浓度为1:100 (图 3). Sci Rep (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫细胞化学; 人类; 图 2b
  • 免疫印迹; 人类; 图 1b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫细胞化学在人类样本上 (图 2b) 和 被用于免疫印迹在人类样本上 (图 1b). Oncotarget (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 小鼠; 1:100; 图 4b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在小鼠样本上浓度为1:100 (图 4b). J Orthop Res (2017) ncbi
小鼠 单克隆(B-9)
  • 免疫印迹; 人类; 1:1000; 图 5d
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-376841)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5d). Oncotarget (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫细胞化学; 人类; 1:200; 图 3
圣克鲁斯生物技术beta连环蛋白抗体(santa Cruz, E-5)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 3). Sci Rep (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 1:500; 图 3a
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3a). Oncotarget (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 小鼠; 图 7
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, SC-7963)被用于被用于免疫印迹在小鼠样本上 (图 7). Cardiovasc Res (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 1:100; 图 3a
圣克鲁斯生物技术beta连环蛋白抗体(SantaCruz, sc-7963)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 3a). Oncotarget (2016) ncbi
小鼠 单克隆(15B8)
  • 免疫印迹; 大鼠; 1:5000; 图 4
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-53483)被用于被用于免疫印迹在大鼠样本上浓度为1:5000 (图 4). Mol Med Rep (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫细胞化学; 人类; 1:100; 图 s5
  • 免疫印迹; 人类; 1:500; 图 s5
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 s5) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 s5). Cell Rep (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 大鼠; 1:1000; 图 2
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, SC-7963)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 2). Int J Mol Sci (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 1:500; 图 8
圣克鲁斯生物技术beta连环蛋白抗体(santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 8). Cancer Cell Int (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫组化-石蜡切片; 小鼠; 图 8
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 8). Invest Ophthalmol Vis Sci (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫组化-冰冻切片; 小鼠; 图 4
圣克鲁斯生物技术beta连环蛋白抗体(santa Cruz, sc-7963)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 4). Int J Mol Sci (2016) ncbi
小鼠 单克隆(12F7)
  • 免疫组化-石蜡切片; 小鼠; 图 5h
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-59737)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5h). elife (2016) ncbi
小鼠 单克隆(12F7)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1a
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc59737)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1a). Oncol Lett (2016) ncbi
小鼠 单克隆(E-5)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 4
  • 免疫印迹; 人类; 图 s2
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 4) 和 被用于免疫印迹在人类样本上 (图 s2). Clin Exp Metastasis (2016) ncbi
小鼠 单克隆(12F7)
  • 免疫组化-石蜡切片; 大鼠; 1:50; 图 4
  • 免疫印迹; 大鼠; 1:50; 图 2
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-59737)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:50 (图 4) 和 被用于免疫印迹在大鼠样本上浓度为1:50 (图 2). Mol Med Rep (2016) ncbi
小鼠 单克隆(10H8)
  • 免疫印迹; 人类; 图 6b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-65480)被用于被用于免疫印迹在人类样本上 (图 6b). Oncol Rep (2016) ncbi
小鼠 单克隆(12F7)
  • 免疫印迹; 人类; 1:500; 图 3c
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-59737)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3c). Sci Rep (2015) ncbi
小鼠 单克隆(D-10)
  • 免疫沉淀; 人类; 图 2
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-133239)被用于被用于免疫沉淀在人类样本上 (图 2). Reproduction (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 1:1000; 图 9C
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 9C). Antioxid Redox Signal (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫细胞化学; 人类; 1:100
圣克鲁斯生物技术beta连环蛋白抗体(Santacruz, Sc-7963)被用于被用于免疫细胞化学在人类样本上浓度为1:100. PLoS ONE (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 1:1000; 图 2
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, SC-7963)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 1:500
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-7963)被用于被用于免疫印迹在人类样本上浓度为1:500. Anticancer Drugs (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 大鼠; 图 7
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在大鼠样本上 (图 7). Biomed Res Int (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 5
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-7963)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 5). BMC Surg (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫组化; 小鼠; 1:50; 图 3
圣克鲁斯生物技术beta连环蛋白抗体(santa Cruz, sc-7963)被用于被用于免疫组化在小鼠样本上浓度为1:50 (图 3). PLoS ONE (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 图 3b
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上 (图 3b). Oncotarget (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫沉淀; 人类; 图 1
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫沉淀在人类样本上 (图 1). Nat Commun (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 1:1000
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-7963)被用于被用于免疫印迹在人类样本上浓度为1:1000. Mol Cells (2014) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 小鼠
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-7963)被用于被用于免疫印迹在小鼠样本上. Neurosci Lett (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-7963)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Oncogene (2015) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 大鼠; 1:600
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在大鼠样本上浓度为1:600. Biomed Res Int (2014) ncbi
小鼠 单克隆(E-5)
  • 免疫细胞化学; 人类
  • 免疫印迹; 小鼠
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类; 图 5
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上 (图 5). Cell (2014) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, E-5)被用于被用于免疫印迹在人类样本上. Stem Cells (2014) ncbi
小鼠 单克隆(E-5)
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz biotechnology, sc-7963)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫印迹在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(E-5)
  • 免疫组化; 人类
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, SC-7963)被用于被用于免疫组化在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(E-5)
  • 免疫印迹; 人类
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc7963)被用于被用于免疫印迹在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(E-5)
  • 免疫细胞化学; 人类; 1:100
  • 免疫印迹; 人类; 1:100
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz Biotechnology, sc-7963)被用于被用于免疫细胞化学在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上浓度为1:100. PLoS ONE (2012) ncbi
小鼠 单克隆(E-5)
  • 染色质免疫沉淀 ; 小鼠
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于染色质免疫沉淀 在小鼠样本上. PLoS ONE (2012) ncbi
小鼠 单克隆(E-5)
  • 免疫组化-石蜡切片; 人类; 1:100
圣克鲁斯生物技术beta连环蛋白抗体(Santa Cruz, sc-7963)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. APMIS (2013) ncbi
武汉三鹰
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 8b
武汉三鹰beta连环蛋白抗体(SanYing, 17565-1-AP)被用于被用于免疫印迹在人类样本上 (图 8b). Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2f
武汉三鹰beta连环蛋白抗体(Proteintech, 17565-1-AP)被用于被用于免疫印迹在人类样本上 (图 2f). Aging (Albany NY) (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:5000; 图 3a
武汉三鹰beta连环蛋白抗体(Proteintech Group, 51067-2-AP)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 3a). Exp Ther Med (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1f
武汉三鹰beta连环蛋白抗体(Proteintech, 51067-2-AP)被用于被用于免疫印迹在人类样本上 (图 1f). Oncogene (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 0.23 ug/ml; 图 1c
武汉三鹰beta连环蛋白抗体(Proteintech, 51067-2-AP)被用于被用于免疫印迹在人类样本上浓度为0.23 ug/ml (图 1c). J Biol Chem (2019) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 小鼠; 图 1:1000
  • 免疫印迹; 小鼠; 1:1000; 图 4a
武汉三鹰beta连环蛋白抗体(Proteintech, 51067-2-AP)被用于被用于免疫细胞化学在小鼠样本上 (图 1:1000) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a). J Clin Invest (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:800; 图 5e
武汉三鹰beta连环蛋白抗体(Proteintech, 51067-2-AP)被用于被用于免疫印迹在人类样本上浓度为1:800 (图 5e). Breast Cancer (Dove Med Press) (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; pigs ; 图 5
武汉三鹰beta连环蛋白抗体(Proteintech Group, 51067-2-AP)被用于被用于免疫印迹在pigs 样本上 (图 5). Sci Rep (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 2
武汉三鹰beta连环蛋白抗体(Proteintech Group, 51067-2-AP)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2). Chin Med J (Engl) (2016) ncbi
亚诺法生技股份有限公司
小鼠 单克隆
  • 免疫印迹; 人类; 1:2000; 图 2b
亚诺法生技股份有限公司beta连环蛋白抗体(Abnova, MAB11143)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 2b). BMC Cancer (2019) ncbi
Enzo Life Sciences
小鼠 单克隆(7D11)
  • 免疫组化-冰冻切片; 小鼠; 1:200; 图 s2,e,f,g
Enzo Life Sciencesbeta连环蛋白抗体(Enzo Life Sceince, ALX-804-060-C100)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:200 (图 s2,e,f,g). BMC Biol (2015) ncbi
小鼠 单克隆(7D11)
  • 免疫印迹; 人类; 1:500
Enzo Life Sciencesbeta连环蛋白抗体(Enzo Life Sciences, ALX-804-060-C100)被用于被用于免疫印迹在人类样本上浓度为1:500. Int J Exp Pathol (2014) ncbi
GeneTex
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5c
GeneTexbeta连环蛋白抗体(GeneTex, GTX101435)被用于被用于免疫印迹在人类样本上 (图 5c). Nucleic Acids Res (2017) ncbi
domestic rabbit 单克隆(E247)
  • 免疫印迹; 人类; 1:1000; 图 6a
GeneTexbeta连环蛋白抗体(GeneTex, GTX61089)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6a). Oncotarget (2016) ncbi
安迪生物R&D
小鼠 单克隆(196621)
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 7c
安迪生物R&Dbeta连环蛋白抗体(R&D Systems, MAB1329)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 7c). Oncotarget (2016) ncbi
小鼠 单克隆(196618)
  • 免疫组化-石蜡切片; 人类; 图 1a
安迪生物R&Dbeta连环蛋白抗体(R&D Systems, MAB13291)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1a). PLoS ONE (2015) ncbi
SICGEN
domestic goat 多克隆
  • 免疫印迹; 非洲爪蛙; 1:500; 图 6b
SICGENbeta连环蛋白抗体(Sicgen, AB0095-200)被用于被用于免疫印迹在非洲爪蛙样本上浓度为1:500 (图 6b). Development (2017) ncbi
Novus Biologicals
domestic rabbit 多克隆
Novus Biologicalsbeta连环蛋白抗体(Novus Biologicals, NBP1-89989)被用于. COPD (2015) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5c). Sci Rep (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:1000; 图 5c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5c). Sci Rep (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:1000; 图 1, 3b, 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, Danvers, MA;, 8480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1, 3b, 5a). Integr Cancer Ther (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 2f, 2g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 2f, 2g). Cell Death Dis (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 3c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 3c). Oncogenesis (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5i
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在人类样本上 (图 5i). PLoS ONE (2020) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 图 5i
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, D13A1)被用于被用于免疫印迹在人类样本上 (图 5i). PLoS ONE (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 小鼠; 图 5, 6e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, #8480)被用于被用于免疫印迹在小鼠样本上 (图 5, 6e). Cancer Med (2020) ncbi
小鼠 单克隆(L87A12)
  • 免疫印迹; 人类; 图 2e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technologies, 2698)被用于被用于免疫印迹在人类样本上 (图 2e). Oncogene (2020) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 1:200; 图 4c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9587)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 4c). Oncogene (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3f
  • 免疫印迹; 人类; 1:1000; 图 3i
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 9562)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3f) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 3i). Nat Commun (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化-石蜡切片; 人类; 图 2a
  • 免疫印迹; 人类; 图 3d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 8480)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2a) 和 被用于免疫印迹在人类样本上 (图 3d). J Cell Mol Med (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 小鼠; 1:10,000; 图 7c, 7d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在小鼠样本上浓度为1:10,000 (图 7c, 7d). elife (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类; 1:500; 图 s1b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫细胞化学在人类样本上浓度为1:500 (图 s1b). Nat Commun (2020) ncbi
domestic rabbit 多克隆
  • 染色质免疫沉淀 ; 小鼠; 1:400; 图 6h
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于染色质免疫沉淀 在小鼠样本上浓度为1:400 (图 6h). Sci Adv (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:1000; 图 s7a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s7a). J Biomed Sci (2020) ncbi
domestic rabbit 多克隆
  • 免疫沉淀; 小鼠; 1:500; 图 6b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 9562L)被用于被用于免疫沉淀在小鼠样本上浓度为1:500 (图 6b). Nat Commun (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 小鼠; 1:1000; 图 9b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 9b). Cell Mol Gastroenterol Hepatol (2020) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 1:1000; 图 9b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 9b). Cell Mol Gastroenterol Hepatol (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 9b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 9b). Cell Mol Gastroenterol Hepatol (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 3i
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 3i). Mol Oncol (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8480)被用于被用于免疫印迹在人类样本上 (图 5a). Oncogene (2020) ncbi
domestic rabbit 单克隆(D10A8)
  • 核糖核酸免疫沉淀; 人类; 1:1000; 图 6c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于核糖核酸免疫沉淀在人类样本上浓度为1:1000 (图 6c). Aging (Albany NY) (2019) ncbi
domestic rabbit 多克隆
  • 核糖核酸免疫沉淀; 人类; 1:500; 图 6c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561)被用于被用于核糖核酸免疫沉淀在人类样本上浓度为1:500 (图 6c). Aging (Albany NY) (2019) ncbi
小鼠 单克隆(L87A12)
  • 免疫印迹; 小鼠; 1:2000; 图 3g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 2698)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 3g). Sci Adv (2019) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:1000; 图 4d
  • 免疫印迹; 小鼠; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 8480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4d) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2c). elife (2019) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫组化-石蜡切片; 人类; 1:800; 图 3s2c
  • 免疫印迹; 人类; 1:1000; 图 8s1d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 8814)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:800 (图 3s2c) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 8s1d). elife (2019) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 2d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 2d). Aging (Albany NY) (2019) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化; 小鼠; 1:100; 图 s1d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 s1d). Science (2019) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 小鼠; 1:1000; 图 4b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 8480)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4b). Sci Adv (2019) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 ex8j
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480S)被用于被用于免疫印迹在人类样本上 (图 ex8j). Nature (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:300; 图 2f
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9587)被用于被用于免疫组化在小鼠样本上浓度为1:300 (图 2f). Nat Commun (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 2f
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2f). elife (2019) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫组化; 小鼠; 图 6b
  • 免疫印迹; 小鼠; 图 6a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫组化在小鼠样本上 (图 6b) 和 被用于免疫印迹在小鼠样本上 (图 6a). FASEB J (2019) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 图 6b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8814S)被用于被用于免疫印迹在人类样本上 (图 6b). Sci Adv (2019) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 小鼠; 图 4a
  • 免疫印迹; 小鼠; 图 1a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9566)被用于被用于免疫细胞化学在小鼠样本上 (图 4a) 和 被用于免疫印迹在小鼠样本上 (图 1a). FASEB J (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 1c
  • 免疫印迹; 人类; 图 1b, 1c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 9566)被用于被用于免疫印迹在小鼠样本上 (图 1c) 和 被用于免疫印迹在人类样本上 (图 1b, 1c). Cell Death Dis (2019) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 图 5e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8814)被用于被用于免疫印迹在小鼠样本上 (图 5e). Nat Commun (2019) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 2a
  • 免疫印迹; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9562)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 2a) 和 被用于免疫印迹在小鼠样本上 (图 3a). Cancer Res (2019) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 小鼠; 1:1000; 图 2d, 4h
  • 免疫印迹; 人类; 1:1000; 图 2d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2d, 4h) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2d). elife (2019) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Oncol Rep (2019) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫组化-冰冻切片; 小鼠; 图 4g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 4g). Nat Commun (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化; 人类; 1:100; 图 8c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480)被用于被用于免疫组化在人类样本上浓度为1:100 (图 8c). Oncogene (2019) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类; 1:500; 图 4d
  • 免疫印迹; 人类; 1:500; 图 4a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫细胞化学在人类样本上浓度为1:500 (图 4d) 和 被用于免疫印迹在人类样本上浓度为1:500 (图 4a). Nat Commun (2018) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫细胞化学; 人类; 1:1000; 图 4d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫细胞化学在人类样本上浓度为1:1000 (图 4d). Nat Commun (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 大鼠; 1:1000; 图 4g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480S)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 4g). Exp Ther Med (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 2c, 2d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2c, 2d). Mol Cell (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类; 1:200; 图 2j
  • 免疫印迹; 人类; 图 2a
  • 免疫组化; 小鼠; 1:100; 图 4o
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 2j), 被用于免疫印迹在人类样本上 (图 2a) 和 被用于免疫组化在小鼠样本上浓度为1:100 (图 4o). Exp Dermatol (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化; 小鼠; 1:30; 图 6a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫组化在小鼠样本上浓度为1:30 (图 6a). Exp Neurol (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 6a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9562)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). Bone Res (2018) ncbi
domestic rabbit 单克隆(D13A1)
  • 其他; 小鼠; 1:500; 图 8j
  • 免疫印迹; 小鼠; 1:2000; 图 8g
  • 免疫组化; 人类; 1:100; 图 s4c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于其他在小鼠样本上浓度为1:500 (图 8j), 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 8g) 和 被用于免疫组化在人类样本上浓度为1:100 (图 s4c). Nat Commun (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:2000; 图 4g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4g). Nat Commun (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500-1:1000; 图 3
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在小鼠样本上浓度为1:500-1:1000 (图 3). Biol Pharm Bull (2018) ncbi
domestic rabbit 单克隆(D8E11)
  • 免疫印迹; 小鼠; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 5651)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a). J Clin Invest (2018) ncbi
domestic rabbit 多克隆
  • 其他; 人类; 图 4c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9565)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
domestic rabbit 多克隆
  • 其他; 人类; 图 4c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
小鼠 单克隆(L87A12)
  • 免疫沉淀; 小鼠; 图 4a
  • 免疫印迹; 小鼠; 1:1000; 图 4a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 2698)被用于被用于免疫沉淀在小鼠样本上 (图 4a) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a). Nat Neurosci (2018) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 1:1000; 图 4b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4b). Nat Neurosci (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 其他; 小鼠; 图 4d
  • 免疫印迹; 小鼠; 1:1000; 图 4b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于其他在小鼠样本上 (图 4d) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4b). Nat Neurosci (2018) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 图 1e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technologies, D13A1)被用于被用于免疫印迹在小鼠样本上 (图 1e). Cell Metab (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹基因敲除验证; 小鼠; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000 (图 3a). elife (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 3a). J Cell Mol Med (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化; 人类; 1:1600; 图 6
  • 免疫印迹; 人类; 1:1000; 图 1c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫组化在人类样本上浓度为1:1600 (图 6) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 1c). Biosci Rep (2018) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹基因敲除验证; 小鼠; 图 s8h
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 s8h). Hepatology (2018) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 1:1000; 图 1a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8814)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). Endocrinology (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 小鼠; 1:1000; 图 1a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8480)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). Endocrinology (2018) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:1000; 图 7j
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7j). J Clin Invest (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 染色质免疫沉淀 ; 人类; 图 5f
  • 免疫沉淀; 人类; 图 5a
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于染色质免疫沉淀 在人类样本上 (图 5f), 被用于免疫沉淀在人类样本上 (图 5a) 和 被用于免疫印迹在人类样本上 (图 5a). EBioMedicine (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 s4a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s4a). Cancer Lett (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Cancer Lett (2017) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 图 3g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫印迹在小鼠样本上 (图 3g). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 3g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在小鼠样本上 (图 3g). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561)被用于被用于免疫印迹在人类样本上 (图 4b). Oncogene (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 s6g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 s6g). Nature (2017) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 7e
  • 免疫印迹; 小鼠; 1:1000; 图 7c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 7e) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7c). J Clin Invest (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:50; 图 5b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在小鼠样本上浓度为1:50 (图 5b). J Cell Biol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在人类样本上 (图 1c). Oncotarget (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 4C
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4C). Oncol Lett (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST Signaling, 9561S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4c). Nat Commun (2017) ncbi
domestic rabbit 单克隆(D8E11)
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 4h
  • 免疫印迹; 小鼠; 1:1000; 图 4d,4c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST Signaling, 5651S)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 (图 4h) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4d,4c). Nat Commun (2017) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫印迹; 小鼠; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST Signaling, 4176S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4c). Nat Commun (2017) ncbi
小鼠 单克隆(L54E2)
  • 免疫印迹; 小鼠; 图 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 4627)被用于被用于免疫印迹在小鼠样本上 (图 5a). Sci Rep (2017) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(cell signalling, 9582)被用于被用于免疫印迹在人类样本上 (图 1b). Cell Death Dis (2017) ncbi
domestic rabbit 多克隆
  • reverse phase protein lysate microarray; 人类; 图 st6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 9562)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 st6). Cancer Cell (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 3g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 9587)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 3g). Genes Dev (2017) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫细胞化学; 小鼠; 图 5b
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫细胞化学在小鼠样本上 (图 5b) 和 被用于免疫印迹在小鼠样本上 (图 5c). Metabolism (2017) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, D13A1)被用于被用于免疫印迹在人类样本上 (图 4a). PLoS ONE (2017) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫细胞化学; 人类; 图 s1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 4176 S)被用于被用于免疫细胞化学在人类样本上 (图 s1). Sci Rep (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 小鼠; 1:1000; 图 3g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, D10A8)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3g). Int J Mol Sci (2017) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; pigs ; 1:200; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(cell signalling, 9562)被用于被用于免疫细胞化学在pigs 样本上浓度为1:200 (图 2). PLoS ONE (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 1a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 9562)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 1a). PLoS ONE (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; pigs ; 图 2a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在pigs 样本上 (图 2a). Sci Rep (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; pigs ; 图 2a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561)被用于被用于免疫印迹在pigs 样本上 (图 2a). Sci Rep (2017) ncbi
小鼠 单克隆(L54E2)
  • 免疫印迹; 人类; 图 5B
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 2677)被用于被用于免疫印迹在人类样本上 (图 5B). Biochem J (2017) ncbi
小鼠 单克隆(L54E2)
  • 免疫细胞化学基因敲除验证; 人类; 1:1000; 图 s11g
  • 免疫细胞化学基因敲除验证; 小鼠; 1:1000; 图 2a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 4627)被用于被用于免疫细胞化学基因敲除验证在人类样本上浓度为1:1000 (图 s11g) 和 被用于免疫细胞化学基因敲除验证在小鼠样本上浓度为1:1000 (图 2a). Nat Methods (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹基因敲除验证; 小鼠; 1:1000; 图 s4d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000 (图 s4d). Nat Methods (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类; 图 3b
  • 免疫印迹; 人类; 图 3e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480)被用于被用于免疫细胞化学在人类样本上 (图 3b) 和 被用于免疫印迹在人类样本上 (图 3e). Oncoimmunology (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹基因敲除验证; 人类; 图 s2c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9587S)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 s2c). Nature (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化; 人类; 图 6a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, D10A8)被用于被用于免疫组化在人类样本上 (图 6a). PLoS ONE (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 小鼠; 1:100; 图 4d
  • 免疫印迹; 小鼠; 1:1000; 图 4e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 4d) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4e). Int J Mol Med (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 小鼠; 1:100; 图 6c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(cell signalling, D10A8)被用于被用于免疫印迹在小鼠样本上浓度为1:100 (图 6c). Cell Commun Signal (2017) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signalling, 8814)被用于被用于免疫印迹在小鼠样本上 (图 5c). Hum Mol Genet (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 10
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, D10A8)被用于被用于免疫印迹在人类样本上 (图 10). Oncotarget (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9562)被用于被用于免疫印迹在人类样本上. Cell Syst (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(cell signalling, 9562)被用于被用于免疫印迹在人类样本上 (图 3a). J Clin Invest (2017) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类; 图 6d, 6e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582)被用于被用于免疫印迹在人类样本上 (图 6d, 6e). Front Pharmacol (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 1:100; 图 6c
  • 免疫印迹; 人类; 图 6a
  • 免疫组化; 小鼠; 图 7b
  • 免疫印迹; 小鼠; 图 7a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(cell signalling, 9562)被用于被用于免疫组化在人类样本上浓度为1:100 (图 6c), 被用于免疫印迹在人类样本上 (图 6a), 被用于免疫组化在小鼠样本上 (图 7b) 和 被用于免疫印迹在小鼠样本上 (图 7a). Cell Death Dis (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 s1a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s1a). Development (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫细胞化学; 小鼠; 1:100; 图 s5h
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 s5h). Cell Discov (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类; 图 4b
  • 免疫印迹; 人类; 图 2b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, D10A8)被用于被用于免疫细胞化学在人类样本上 (图 4b) 和 被用于免疫印迹在人类样本上 (图 2b). J Biol Chem (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化-石蜡切片; 小鼠; 图 6a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6a). J Clin Invest (2016) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类; 图 1a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 9582S)被用于被用于免疫印迹在人类样本上 (图 1a). Int J Mol Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在小鼠样本上 (图 3a). Cell Chem Biol (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 1:5000; 图 1b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8814)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1b). J Cell Sci (2016) ncbi
小鼠 单克隆(L54E2)
  • 免疫细胞化学; 人类; 图 s12
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 4627S)被用于被用于免疫细胞化学在人类样本上 (图 s12). Mol Biol Cell (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 9562)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5e). Nat Commun (2016) ncbi
小鼠 单克隆(L54E2)
  • 免疫细胞化学; 人类; 1:200; 图 5f
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 2677)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 5f). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Nat Immunol (2016) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582)被用于被用于免疫印迹在人类样本上 (图 2). Neoplasia (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:200; 图 st1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9565)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 st1). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:200; 图 st1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9567)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 st1). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:200; 图 st1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9566)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 st1). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 2a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9587)被用于被用于免疫细胞化学在人类样本上 (图 2a). J Clin Invest (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; African green monkey; 1:1000; 图 2c
  • 免疫印迹; 小鼠; 1:1000; 图 2d
  • 免疫印迹; 人类; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9565)被用于被用于免疫印迹在African green monkey样本上浓度为1:1000 (图 2c), 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2d) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D8E11)
  • 免疫印迹; 小鼠; 1:1000; 图 2d
  • 免疫印迹; African green monkey; 1:1000; 图 2c
  • 免疫印迹; 人类; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 5651)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2d), 被用于免疫印迹在African green monkey样本上浓度为1:1000 (图 2c) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫印迹; African green monkey; 1:1000; 图 2c
  • 免疫印迹; 小鼠; 1:1000; 图 2d
  • 免疫印迹; 人类; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 4176)被用于被用于免疫印迹在African green monkey样本上浓度为1:1000 (图 2c), 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2d) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 人类; 1:100; 图 2b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫组化在人类样本上浓度为1:100 (图 2b). J Cell Sci (2017) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫沉淀; 人类; 图 5
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480)被用于被用于免疫沉淀在人类样本上 (图 5) 和 被用于免疫印迹在人类样本上 (图 5). Mol Ther Methods Clin Dev (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 图 6a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8814)被用于被用于免疫印迹在人类样本上 (图 6a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 6a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 6a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 3b
  • 免疫印迹; 小鼠; 图 2c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 3b) 和 被用于免疫印迹在小鼠样本上 (图 2c). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9561)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3d). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 9587)被用于被用于免疫印迹在小鼠样本上 (图 3a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫细胞化学; 小鼠; 图 6c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814S)被用于被用于免疫细胞化学在小鼠样本上 (图 6c). Stem Cell Rev (2016) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类; 1:1000; 图 1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Biomed Res Int (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类; 1:100; 图 1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480S)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 1). Biomed Res Int (2016) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 1g
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 1g
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signalling, 9582)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 (图 1g) 和 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 1g). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 3
  • 免疫印迹; 小鼠; 图 6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 3) 和 被用于免疫印迹在小鼠样本上 (图 6). Sci Rep (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:1000; 图 1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Oncol Lett (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). Oncol Lett (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 1:4000; 图 6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫印迹在人类样本上浓度为1:4000 (图 6). Mol Med Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9562)被用于被用于免疫印迹在人类样本上 (图 6e). Biochim Biophys Acta (2016) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化-冰冻切片; 小鼠; 1:25; 图 6a
  • 免疫细胞化学; 小鼠; 1:25; 图 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582s)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:25 (图 6a) 和 被用于免疫细胞化学在小鼠样本上浓度为1:25 (图 5a). J Cell Biol (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化; 小鼠; 图 4c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫组化在小鼠样本上 (图 4c). Oncogene (2017) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫细胞化学; 人类; 图 2b
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582)被用于被用于免疫细胞化学在人类样本上 (图 2b) 和 被用于免疫印迹在人类样本上 (图 1b). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signalling, 8814)被用于被用于免疫印迹在小鼠样本上 (图 2). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 小鼠; 1:1000; 图 7
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480s)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7). Dev Biol (2016) ncbi
小鼠 单克隆(L54E2)
  • 免疫组化-冰冻切片; 小鼠; 1:200; 图 9
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 2677s)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:200 (图 9). Dev Biol (2016) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类; 图 s1b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 9582S)被用于被用于免疫印迹在人类样本上 (图 s1b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s1b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 9561S)被用于被用于免疫印迹在人类样本上 (图 s1b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Tech, 9561)被用于被用于免疫印迹在人类样本上 (图 3). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 3
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Tech, 8480)被用于被用于免疫印迹在人类样本上 (图 3). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9565)被用于被用于免疫印迹在人类样本上 (图 5a). Nat Struct Mol Biol (2016) ncbi
domestic rabbit 多克隆
  • 核糖核酸免疫沉淀; 人类; 图 3f
  • EMSA; 人类; 图 3c
  • 免疫沉淀; 人类; 图 3h
  • 免疫组化; 人类; 图 3e
  • 免疫印迹; 人类; 图 3b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9587)被用于被用于核糖核酸免疫沉淀在人类样本上 (图 3f), 被用于EMSA在人类样本上 (图 3c), 被用于免疫沉淀在人类样本上 (图 3h), 被用于免疫组化在人类样本上 (图 3e) 和 被用于免疫印迹在人类样本上 (图 3b). Nat Struct Mol Biol (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 5d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 5d). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 1:1000; 图 4e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4e). PLoS ONE (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(BD Biosciences, 9561)被用于被用于免疫印迹在人类样本上 (图 4b). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在人类样本上 (图 2). Stem Cells Dev (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s5
  • 免疫印迹; 小鼠; 图 s1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 9562)被用于被用于免疫印迹在人类样本上 (图 s5) 和 被用于免疫印迹在小鼠样本上 (图 s1). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Tech, 9561)被用于被用于免疫印迹在小鼠样本上 (图 6). Cell Rep (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signalling, 8480)被用于被用于免疫印迹在人类样本上 (图 6). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 9587P)被用于被用于免疫印迹在人类样本上 (图 6). J Biol Chem (2016) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 小鼠; 图 7
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582S)被用于被用于免疫印迹在小鼠样本上 (图 7). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类; 图 4
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫细胞化学在人类样本上 (图 4) 和 被用于免疫印迹在人类样本上 (图 4). Cell Death Dis (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 小鼠; 1:500; 图 5
  • 免疫印迹; 小鼠; 1:1000; 图 5
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8480)被用于被用于免疫细胞化学在小鼠样本上浓度为1:500 (图 5) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5). Front Cell Neurosci (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上. J Mol Med (Berl) (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 大鼠; 图 6
  • 免疫印迹; 小鼠; 图 4
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9567)被用于被用于免疫印迹在大鼠样本上 (图 6) 和 被用于免疫印迹在小鼠样本上 (图 4). Sci Rep (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫组化-石蜡切片; 人类; 0.5 ug/ml; 图 st1
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8814S)被用于被用于免疫组化-石蜡切片在人类样本上浓度为0.5 ug/ml (图 st1) 和 被用于免疫印迹在人类样本上 (图 2). Nature (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2). Endocrinology (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在人类样本上 (图 1). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化; 人类; 1:500; 图 4
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, D10A8)被用于被用于免疫组化在人类样本上浓度为1:500 (图 4). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫细胞化学在人类样本上 (图 1). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:25; 图 s1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:25 (图 s1). BMC Cancer (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫组化-石蜡切片; 小鼠; 1:400; 图 s7
  • 免疫细胞化学; 小鼠; 1:800; 图 s7
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8814S)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:400 (图 s7) 和 被用于免疫细胞化学在小鼠样本上浓度为1:800 (图 s7). Nature (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 5). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 4270)被用于被用于免疫印迹在人类样本上 (图 6b). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 染色质免疫沉淀 ; 人类; 图 6
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9587)被用于被用于染色质免疫沉淀 在人类样本上 (图 6) 和 被用于免疫印迹在人类样本上 (图 2). Cell Cycle (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 2009)被用于被用于免疫印迹在人类样本上 (图 2). Cell Cycle (2016) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫细胞化学; 人类; 图 4
  • 免疫印迹; 人类; 1:1000; 图 4
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 4176)被用于被用于免疫细胞化学在人类样本上 (图 4) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 4). Mol Med Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 7
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 4270)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7). J Cell Mol Med (2016) ncbi
小鼠 单克隆(L54E2)
  • 免疫印迹; 人类; 1:1000; 图 7
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 2677)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 7). J Cell Mol Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 s10
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在小鼠样本上 (图 s10). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 4b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9566)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4b). Nat Commun (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8814)被用于被用于免疫印迹在人类样本上 (图 5a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类; 图 s3
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 8480)被用于被用于免疫细胞化学在人类样本上 (图 s3) 和 被用于免疫印迹在人类样本上 (图 6). Oncotarget (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫组化-石蜡切片; 小鼠; 1:250; 图 6d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, D13A1)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:250 (图 6d). Dev Dyn (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5A
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9562)被用于被用于免疫印迹在小鼠样本上 (图 5A). Mol Med Rep (2016) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化; 人类; 1:500; 图 5d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9582P)被用于被用于免疫组化在人类样本上浓度为1:500 (图 5d). Endocr Relat Cancer (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 图 11c
  • 免疫印迹; 人类; 图 11a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9581)被用于被用于免疫细胞化学在人类样本上 (图 11c) 和 被用于免疫印迹在人类样本上 (图 11a). J Clin Invest (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9561S)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). J Cell Sci (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:2000; 图 6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(CST, 8480S)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 6). Oncotarget (2015) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 1:500; 图 2a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8814)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 2a). Eur Surg Res (2015) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 1:1000; 图 3c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3c). Sci Rep (2015) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 5d
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 5d). Oncogene (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 人类; 1:1000; 图 3a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3a). Exp Cell Res (2015) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 s1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Millipore, 9561)被用于被用于免疫印迹在小鼠样本上 (图 s1). Nucleic Acids Res (2016) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫细胞化学; 人类
  • 免疫组化; 人类
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫细胞化学在人类样本上, 被用于免疫组化在人类样本上 和 被用于免疫印迹在人类样本上 (图 4). Reproduction (2015) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化-冰冻切片; 人类; 1:100; 图 1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(cell Signaling Tech, 9582P)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:100 (图 1). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类; 1:1000; 图 s5
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9582)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s5). PLoS ONE (2015) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 7a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9565)被用于被用于免疫印迹在人类样本上 (图 7a). Oncogene (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 7a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8480)被用于被用于免疫印迹在人类样本上 (图 7a). Oncogene (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 8
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上 (图 8). Neuroendocrinology (2016) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫印迹; 小鼠; 1:1000; 图 6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 4176)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6). Nat Commun (2015) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 大鼠; 1:1000; 图 3b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signalling, 9582)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 3b). Acupunct Med (2016) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 1f
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 1f). PLoS Genet (2015) ncbi
小鼠 单克隆(L54E2)
  • 免疫组化; 人类; 图 6b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 2677)被用于被用于免疫组化在人类样本上 (图 6b). Leukemia (2015) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化; 人类; 1:100; 图 1
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, #8480)被用于被用于免疫组化在人类样本上浓度为1:100 (图 1). Anticancer Res (2015) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫细胞化学; 人类; 图 3C
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814S)被用于被用于免疫细胞化学在人类样本上 (图 3C). J Hematol Oncol (2015) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类; 图 6d
  • 免疫印迹; 人类; 图 6c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫细胞化学在人类样本上 (图 6d) 和 被用于免疫印迹在人类样本上 (图 6c). Oncotarget (2015) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480s)被用于被用于免疫印迹在人类样本上浓度为1:1000. Biochim Biophys Acta (2015) ncbi
小鼠 单克隆(L87A12)
  • 免疫组化-石蜡切片; 人类; 1:200
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 2698S)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Exp Cell Res (2015) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 4176)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Carcinogenesis (2015) ncbi
小鼠 单克隆(L87A12)
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 2698)被用于被用于免疫印迹在人类样本上 (图 4). Sci Rep (2015) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 3
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 6B3)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 3) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). BMC Complement Altern Med (2015) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类; 图 2c
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8480)被用于被用于免疫印迹在人类样本上 (图 2c). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫组化; 人类; 1:100
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8480)被用于被用于免疫组化在人类样本上浓度为1:100. Fluids Barriers CNS (2015) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582S)被用于被用于免疫印迹在人类样本上 (图 4). Int J Gynecol Cancer (2015) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫印迹; 小鼠; 1:1000; 图 2e
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2e). Nat Biotechnol (2015) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫印迹; 人类; 1:500; 图 5f
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technologies,, D2F1)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 5f). J Neural Transm (Vienna) (2015) ncbi
domestic rabbit 单克隆(D10A8)
  • 染色质免疫沉淀 ; 人类; 图 4
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于染色质免疫沉淀 在人类样本上 (图 4) 和 被用于免疫印迹在人类样本上 (图 2). Sci Signal (2015) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 4176)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2015) ncbi
domestic rabbit 单克隆(D13A1)
  • 抑制或激活实验; 人类; 图 5b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, D13A1)被用于被用于抑制或激活实验在人类样本上 (图 5b). Mol Cell Proteomics (2015) ncbi
domestic rabbit 单克隆(D10A8)
  • 流式细胞仪; 人类
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8480)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2015) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9582)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫印迹; 人类; 1:1000; 图 5b
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signalling, 4176)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5b). Reprod Fertil Dev (2016) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 人类; 1:200
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9561S)被用于被用于免疫细胞化学在人类样本上浓度为1:200. Methods Mol Biol (2016) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫细胞化学; 人类; 1:2000; 图 5c
  • 免疫印迹; 人类; 1:2000; 图 5a
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 4176)被用于被用于免疫细胞化学在人类样本上浓度为1:2000 (图 5c) 和 被用于免疫印迹在人类样本上浓度为1:2000 (图 5a). J Cell Mol Med (2015) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫组化-石蜡切片; 小鼠; 图 4
  • 免疫印迹; 小鼠; 图 4
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8814)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4) 和 被用于免疫印迹在小鼠样本上 (图 4). J Biol Chem (2014) ncbi
domestic rabbit 单克隆(D13A1)
  • 免疫组化-石蜡切片; 小鼠
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 8814)被用于被用于免疫组化-石蜡切片在小鼠样本上. Prostate (2014) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 8480)被用于被用于免疫印迹在人类样本上. Cancer Cell (2014) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫细胞化学; 人类; 1:100
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582)被用于被用于免疫细胞化学在人类样本上浓度为1:100. Mol Endocrinol (2014) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化-石蜡切片; 小鼠; 图 6
  • 免疫组化-石蜡切片; 人类; 图 7
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 9582)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6) 和 被用于免疫组化-石蜡切片在人类样本上 (图 7). Cancer Res (2014) ncbi
小鼠 单克隆(L87A12)
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 5
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 2698)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 5). J Cancer Res Clin Oncol (2015) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化-石蜡切片; 小鼠
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582)被用于被用于免疫组化-石蜡切片在小鼠样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(L87A12)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell signaling, 2698)被用于被用于免疫印迹在人类样本上浓度为1:1000. Cell Signal (2014) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, 9582)被用于被用于免疫印迹在人类样本上 (图 6). J Pathol (2014) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Tech, 4176)被用于被用于免疫印迹在人类样本上 (图 2). Oncogene (2015) ncbi
domestic rabbit 单克隆(D2F1)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 4176)被用于被用于免疫印迹在人类样本上. PLoS ONE (2014) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化; 小鼠; 1:200
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582)被用于被用于免疫组化在小鼠样本上浓度为1:200. Mol Cell Biol (2014) ncbi
domestic rabbit 单克隆(D8E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, D8E11)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫组化-石蜡切片; 小鼠; 1:800
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, 9582S)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:800. Dev Biol (2014) ncbi
小鼠 单克隆(L54E2)
  • 流式细胞仪; 小鼠
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling, L54E2)被用于被用于流式细胞仪在小鼠样本上. Eur J Immunol (2014) ncbi
domestic rabbit 单克隆(D10A8)
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology, D10A8)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Cell Mol Life Sci (2014) ncbi
domestic rabbit 单克隆(6B3)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司beta连环蛋白抗体(Cell Signaling Technology Inc, 9582)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. J Biol Chem (2013) ncbi
丹科医疗器械技术服务(上海)有限公司
小鼠 单克隆(?-Catenin-1)
  • 免疫组化; 人类; 图 2a
丹科医疗器械技术服务(上海)有限公司beta连环蛋白抗体(Dako, ??-Catenin-1)被用于被用于免疫组化在人类样本上 (图 2a). PLoS ONE (2020) ncbi
小鼠 单克隆(?-Catenin-1)
  • 免疫组化-冰冻切片; 人类
丹科医疗器械技术服务(上海)有限公司beta连环蛋白抗体(Dako, M3539)被用于被用于免疫组化-冰冻切片在人类样本上. Dermatol Reports (2009) ncbi
小鼠 单克隆(?-Catenin-1)
  • 免疫组化-自由浮动切片; 人类; 1:200
丹科医疗器械技术服务(上海)有限公司beta连环蛋白抗体(Dako, M3539)被用于被用于免疫组化-自由浮动切片在人类样本上浓度为1:200. Int J Exp Pathol (2014) ncbi
小鼠 单克隆(?-Catenin-1)
  • 免疫组化-石蜡切片; 人类; ready-to-use
丹科医疗器械技术服务(上海)有限公司beta连环蛋白抗体(Dako, beta-Catenin-1)被用于被用于免疫组化-石蜡切片在人类样本上浓度为ready-to-use. Ann Diagn Pathol (2014) ncbi
小鼠 单克隆(?-Catenin-1)
  • 免疫组化; 人类; 1:300
丹科医疗器械技术服务(上海)有限公司beta连环蛋白抗体(Dako, B-Catenin-1)被用于被用于免疫组化在人类样本上浓度为1:300. Fetal Pediatr Pathol (2014) ncbi
小鼠 单克隆(?-Catenin-1)
  • 免疫印迹; 人类; 1:1000
丹科医疗器械技术服务(上海)有限公司beta连环蛋白抗体(Dako, M3539)被用于被用于免疫印迹在人类样本上浓度为1:1000. Arch Dermatol Res (2014) ncbi
Cell Marque
单克隆(14)
  • 免疫组化; domestic rabbit; 1:500; 图 2d
Cell Marquebeta连环蛋白抗体(CellMarque, 14)被用于被用于免疫组化在domestic rabbit样本上浓度为1:500 (图 2d). Exp Anim (2019) ncbi
碧迪BD
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:200; 图 1e
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 1e). elife (2020) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:500; 图 4h
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 4h). elife (2020) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:500; 图 3i
碧迪BDbeta连环蛋白抗体(BD Transduction, 610153)被用于被用于免疫组化在小鼠样本上浓度为1:500 (图 3i). Nat Commun (2020) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:2000; 图 6b
碧迪BDbeta连环蛋白抗体(BD bioscience, 610153)被用于被用于免疫组化在小鼠样本上浓度为1:2000 (图 6b). Cell Stem Cell (2020) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 4h, e9r
碧迪BDbeta连环蛋白抗体(BD Transduction, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 4h, e9r). Nature (2020) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:5000; 图 1c
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610154)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1c). elife (2020) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:5000; 图 s4c
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:5000 (图 s4c). Nat Commun (2020) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:2000; 图 5s1a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 14)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 5s1a). elife (2020) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 s1h
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s1h). Cell (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:25; 图 s1d
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫组化在小鼠样本上浓度为1:25 (图 s1d). Sci Adv (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:1000; 图 6a
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610153)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). Science (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学基因敲除验证; 人类; 1:2000; 图 2d
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫细胞化学基因敲除验证在人类样本上浓度为1:2000 (图 2d). Nat Commun (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 6b
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在人类样本上 (图 6b). Cell (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 图 1a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在小鼠样本上 (图 1a). FASEB J (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:300; 图 3a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化在小鼠样本上浓度为1:300 (图 3a). elife (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 3c
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 3c). Cell Stem Cell (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:200; 图 s1a
  • 免疫印迹; 人类; 1:20,000; 图 s1b
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 s1a) 和 被用于免疫印迹在人类样本上浓度为1:20,000 (图 s1b). Proc Natl Acad Sci U S A (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 7a
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610153)被用于被用于免疫印迹在人类样本上 (图 7a). Autophagy (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫沉淀; 人类; 图 1b
  • 免疫组化; 人类; 图 1e
  • 免疫印迹; 人类; 图 1b
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫沉淀在人类样本上 (图 1b), 被用于免疫组化在人类样本上 (图 1e) 和 被用于免疫印迹在人类样本上 (图 1b). J Pathol (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:1000; 图 s5b
碧迪BDbeta连环蛋白抗体(Becton-Dickinson, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s5b). J Hematol Oncol (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:1000; 图 4a, s2h,
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4a, s2h, ). Hepatology (2019) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:10,000; 图 1h
  • 免疫印迹; 人类; 1:10,000; 图 1a, 1g, 1h
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:10,000 (图 1h) 和 被用于免疫印迹在人类样本上浓度为1:10,000 (图 1a, 1g, 1h). Mol Cell (2018) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:2000; 图 6j
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫组化在小鼠样本上浓度为1:2000 (图 6j). J Cell Biol (2018) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 3a
碧迪BDbeta连环蛋白抗体(BD BioScience, 610154)被用于被用于免疫印迹在人类样本上 (图 3a). EMBO J (2018) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫沉淀; 小鼠; 图 5d
  • 免疫印迹; 小鼠; 1:1000; 图 1a
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫沉淀在小鼠样本上 (图 5d) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1a). Dev Cell (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 6a
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 6a). JCI Insight (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:100; 图 3c
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, BD610153)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 3c). Stem Cells (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:2000; 图 2b
碧迪BDbeta连环蛋白抗体(BD biosciences, 610154)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 2b). Nat Commun (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:100; 图 s4i
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 s4i). Science (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-冰冻切片; 小鼠; 图 1d
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 1d). Dev Biol (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 图 2c
  • 免疫组化; 人类; 图 s3j
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫组化在小鼠样本上 (图 2c) 和 被用于免疫组化在人类样本上 (图 s3j). Nature (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:100; 图 5a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 5a). Oncol Lett (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 3a
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫印迹在人类样本上 (图 3a). Oncotarget (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 鸡; 图 5e
  • 免疫细胞化学; 小鼠; 图 6e
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫细胞化学在鸡样本上 (图 5e) 和 被用于免疫细胞化学在小鼠样本上 (图 6e). PLoS ONE (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 人类; 1:100; 图 3e
碧迪BDbeta连环蛋白抗体(BD BioScience, 610153)被用于被用于免疫组化在人类样本上浓度为1:100 (图 3e). PLoS ONE (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:100; 图 3b
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 3b). Nature (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:2000; 图 2d
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 2d). Biol Open (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 图 s4a
碧迪BDbeta连环蛋白抗体(BD Bioscience, 14)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s4a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:1000; 图 4e
  • 免疫细胞化学; 人类; 图 5a
  • 免疫印迹; 人类; 1:1000; 图 6c
碧迪BDbeta连环蛋白抗体(BD Biosciences, 14/Beta-Catenin)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4e), 被用于免疫细胞化学在人类样本上 (图 5a) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 6c). Nucleic Acids Res (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 st2
碧迪BDbeta连环蛋白抗体(BD Transduction, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 st2). J Toxicol Pathol (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫印迹在小鼠样本上. J Exp Med (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:200; 图 s7a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在小鼠样本上浓度为1:200 (图 s7a). J Clin Invest (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 犬; 0.8 ug/ml; 图 4m
碧迪BDbeta连环蛋白抗体(BD Biosciences, 14/Beta-catenin)被用于被用于免疫组化-石蜡切片在犬样本上浓度为0.8 ug/ml (图 4m). J Vet Med Sci (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:5000; 图 1f
碧迪BDbeta连环蛋白抗体(BD biosciences, 610153)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 1f). Mol Cell Biol (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 5b
碧迪BDbeta连环蛋白抗体(BD Biosciences, 14)被用于被用于免疫印迹在人类样本上 (图 5b). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:500; 图 3-s2b
  • 免疫印迹; 人类; 1:1000; 图 2c
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在人类样本上浓度为1:500 (图 3-s2b) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). elife (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 图 e5b
  • 免疫组化-石蜡切片; 小鼠; 图 e5h
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫细胞化学在人类样本上 (图 e5b) 和 被用于免疫组化-石蜡切片在小鼠样本上 (图 e5h). Nature (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 s4d
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s4d). Nature (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 5
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610153)被用于被用于免疫印迹在人类样本上 (图 5). Oncogene (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 图 1a
碧迪BDbeta连环蛋白抗体(BD Transduction, 610153)被用于被用于免疫印迹在小鼠样本上 (图 1a). J Clin Invest (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 5c
碧迪BDbeta连环蛋白抗体(BD Transduction, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 5c). Cell Death Dis (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 小鼠; 1:100; 图 s8b
  • 免疫组化; 小鼠; 1:100; 图 7a
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610153)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 s8b) 和 被用于免疫组化在小鼠样本上浓度为1:100 (图 7a). Development (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 6a
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 6a). Nat Commun (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:1000; 图 7a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 7a). JCI Insight (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 2.5 ug/ml; 图 4e
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫细胞化学在人类样本上浓度为2.5 ug/ml (图 4e). J Cell Physiol (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 犬; 图 6a
碧迪BDbeta连环蛋白抗体(BD Transduction, 610154)被用于被用于免疫印迹在犬样本上 (图 6a). Sci Rep (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:1000; 图 3b
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3b). Nat Commun (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; African green monkey; 1:1000; 图 2c
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 1b
  • 免疫印迹; 小鼠; 1:1000; 图 2d
  • 免疫印迹; 人类; 1:1000; 图 2c
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫印迹在African green monkey样本上浓度为1:1000 (图 2c), 被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 1b), 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2d) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Nat Commun (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:500; 图 6
碧迪BDbeta连环蛋白抗体(bD Bioscience, 610154)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 6). Oncol Lett (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:1000; 图 3
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3). Oncol Lett (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学基因敲除验证; 人类; 1:1000; 图 2
  • 免疫印迹基因敲除验证; 人类; 1:1000; 图 2
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610154)被用于被用于免疫细胞化学基因敲除验证在人类样本上浓度为1:1000 (图 2) 和 被用于免疫印迹基因敲除验证在人类样本上浓度为1:1000 (图 2). Stem Cell Reports (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:200; 图 s1a
碧迪BDbeta连环蛋白抗体(BD Transduction Labs, 610154)被用于被用于免疫细胞化学在人类样本上浓度为1:200 (图 s1a). PLoS Genet (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 1b
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫印迹在人类样本上 (图 1b). Oncotarget (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:100; 图 5
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 5). Nat Commun (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 6
碧迪BDbeta连环蛋白抗体(bD Bioscience, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 6). PLoS Genet (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:1000; 表 3
碧迪BDbeta连环蛋白抗体(BD TL, 610153)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (表 3). Oncol Lett (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-冰冻切片; 小鼠; 1:75; 图 2
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:75 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 图 2
碧迪BDbeta连环蛋白抗体(BD Trasduction Laborotories, 610153)被用于被用于免疫印迹在小鼠样本上 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:150; 图 4
  • 免疫印迹; 小鼠
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:150 (图 4) 和 被用于免疫印迹在小鼠样本上. PLoS ONE (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:1000; 图 3c
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫组化在小鼠样本上浓度为1:1000 (图 3c). Oncogene (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-冰冻切片; 小鼠; 1:250; 图 7
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:250 (图 7). Oncogene (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:300; 图 1
碧迪BDbeta连环蛋白抗体(BD Pharmingen, 610154)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:300 (图 1). Mol Carcinog (2017) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-冰冻切片; 小鼠; 图 1
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 1). PLoS ONE (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:2000; 图 4e
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4e). PLoS ONE (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 图 6
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫印迹在小鼠样本上 (图 6). PLoS Genet (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 图 1
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在小鼠样本上 (图 1). Sci Rep (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 图 1
  • 免疫印迹; 人类; 1:1000; 图 1
  • 免疫细胞化学; pigs ; 图 1
  • 免疫印迹; pigs ; 1:1000; 图 1
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫细胞化学在人类样本上 (图 1), 被用于免疫印迹在人类样本上浓度为1:1000 (图 1), 被用于免疫细胞化学在pigs 样本上 (图 1) 和 被用于免疫印迹在pigs 样本上浓度为1:1000 (图 1). Int J Mol Med (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:400; 图 6
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:400 (图 6). PLoS ONE (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 染色质免疫沉淀 ; 小鼠; 图 6
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于染色质免疫沉淀 在小鼠样本上 (图 6). Mol Cell Biol (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 s4a
  • 免疫细胞化学; 人类; 1:400; 图 s7b
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s4a) 和 被用于免疫细胞化学在人类样本上浓度为1:400 (图 s7b). Dev Cell (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 4e
碧迪BDbeta连环蛋白抗体(BDBiosciences, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4e). Int J Biol Sci (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 2b
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在人类样本上 (图 2b). Oncol Lett (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:800; 图 2
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:800 (图 2). Oncol Lett (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:1000; 图 6
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6). Mol Cancer Ther (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 s1
碧迪BDbeta连环蛋白抗体(BD科学, 610153)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 s1). BMC Cancer (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 3
碧迪BDbeta连环蛋白抗体(BD-Bioscience, BD610154)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 3). elife (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:10,000; 图 s1
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫印迹在人类样本上浓度为1:10,000 (图 s1). J Cell Sci (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 4a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4a). Neoplasia (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 s10
  • 免疫印迹; 小鼠; 图 s7
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 s10) 和 被用于免疫印迹在小鼠样本上 (图 s7). Nature (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:500; 图 5
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 5). Acta Neuropathol (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 3
碧迪BDbeta连环蛋白抗体(BD transduction laboratories, 610154)被用于被用于免疫印迹在人类样本上 (图 3). Oncotarget (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 7
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 7). elife (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 0.33 mg/ml; 图 4
碧迪BDbeta连环蛋白抗体(Transduction Laboratories, 610154)被用于被用于免疫组化-石蜡切片在人类样本上浓度为0.33 mg/ml (图 4). Hum Reprod (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫沉淀; 人类; 图 3d
  • 免疫印迹; 人类; 图 2a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫沉淀在人类样本上 (图 3d) 和 被用于免疫印迹在人类样本上 (图 2a). Sci Rep (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:500; 图 2
  • 免疫印迹; 人类; 1:2500; 图 2
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫细胞化学在人类样本上浓度为1:500 (图 2) 和 被用于免疫印迹在人类样本上浓度为1:2500 (图 2). Nat Commun (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 4
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在人类样本上 (图 4). Oncogene (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 小鼠; 10 ug/ml; 图 2
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在小鼠样本上浓度为10 ug/ml (图 2). Fluids Barriers CNS (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:2000; 图 1
碧迪BDbeta连环蛋白抗体(bD Bioscience, 610154)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 1). Sci Rep (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 其他; 人类; 图 st1
碧迪BDbeta连环蛋白抗体(BD, 14)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 犬; 图 s8
  • 免疫印迹; 犬; 1:2000; 图 1
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在犬样本上 (图 s8) 和 被用于免疫印迹在犬样本上浓度为1:2000 (图 1). Nat Commun (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:500; 图 5
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫组化在小鼠样本上浓度为1:500 (图 5). J Cell Sci (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 4c
碧迪BDbeta连环蛋白抗体(BD Transduction Lab, 610154)被用于被用于免疫印迹在人类样本上 (图 4c). Sci Rep (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 1
碧迪BDbeta连环蛋白抗体(Transduction Laboratories, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 1). Stem Cell Reports (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:400; 图 2
  • 免疫印迹; 小鼠; 图 4
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化在小鼠样本上浓度为1:400 (图 2) 和 被用于免疫印迹在小鼠样本上 (图 4). Development (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 小鼠; 图 2
  • 免疫印迹; 小鼠; 图 2
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫细胞化学在小鼠样本上 (图 2) 和 被用于免疫印迹在小鼠样本上 (图 2). J Cell Biol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 小鼠; 1:100; 图 5
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 5). Mol Biol Cell (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 图 3
碧迪BDbeta连环蛋白抗体(BD Biosciences, BD610154)被用于被用于免疫印迹在小鼠样本上 (图 3). Nutr Res (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:1000; 图 3
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). J Cell Sci (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 大鼠; 500 ng/ml; 图 3
碧迪BDbeta连环蛋白抗体(BD Transduction Labs, 610154)被用于被用于免疫细胞化学在大鼠样本上浓度为500 ng/ml (图 3). Asian J Androl (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 小鼠; 1:100; 图 1d
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (图 1d). PLoS ONE (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 1B
  • 免疫印迹; 人类; 1:1000; 图 2A
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 1B) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2A). Mol Oncol (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:2000; 图 2
  • 免疫印迹; 人类; 1:1000; 图 6
  • 免疫细胞化学; 小鼠; 1:200; 图 s2
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在人类样本上浓度为1:2000 (图 2), 被用于免疫印迹在人类样本上浓度为1:1000 (图 6) 和 被用于免疫细胞化学在小鼠样本上浓度为1:200 (图 s2). Oncotarget (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 小鼠; 1:200; 图 6
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫细胞化学在小鼠样本上浓度为1:200 (图 6). Nat Commun (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:150; 图 7
碧迪BDbeta连环蛋白抗体(BD Biosciences, BD610154)被用于被用于免疫印迹在小鼠样本上浓度为1:150 (图 7). Am J Pathol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠
碧迪BDbeta连环蛋白抗体(BD-Transduction laboratories, 610153)被用于被用于免疫组化在小鼠样本上. Dev Biol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 染色质免疫沉淀 ; 小鼠; 图 5
  • 免疫细胞化学; 小鼠; 图 10
  • 免疫印迹; 小鼠; 图 3
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610154)被用于被用于染色质免疫沉淀 在小鼠样本上 (图 5), 被用于免疫细胞化学在小鼠样本上 (图 10) 和 被用于免疫印迹在小鼠样本上 (图 3). Nucleic Acids Res (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:400; 图 5
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:400 (图 5). Oncotarget (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 图 st1
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫组化-石蜡切片在人类样本上 (图 st1). PLoS ONE (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫细胞化学在人类样本上. J Cell Sci (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:1000; 图 s12c
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000 (图 s12c). Nat Med (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 s4
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 s4). Nat Commun (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 染色质免疫沉淀 ; 小鼠; 图 4f,g
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于染色质免疫沉淀 在小鼠样本上 (图 4f,g). Nature (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 6a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 6a). BMC Cancer (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在人类样本上. Cardiovasc Res (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化在小鼠样本上. J Neurosci (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 图 7
  • 免疫印迹; 人类; 图 6
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫细胞化学在人类样本上 (图 7) 和 被用于免疫印迹在人类样本上 (图 6). PLoS ONE (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 图 6
碧迪BDbeta连环蛋白抗体(BD biosciences, 610153)被用于被用于免疫印迹在小鼠样本上 (图 6). PLoS Genet (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 图 1a
碧迪BDbeta连环蛋白抗体(Becton, 14)被用于被用于免疫细胞化学在人类样本上 (图 1a). J Transl Med (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:200; 表 2
碧迪BDbeta连环蛋白抗体(BD Bioscience, 14)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (表 2). Hum Pathol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 1c
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫印迹在人类样本上 (图 1c). Leukemia (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 3
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 3). Sci Rep (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:400; 图 3
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫印迹在人类样本上浓度为1:400 (图 3). PLoS ONE (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:100
碧迪BDbeta连环蛋白抗体(Becton Dickinson, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:100. Dev Biol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 图 5
碧迪BDbeta连环蛋白抗体(Transduction Laboratories, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5). Invest Ophthalmol Vis Sci (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 图 6
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610154)被用于被用于免疫印迹在小鼠样本上 (图 6). PLoS ONE (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:500; 图 s2
碧迪BDbeta连环蛋白抗体(BD Pharmingen, 14)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 s2). Appl Immunohistochem Mol Morphol (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫组化在小鼠样本上. Dis Model Mech (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫印迹在人类样本上. Oncogene (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 4
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫印迹在人类样本上 (图 4). J Cell Biol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD Transduction laboratories, 610154)被用于被用于免疫印迹在人类样本上. BMC Cancer (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 2
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在人类样本上 (图 2). J Biol Chem (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1). J Clin Endocrinol Metab (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 大鼠
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫细胞化学在大鼠样本上. Am J Physiol Lung Cell Mol Physiol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 小鼠; 1:100
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100. Cell Signal (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:1000; 图 5c
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5c). PLoS ONE (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 尼罗河罗非鱼
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫组化-石蜡切片在尼罗河罗非鱼样本上. Int Wound J (2016) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:2000; 图 1c
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 1c). Sci Signal (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:150; 图 2
碧迪BDbeta连环蛋白抗体(BDTransduction实验室, 610153)被用于被用于免疫细胞化学在人类样本上浓度为1:150 (图 2). Int J Oncol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD-Transduction Laboratories, 610153)被用于被用于免疫印迹在人类样本上. Mol Cell Biol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:200
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫细胞化学在人类样本上浓度为1:200. Front Cell Dev Biol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 人类; 图 3
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫组化在人类样本上 (图 3). Nat Cell Biol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:500; 图 3
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 3). Nature (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:20; 图 8
  • 免疫印迹; 小鼠; 1:1000; 图 8
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:20 (图 8) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 8). PLoS ONE (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; pigs ; 1:200
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫细胞化学在pigs 样本上浓度为1:200. Tissue Eng Part C Methods (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 人类; 1:100
碧迪BDbeta连环蛋白抗体(BD, 14/Beta-Catenin)被用于被用于免疫组化在人类样本上浓度为1:100. Gynecol Oncol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 染色质免疫沉淀 ; 人类; 图 s6
碧迪BDbeta连环蛋白抗体(BD transduction, 610153)被用于被用于染色质免疫沉淀 在人类样本上 (图 s6). Sci Signal (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 人类
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610154)被用于被用于免疫组化在人类样本上. J Invest Dermatol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠
碧迪BDbeta连环蛋白抗体(BD Bioscience, 14/Beta-Catenin)被用于被用于免疫印迹在小鼠样本上. Neoplasia (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 s1
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫印迹在人类样本上 (图 s1). FEBS Lett (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 4
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 其他; 人类; 图 3a
  • 免疫沉淀; 人类; 图 7b
  • 免疫印迹; 人类; 图 4a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 14)被用于被用于其他在人类样本上 (图 3a), 被用于免疫沉淀在人类样本上 (图 7b) 和 被用于免疫印迹在人类样本上 (图 4a). Mol Cell Proteomics (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:200; 图 4
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 4). Dis Model Mech (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:2000
  • 免疫印迹; 人类; 1:2000
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫细胞化学在人类样本上浓度为1:2000 和 被用于免疫印迹在人类样本上浓度为1:2000. PLoS ONE (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:500; 图 s2d
碧迪BDbeta连环蛋白抗体(BD Biosciences, 14/beta-catenin)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 s2d). Nat Med (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫印迹在小鼠样本上. Dev Biol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上. Nat Med (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 1
碧迪BDbeta连环蛋白抗体(BD Pharmigen, 610154)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 1). Mod Pathol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:200
  • 染色质免疫沉淀 ; 人类
碧迪BDbeta连环蛋白抗体(BD Bioscience, 14)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 和 被用于染色质免疫沉淀 在人类样本上. elife (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 人类; 1:400
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫组化在人类样本上浓度为1:400. Br J Cancer (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 大鼠; 1:800
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫印迹在大鼠样本上浓度为1:800. Mol Neurobiol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:1000
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫印迹在人类样本上浓度为1:1000. J Cell Physiol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类; 1:100
碧迪BDbeta连环蛋白抗体(Beckton Dickinson, 14)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Cancer Med (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:200
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化在小鼠样本上浓度为1:200. Mol Vis (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 3c
碧迪BDbeta连环蛋白抗体(BD Pharmingen, 610153)被用于被用于免疫印迹在人类样本上 (图 3c). FASEB J (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在人类样本上. Mol Med Rep (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:2000; 图 5a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 5a). J Cell Mol Med (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫组化-石蜡切片在人类样本上. J Cutan Pathol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:500
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610153)被用于被用于免疫印迹在人类样本上浓度为1:500. Mol Carcinog (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫印迹在人类样本上. Cell Death Differ (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠
碧迪BDbeta连环蛋白抗体(BD transduction laboratories, ARH03610154)被用于被用于免疫组化在小鼠样本上. Biol Open (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类
碧迪BDbeta连环蛋白抗体(BD Transduction, 610153)被用于被用于免疫细胞化学在人类样本上. Cancer Res (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-冰冻切片; 小鼠; 1:100
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100. Am J Pathol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 人类; 1:2500; 图 s3
碧迪BDbeta连环蛋白抗体(BD Pharmingen, 610153)被用于被用于免疫组化在人类样本上浓度为1:2500 (图 s3). Cancer Res (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:100; 图 3
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 3). Int J Biochem Cell Biol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫细胞化学在人类样本上. J Invest Dermatol (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫组化在小鼠样本上. Cancer Res (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 犬; 图 1
碧迪BDbeta连环蛋白抗体(BD Biosciences, 14)被用于被用于免疫印迹在犬样本上 (图 1). Am J Vet Res (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在人类样本上. J Neurosci (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在人类样本上. Carcinogenesis (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上. PLoS Genet (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:1000
碧迪BDbeta连环蛋白抗体(Transduction Laboratories, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000. Am J Physiol Gastrointest Liver Physiol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 1:1000
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫印迹在人类样本上浓度为1:1000. PLoS ONE (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫沉淀; 小鼠
  • 免疫组化; 小鼠
  • 免疫印迹; 小鼠
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫沉淀在小鼠样本上, 被用于免疫组化在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Mol Psychiatry (2015) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-冰冻切片; 小鼠; 1:500
  • 免疫印迹; 小鼠; 1:500
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:500 和 被用于免疫印迹在小鼠样本上浓度为1:500. Development (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:2000; 图 3a
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 3a). Eur J Neurosci (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-自由浮动切片; 猕猴; 1:500
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-自由浮动切片在猕猴样本上浓度为1:500. J Comp Neurol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类
碧迪BDbeta连环蛋白抗体(Millipore, 610153)被用于被用于免疫组化-石蜡切片在人类样本上. Arch Toxicol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 染色质免疫沉淀 ; 小鼠; 5 ug/time
碧迪BDbeta连环蛋白抗体(BD Transduction, 610154)被用于被用于染色质免疫沉淀 在小鼠样本上浓度为5 ug/time. Mol Cell Biol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫沉淀; 人类; 图 st13
  • 免疫细胞化学; 人类; 1:200; 图 st13
  • 免疫印迹; 人类; 1:1000; 图 st13
碧迪BDbeta连环蛋白抗体(BD, 610154)被用于被用于免疫沉淀在人类样本上 (图 st13), 被用于免疫细胞化学在人类样本上浓度为1:200 (图 st13) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 st13). Nat Cell Biol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 人类
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-石蜡切片在人类样本上. Neuro Oncol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫沉淀; 人类; 1:2000; 图 3g
碧迪BDbeta连环蛋白抗体(BD Transduction lab, 610154)被用于被用于免疫沉淀在人类样本上浓度为1:2000 (图 3g). Nat Cell Biol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 小鼠
碧迪BDbeta连环蛋白抗体(BD, 610153)被用于被用于免疫细胞化学在小鼠样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. J Am Soc Nephrol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:1000
碧迪BDbeta连环蛋白抗体(BD Transduction, 610154)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:1000. Cell Stem Cell (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 染色质免疫沉淀 ; 人类
  • 免疫印迹; 人类; 1:1000
碧迪BDbeta连环蛋白抗体(BD Transduction, 610154)被用于被用于染色质免疫沉淀 在人类样本上 和 被用于免疫印迹在人类样本上浓度为1:1000. Biochem Biophys Res Commun (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 大鼠
碧迪BDbeta连环蛋白抗体(BD Transduction Labs, 14)被用于被用于免疫组化在大鼠样本上. Dev Biol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-冰冻切片; 小鼠
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610154)被用于被用于免疫组化-冰冻切片在小鼠样本上. Mol Cell Biol (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类
  • 免疫印迹; 人类
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在人类样本上 和 被用于免疫印迹在人类样本上. Cell Signal (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫细胞化学在人类样本上. Carcinogenesis (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:8000; 图 3
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:8000 (图 3). PLoS ONE (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 染色质免疫沉淀 ; 小鼠
  • 免疫印迹; 小鼠
碧迪BDbeta连环蛋白抗体(BD Pharmingen, 610153)被用于被用于染色质免疫沉淀 在小鼠样本上 和 被用于免疫印迹在小鼠样本上. Oncogene (2014) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:500
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500. Am J Physiol Gastrointest Liver Physiol (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 犬; 1:200
碧迪BDbeta连环蛋白抗体(BD Transduction Lab, 610154)被用于被用于免疫细胞化学在犬样本上浓度为1:200. PLoS ONE (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫印迹在小鼠样本上. Cytoskeleton (Hoboken) (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫沉淀; 人类; 2 ug/time
  • 免疫印迹; 人类; 1:2000; 图 7a
碧迪BDbeta连环蛋白抗体(BD Bioscience, 14/beta-catenin)被用于被用于免疫沉淀在人类样本上浓度为2 ug/time 和 被用于免疫印迹在人类样本上浓度为1:2000 (图 7a). Endocr Relat Cancer (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠; 1:200
  • 免疫印迹; 小鼠; 1:1000
碧迪BDbeta连环蛋白抗体(BD Pharmingen, 610153)被用于被用于免疫组化在小鼠样本上浓度为1:200 和 被用于免疫印迹在小鼠样本上浓度为1:1000. J Neurosci (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 大鼠
碧迪BDbeta连环蛋白抗体(BD Transduction Labs, 14)被用于被用于免疫印迹在大鼠样本上. Invest Ophthalmol Vis Sci (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 大鼠; 1:1000
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610154)被用于被用于免疫组化-石蜡切片在大鼠样本上浓度为1:1000. BMC Cancer (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化; 小鼠
  • 免疫印迹; 小鼠
  • 免疫印迹; 人类; 图 1
碧迪BDbeta连环蛋白抗体(BD Bioscience, 610153)被用于被用于免疫组化在小鼠样本上, 被用于免疫印迹在小鼠样本上 和 被用于免疫印迹在人类样本上 (图 1). Mol Cancer Res (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-石蜡切片; 小鼠; 1:100
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100. Nat Genet (2013) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫细胞化学; 人类; 1:500; 图 3
碧迪BDbeta连环蛋白抗体(BD Bioscience, 14)被用于被用于免疫细胞化学在人类样本上浓度为1:500 (图 3). J Neurosci (2012) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:1000
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610 154)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Nucleic Acids Res (2012) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫印迹在小鼠样本上. Mol Cell Biol (2012) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 图 3
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610154)被用于被用于免疫印迹在小鼠样本上 (图 3). PLoS ONE (2012) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 犬; 0.08 ug/ml; 图 1
  • 免疫组化; 小鼠; 0.8 ug/ml; 图 2i
碧迪BDbeta连环蛋白抗体(BD Biosciences, 14/beta-catenin)被用于被用于免疫印迹在犬样本上浓度为0.08 ug/ml (图 1) 和 被用于免疫组化在小鼠样本上浓度为0.8 ug/ml (图 2i). Am J Vet Res (2011) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 小鼠; 1:2000; 图 6a
碧迪BDbeta连环蛋白抗体(Pharmingen, 14)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 6a). Dev Cell (2010) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫印迹; 人类; 图 3
碧迪BDbeta连环蛋白抗体(BD Transduction Laboratories, 610153)被用于被用于免疫印迹在人类样本上 (图 3). Cancer Lett (2010) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化基因敲除验证; 小鼠; 1:100; 图 3d
碧迪BDbeta连环蛋白抗体(Millipore, 05-665)被用于被用于免疫组化基因敲除验证在小鼠样本上浓度为1:100 (图 3d). Invest Ophthalmol Vis Sci (2009) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-冰冻切片; 小鼠; 1:100
碧迪BDbeta连环蛋白抗体(BD, 14)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100. Development (2007) ncbi
小鼠 单克隆(14/Beta-Catenin)
  • 免疫组化-冰冻切片; 小鼠; 1:100
  • 免疫印迹; 小鼠; 1:1000
碧迪BDbeta连环蛋白抗体(BD Biosciences, 610153)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 和 被用于免疫印迹在小鼠样本上浓度为1:1000. J Comp Neurol (2006) ncbi
徕卡显微系统(上海)贸易有限公司
单克隆(17C2)
  • 免疫组化-石蜡切片; 人类; 图 1a
徕卡显微系统(上海)贸易有限公司beta连环蛋白抗体(Leica, 17C2)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1a). J Thorac Oncol (2016) ncbi
单克隆(17C2)
  • 免疫组化-石蜡切片; 人类; 1:20
徕卡显微系统(上海)贸易有限公司beta连环蛋白抗体(Novocastra, 17C2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:20. Stem Cells Int (2016) ncbi
单克隆(17C2)
  • 免疫组化-石蜡切片; 人类; 1:40
徕卡显微系统(上海)贸易有限公司beta连环蛋白抗体(Novocastra, 17C2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:40. J Pathol (2016) ncbi
单克隆(17C2)
  • 免疫组化-石蜡切片; 人类
徕卡显微系统(上海)贸易有限公司beta连环蛋白抗体(Novacastra, 17C2)被用于被用于免疫组化-石蜡切片在人类样本上. Indian J Pathol Microbiol (2015) ncbi
单克隆(17C2)
  • 免疫组化-石蜡切片; 人类
徕卡显微系统(上海)贸易有限公司beta连环蛋白抗体(Novocastra, clone 17C2)被用于被用于免疫组化-石蜡切片在人类样本上. Clin Epigenetics (2015) ncbi
单克隆(17C2)
  • 免疫组化; 人类; 1:100; 图 2
徕卡显微系统(上海)贸易有限公司beta连环蛋白抗体(Novocastra, 17C2)被用于被用于免疫组化在人类样本上浓度为1:100 (图 2). Int J Gynecol Pathol (2015) ncbi
单克隆(17C2)
  • 免疫组化; 人类; 1:100
徕卡显微系统(上海)贸易有限公司beta连环蛋白抗体(Novocastra, 17C2)被用于被用于免疫组化在人类样本上浓度为1:100. Pathol Res Pract (2014) ncbi
文章列表
  1. Matos I, Asare A, Levorse J, Ouspenskaia T, de la Cruz Racelis J, Schuhmacher L, et al. Progenitors oppositely polarize WNT activators and inhibitors to orchestrate tissue development. elife. 2020;9: pubmed 出版商
  2. Singh S, Adam M, Matkar P, Bugyei Twum A, Desjardins J, Chen H, et al. Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis. Sci Rep. 2020;10:4466 pubmed 出版商
  3. Rübben A, Wahl R, Eggermann T, Dahl E, Ortiz Brüchle N, Cacchi C. Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype. PLoS ONE. 2020;15:e0230003 pubmed 出版商
  4. Kim K, Shin W, Kang M, Lee S, Kim D, Kang R, et al. Presynaptic PTPσ regulates postsynaptic NMDA receptor function through direct adhesion-independent mechanisms. elife. 2020;9: pubmed 出版商
  5. Marchetti M, Meloni M, Anwar M, Zen A, Sala Newby G, Slater S, et al. MicroRNA-24-3p Targets Notch and Other Vascular Morphogens to Regulate Post-ischemic Microvascular Responses in Limb Muscles. Int J Mol Sci. 2020;21: pubmed 出版商
  6. Chen Z, Zhang J, Xue H, Qian M, Guo X, Gao X, et al. Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition. Integr Cancer Ther. 2020;19:1534735419900927 pubmed 出版商
  7. Wang S, Qi Y, Gao X, Qiu W, Liu Q, Guo X, et al. Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma. Cell Death Dis. 2020;11:168 pubmed 出版商
  8. Du X, He W, He H, Wang H. Beta-catenin inhibits bovine parainfluenza virus type 3 replication via innate immunity pathway. BMC Vet Res. 2020;16:72 pubmed 出版商
  9. Kasacka I, Piotrowska Z, Niezgoda M, Lewandowska A, Łebkowski W. Ageing-related changes in the levels of β-catenin, CacyBP/SIP, galectin-3 and immunoproteasome subunit LMP7 in the heart of men. PLoS ONE. 2020;15:e0229462 pubmed 出版商
  10. Padthaisong S, Thanee M, Namwat N, Phetcharaburanin J, Klanrit P, Khuntikeo N, et al. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. BMC Cancer. 2020;20:154 pubmed 出版商
  11. Tian S, Peng P, Li J, Deng H, Zhan N, Zeng Z, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway. Aging (Albany NY). 2020;12:3574-3593 pubmed 出版商
  12. Chandrasekaran B, Dahiya N, Tyagi A, Kolluru V, Saran U, Baby B, et al. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23 pubmed 出版商
  13. Eom T, Han S, Kim J, Blundon J, Wang Y, Yu J, et al. Schizophrenia-related microdeletion causes defective ciliary motility and brain ventricle enlargement via microRNA-dependent mechanisms in mice. Nat Commun. 2020;11:912 pubmed 出版商
  14. Ear J, Saklecha A, Rajapakse N, Choi J, Ghassemian M, Kufareva I, et al. Tyrosine-Based Signals Regulate the Assembly of Daple⋅PARD3 Complex at Cell-Cell Junctions. iScience. 2020;23:100859 pubmed 出版商
  15. Rinastiti P, Ikeda K, Rahardini E, Miyagawa K, Tamada N, Kuribayashi Y, et al. Loss of family with sequence similarity 13, member A exacerbates pulmonary hypertension through accelerating endothelial-to-mesenchymal transition. PLoS ONE. 2020;15:e0226049 pubmed 出版商
  16. Kjell J, Fischer Sternjak J, Thompson A, Friess C, Sticco M, Salinas F, et al. Defining the Adult Neural Stem Cell Niche Proteome Identifies Key Regulators of Adult Neurogenesis. Cell Stem Cell. 2020;26:277-293.e8 pubmed 出版商
  17. Tan S, Swathi Y, Tan S, Goh J, Seishima R, Murakami K, et al. AQP5 enriches for stem cells and cancer origins in the distal stomach. Nature. 2020;578:437-443 pubmed 出版商
  18. You F, Li J, Zhang P, Zhang H, Cao X. miR106a Promotes the Growth of Transplanted Breast Cancer and Decreases the Sensitivity of Transplanted Tumors to Cisplatin. Cancer Manag Res. 2020;12:233-246 pubmed 出版商
  19. Lin L, Li Y, Liu M, Li Q, Liu Q, Li R. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation. Aging (Albany NY). 2020;12:1685-1703 pubmed 出版商
  20. Mei X, Qi D, Zhang T, Zhao Y, Jin L, Hou J, et al. Inhibiting MARSs reduces hyperhomocysteinemia-associated neural tube and congenital heart defects. EMBO Mol Med. 2020;12:e9469 pubmed 出版商
  21. Ju L, Shan L, Yin B, Song Y. δ-Catenin regulates proliferation and apoptosis in renal cell carcinoma via promoting β-catenin nuclear localization and activating its downstream target genes. Cancer Med. 2020;9:2201-2212 pubmed 出版商
  22. McGinn O, Ward A, Fettig L, Riley D, Ivie J, Paul K, et al. Cytokeratin 5 alters β-catenin dynamics in breast cancer cells. Oncogene. 2020;39:2478-2492 pubmed 出版商
  23. Zhu K, Lai Y, Cao H, Bai X, Liu C, Yan Q, et al. Kindlin-2 modulates MafA and β-catenin expression to regulate β-cell function and mass in mice. Nat Commun. 2020;11:484 pubmed 出版商
  24. Liao S, Chen H, Liu M, Gan L, Li C, Zhang W, et al. Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway. Aging (Albany NY). 2020;12:1527-1544 pubmed 出版商
  25. Deng M, Chen Z, Tan J, Liu H. Down-regulation of SLC35C1 induces colon cancer through over-activating Wnt pathway. J Cell Mol Med. 2020;24:3079-3090 pubmed 出版商
  26. Fine J, Kosyakovsky J, Baillargeon A, Tokarev J, Cooner J, Svitak A, et al. Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement. Brain Behav. 2020;10:e01536 pubmed 出版商
  27. Zhou L, Shao C, Xie Y, Wang N, Xu S, Luo B, et al. Gab1 mediates PDGF signaling and is essential to oligodendrocyte differentiation and CNS myelination. elife. 2020;9: pubmed 出版商
  28. Boukhalfa A, Nascimbeni A, Ramel D, Dupont N, Hirsch E, Gayral S, et al. PI3KC2α-dependent and VPS34-independent generation of PI3P controls primary cilium-mediated autophagy in response to shear stress. Nat Commun. 2020;11:294 pubmed 出版商
  29. Chang L, Kim M, Glinka A, Reinhard C, Niehrs C. The tumor suppressor PTPRK promotes ZNRF3 internalization and is required for Wnt inhibition in the Spemann organizer. elife. 2020;9: pubmed 出版商
  30. Chen M, Lu P, Ma Q, Cao Y, Chen N, Li W, et al. CTNNB1/β-catenin dysfunction contributes to adiposity by regulating the cross-talk of mature adipocytes and preadipocytes. Sci Adv. 2020;6:eaax9605 pubmed 出版商
  31. Hsu H, Liu C, Lin J, Hsu T, Hsu J, Li A, et al. Involvement of collagen XVII in pluripotency gene expression and metabolic reprogramming of lung cancer stem cells. J Biomed Sci. 2020;27:5 pubmed 出版商
  32. Wang F, Duan X, Chen J, Gao Z, Zhou J, Wu X, et al. Integrated Imaging Methodology Detects Claudin-1 Expression in Premalignant Nonpolypoid and Polypoid Colonic Epithelium in Mice. Clin Transl Gastroenterol. 2020;11:e00089 pubmed 出版商
  33. Jiang M, Kang Y, Sewastianik T, Wang J, Tanton H, Alder K, et al. BCL9 provides multi-cellular communication properties in colorectal cancer by interacting with paraspeckle proteins. Nat Commun. 2020;11:19 pubmed 出版商
  34. Dos Santos Carvalho S, Moreau M, Hien Y, Garcia M, Aubailly N, Henderson D, et al. Vangl2 acts at the interface between actin and N-cadherin to modulate mammalian neuronal outgrowth. elife. 2020;9: pubmed 出版商
  35. Xing T, Benderman L, Sabu S, Parker J, Yang J, Lu Q, et al. Tight Junction Protein Claudin-7 Is Essential for Intestinal Epithelial Stem Cell Self-Renewal and Differentiation. Cell Mol Gastroenterol Hepatol. 2020;9:641-659 pubmed 出版商
  36. Wang H, Chen Z, Wang S, Gao X, Qian M, Qiu W, et al. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas. Mol Oncol. 2020;14:407-425 pubmed 出版商
  37. Luo C, Wang Y, Wei C, Chen Y, Ji Z. The anti-migration and anti-invasion effects of Bruceine D in human triple-negative breast cancer MDA-MB-231 cells. Exp Ther Med. 2020;19:273-279 pubmed 出版商
  38. Li K, Zhang J, Tian Y, He Y, Xu X, Pan W, et al. The Wnt/β-catenin/VASP positive feedback loop drives cell proliferation and migration in breast cancer. Oncogene. 2019;: pubmed 出版商
  39. Yang X, Jiang J, Zhang C, Li Y. Baicalein restrains proliferation, migration, and invasion of human malignant melanoma cells by down-regulating colon cancer associated transcript-1. Braz J Med Biol Res. 2019;52:e8934 pubmed 出版商
  40. Xuan F, Yano F, Mori D, Chijimatsu R, Maenohara Y, Nakamoto H, et al. Wnt/β-catenin signaling contributes to articular cartilage homeostasis through lubricin induction in the superficial zone. Arthritis Res Ther. 2019;21:247 pubmed 出版商
  41. Wang Y, Chiang I, Ohara T, Fujii S, Cheng J, Muegge B, et al. Long-Term Culture Captures Injury-Repair Cycles of Colonic Stem Cells. Cell. 2019;179:1144-1159.e15 pubmed 出版商
  42. Chen X, Xiong X, Cui D, Yang F, Wei D, Li H, et al. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 2020;39:1557-1571 pubmed 出版商
  43. Hu Y, Zhao Y, Shi C, Ren P, Wei B, Guo Y, et al. A circular RNA from APC inhibits the proliferation of diffuse large B-cell lymphoma by inactivating Wnt/β-catenin signaling via interacting with TET1 and miR-888. Aging (Albany NY). 2019;11:8068-8084 pubmed 出版商
  44. Guo H, Li Y, Shen L, Wang T, Jia X, Liu L, et al. Disruptive variants of CSDE1 associate with autism and interfere with neuronal development and synaptic transmission. Sci Adv. 2019;5:eaax2166 pubmed 出版商
  45. Deng Q, Li P, Che M, Liu J, Biswas S, Ma G, et al. Activation of hedgehog signaling in mesenchymal stem cells induces cartilage and bone tumor formation via Wnt/β-Catenin. elife. 2019;8: pubmed 出版商
  46. Diaz Osterman C, Ozmadenci D, Kleinschmidt E, Taylor K, Barrie A, Jiang S, et al. FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy. elife. 2019;8: pubmed 出版商
  47. Wei C, Zhu M, Zhang P, Yang X, Wang L, Ying J, et al. Elevated kindlin-2 promotes tumour progression and angiogenesis through the mTOR/VEGFA pathway in melanoma. Aging (Albany NY). 2019;11:6273-6285 pubmed 出版商
  48. Dumortier J, Le Verge Serandour M, Tortorelli A, Mielke A, de Plater L, Turlier H, et al. Hydraulic fracturing and active coarsening position the lumen of the mouse blastocyst. Science. 2019;365:465-468 pubmed 出版商
  49. van de Vlekkert D, Demmers J, Nguyen X, Campos Y, Machado E, Annunziata I, et al. Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis. Sci Adv. 2019;5:eaav3270 pubmed 出版商
  50. Petersen C, Mahmood B, Badsted C, Dahlby T, Rasmussen H, Hansen M, et al. Possible predisposition for colorectal carcinogenesis due to altered gene expressions in normal appearing mucosa from patients with colorectal neoplasia. BMC Cancer. 2019;19:643 pubmed 出版商
  51. Chen J, Huang W, Bamodu O, Chang P, Chao T, Huang T. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo. BMC Cancer. 2019;19:634 pubmed 出版商
  52. Parolia A, Cieslik M, Chu S, Xiao L, Ouchi T, Zhang Y, et al. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer. Nature. 2019;: pubmed 出版商
  53. Chaves Pérez A, Yilmaz M, Perna C, de la Rosa S, Djouder N. URI is required to maintain intestinal architecture during ionizing radiation. Science. 2019;364: pubmed 出版商
  54. Choi J, Zhong X, McAlpine W, Liao T, Zhang D, Fang B, et al. LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. Science. 2019;364: pubmed 出版商
  55. Shang Z, Zhao J, Zhang Q, Cao C, Tian S, Zhang K, et al. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis. J Biol Chem. 2019;294:9844-9857 pubmed 出版商
  56. Kim E, Lisby A, Ma C, Lo N, Ehmer U, Hayer K, et al. Promotion of growth factor signaling as a critical function of β-catenin during HCC progression. Nat Commun. 2019;10:1909 pubmed 出版商
  57. Tang L, Wen J, Wen P, Li X, Gong M, Li Q. Long non-coding RNA LINC01314 represses cell migration, invasion, and angiogenesis in gastric cancer via the Wnt/β-catenin signaling pathway by down-regulating KLK4. Cancer Cell Int. 2019;19:94 pubmed 出版商
  58. Nakanishi M, Mitchell R, Benoit Y, Orlando L, Reid J, Shimada K, et al. Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Cell. 2019;177:910-924.e22 pubmed 出版商
  59. Montalbán Loro R, Lozano Ureña A, Ito M, Krueger C, Reik W, Ferguson Smith A, et al. TET3 prevents terminal differentiation of adult NSCs by a non-catalytic action at Snrpn. Nat Commun. 2019;10:1726 pubmed 出版商
  60. Gong L, Xiao Y, Xia F, Wu P, Zhao T, Xie S, et al. The mevalonate coordinates energy input and cell proliferation. Cell Death Dis. 2019;10:327 pubmed 出版商
  61. Li Y, Lu Y, Chen Y. Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p. Biosci Rep. 2019;39: pubmed 出版商
  62. Fearnley G, Young K, Edgar J, Antrobus R, Hay I, Liang W, et al. The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion. elife. 2019;8: pubmed 出版商
  63. Huang K, Ru B, Zhang Y, Chan W, Chow S, Zhang J, et al. Sertoli cell-specific coxsackievirus and adenovirus receptor knockout regulates cell adhesion and gene transcription via β-catenin inactivation and Cdc42 activation. FASEB J. 2019;33:7588-7602 pubmed 出版商
  64. Wei X, Guo J, Li Q, Jia Q, Jing Q, Li Y, et al. Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells. Sci Adv. 2019;5:eaau7887 pubmed 出版商
  65. Borhani S, Corciulo C, Larrañaga Vera A, Cronstein B. Adenosine A2A receptor (A2AR) activation triggers Akt signaling and enhances nuclear localization of β-catenin in osteoblasts. FASEB J. 2019;33:7555-7562 pubmed 出版商
  66. Storti F, Klee K, Todorova V, Steiner R, Othman A, van der Velde Visser S, et al. Impaired ABCA1/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration. elife. 2019;8: pubmed 出版商
  67. Johansson J, Nászai M, Hodder M, Pickering K, Miller B, Ridgway R, et al. RAL GTPases Drive Intestinal Stem Cell Function and Regeneration through Internalization of WNT Signalosomes. Cell Stem Cell. 2019;24:592-607.e7 pubmed 出版商
  68. Massey J, Liu Y, Alvarenga O, Saez T, Schmerer M, Warmflash A. Synergy with TGFβ ligands switches WNT pathway dynamics from transient to sustained during human pluripotent cell differentiation. Proc Natl Acad Sci U S A. 2019;116:4989-4998 pubmed 出版商
  69. Zhang X, Qin Q, Dai H, Cai S, Zhou C, Guan J. Emodin protects H9c2 cells from hypoxia-induced injury by up-regulating miR-138 expression. Braz J Med Biol Res. 2019;52:e7994 pubmed 出版商
  70. Cao J, Zhao M, Liu J, Zhang X, Pei Y, Wang J, et al. RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog. Theranostics. 2019;9:811-828 pubmed 出版商
  71. Majumdar T, Sharma S, Kumar M, Hussain M, Chauhan N, Kalia I, et al. Tryptophan-kynurenine pathway attenuates β-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in Toxoplasma gondii infection. Cell Death Dis. 2019;10:161 pubmed 出版商
  72. Zhou L, Chen X, Lu M, Wu Q, Yuan Q, Hu C, et al. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria. Kidney Int. 2019;95:830-845 pubmed 出版商
  73. Birgisdottir A, Mouilleron S, Bhujabal Z, Wirth M, Sjøttem E, Evjen G, et al. Members of the autophagy class III phosphatidylinositol 3-kinase complex I interact with GABARAP and GABARAPL1 via LIR motifs. Autophagy. 2019;15:1333-1355 pubmed 出版商
  74. Paul D, Islam S, Manne R, Dinesh U, Malonia S, Maity B, et al. F-box protein FBXO16 functions as a tumor suppressor by attenuating nuclear β-catenin function. J Pathol. 2019;248:266-279 pubmed 出版商
  75. Hwang W, Lan H, Cheng W, Huang S, Yang M. Tumor stem-like cell-derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer. J Hematol Oncol. 2019;12:10 pubmed 出版商
  76. Hwang J, Kim A, Kim K, Il Park J, Oh H, Moon S, et al. TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression. Nat Commun. 2019;10:421 pubmed 出版商
  77. Bishnupuri K, Alvarado D, Khouri A, Shabsovich M, Chen B, Dieckgraefe B, et al. IDO1 and kynurenine pathway metabolites activate PI3K-Akt signaling in the neoplastic colon epithelium to promote cancer cell proliferation and inhibit apoptosis. Cancer Res. 2019;: pubmed 出版商
  78. Shen B, Vardy K, Hughes P, Tasdogan A, Zhao Z, Yue R, et al. Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass. elife. 2019;8: pubmed 出版商
  79. Weng J, Yu L, Chen Z, Su H, Yu S, Zhang Y, et al. β-Catenin phosphorylation at Y654 and Y142 is crucial for high mobility group box-1 protein-induced pulmonary vascular hyperpermeability. J Mol Cell Cardiol. 2019;127:174-184 pubmed 出版商
  80. Yang F, Fang E, Mei H, Chen Y, Li H, Li D, et al. Cis-Acting circ-CTNNB1 Promotes β-Catenin Signaling and Cancer Progression via DDX3-Mediated Transactivation of YY1. Cancer Res. 2019;79:557-571 pubmed 出版商
  81. Peng J, Liang S, Li L. sFRP1 exerts effects on gastric cancer cells through GSK3β/Rac1‑mediated restraint of TGFβ/Smad3 signaling. Oncol Rep. 2019;41:224-234 pubmed 出版商
  82. Xu H, Li J, Chen H, Ghishan F. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells. Cell Mol Gastroenterol Hepatol. 2019;7:19-31 pubmed 出版商
  83. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed 出版商
  84. Koren E, Yosefzon Y, Ankawa R, Soteriou D, Jacob A, Nevelsky A, et al. ARTS mediates apoptosis and regeneration of the intestinal stem cell niche. Nat Commun. 2018;9:4582 pubmed 出版商
  85. Wang H, Deng G, Ai M, Xu Z, Mou T, Yu J, et al. Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt/β-catenin signaling pathways in gastric cancer progression. Oncogene. 2019;38:1489-1507 pubmed 出版商
  86. Mangolini M, Götte F, Moore A, Ammon T, Oelsner M, Lutzny Geier G, et al. Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia. Nat Commun. 2018;9:3839 pubmed 出版商
  87. Yang J, Sun L, Fan X, Yin B, Kang Y, Tang L, et al. Effect of exercise on bone in poorly controlled type 1 diabetes mediated by the ActRIIB/Smad signaling pathway. Exp Ther Med. 2018;16:3686-3693 pubmed 出版商
  88. Russell J, Lu W, Okabe H, Abrams M, Oertel M, Poddar M, et al. Hepatocyte-Specific β-Catenin Deletion During Severe Liver Injury Provokes Cholangiocytes to Differentiate Into Hepatocytes. Hepatology. 2019;69:742-759 pubmed 出版商
  89. Ji L, Lu B, Wang Z, Yang Z, Reece Hoyes J, Russ C, et al. Identification of ICAT as an APC Inhibitor, Revealing Wnt-Dependent Inhibition of APC-Axin Interaction. Mol Cell. 2018;72:37-47.e4 pubmed 出版商
  90. Zhou L, Jing J, Wang H, Wu X, Lu Z. Decorin promotes proliferation and migration of ORS keratinocytes and maintains hair anagen in mice. Exp Dermatol. 2018;27:1237-1244 pubmed 出版商
  91. Phakdeedindan P, Setthawong P, Tiptanavattana N, Rungarunlert S, Ingrungruanglert P, Israsena N, et al. Rabbit induced pluripotent stem cells retain capability of in vitro cardiac differentiation. Exp Anim. 2019;68:35-47 pubmed 出版商
  92. Qiu C, Liu Z, Hou K, Liu S, Hu Y, Zhang L, et al. Wip1 knockout inhibits neurogenesis by affecting the Wnt/β-catenin signaling pathway in focal cerebral ischemia in mice. Exp Neurol. 2018;309:44-53 pubmed 出版商
  93. Wang L, Chai Y, Li C, Liu H, Su W, Liu X, et al. Oxidized phospholipids are ligands for LRP6. Bone Res. 2018;6:22 pubmed 出版商
  94. Pan B, Wu L, Pan L, Yang Y, Li H, Dai Y, et al. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway. Biosci Rep. 2018;38: pubmed 出版商
  95. Hsu J, Xia W, Hsu Y, Chan L, Yu W, Cha J, et al. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018;9:1908 pubmed 出版商
  96. Suzuki S, Tanaka A, Nakamura H, Murayama T. Knockout of Ceramide Kinase Aggravates Pathological and Lethal Responses in Mice with Experimental Colitis. Biol Pharm Bull. 2018;41:797-805 pubmed 出版商
  97. Hoefert J, Bjerke G, Wang D, Yi R. The microRNA-200 family coordinately regulates cell adhesion and proliferation in hair morphogenesis. J Cell Biol. 2018;217:2185-2204 pubmed 出版商
  98. Zhang Y, Xia F, Liu X, Yu Z, Xie L, Liu L, et al. JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/?-catenin/CCND1 signaling. J Clin Invest. 2018;128:1737-1751 pubmed 出版商
  99. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  100. Qin L, Ma K, Wang Z, Hu Z, Matas E, Wei J, et al. Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition. Nat Neurosci. 2018;21:564-575 pubmed 出版商
  101. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed 出版商
  102. Sarikhani M, Mishra S, Maity S, Kotyada C, Wolfgeher D, Gupta M, et al. SIRT2 deacetylase regulates the activity of GSK3 isoforms independent of inhibitory phosphorylation. elife. 2018;7: pubmed 出版商
  103. Rogerson C, Gissen P. VPS33B and VIPAR are essential for epidermal lamellar body biogenesis and function. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1609-1621 pubmed 出版商
  104. Glaeser K, Urban M, Fenech E, Voloshanenko O, Kranz D, Lari F, et al. ERAD-dependent control of the Wnt secretory factor Evi. EMBO J. 2018;37: pubmed 出版商
  105. Vl kov K, Vachtenheim J, R da J, Hor k P, Ondru ov L. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med. 2018;22:2240-2251 pubmed 出版商
  106. Xue C, Hong L, Lin J, Yao X, Wu D, Lin X, et al. β-Elemene inhibits the proliferation of primary human airway granulation fibroblasts by down-regulating canonical Wnt/β-catenin pathway. Biosci Rep. 2018;38: pubmed 出版商
  107. Wang Y, Liu X, Zhou L, Duong D, Bhuripanyo K, Zhao B, et al. Identifying the ubiquitination targets of E6AP by orthogonal ubiquitin transfer. Nat Commun. 2017;8:2232 pubmed 出版商
  108. Chen X, Wang R, Liu X, Wu Y, Zhou T, Yang Y, et al. A Chemical-Genetic Approach Reveals the Distinct Roles of GSK3? and GSK3? in Regulating Embryonic Stem Cell Fate. Dev Cell. 2017;43:563-576.e4 pubmed 出版商
  109. Wang W, Wang Y, Qu C, Wang S, Zhou J, Cao W, et al. The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response. Hepatology. 2018;67:2096-2112 pubmed 出版商
  110. Vassilev V, Platek A, Hiver S, Enomoto H, Takeichi M. Catenins Steer Cell Migration via Stabilization of Front-Rear Polarity. Dev Cell. 2017;43:463-479.e5 pubmed 出版商
  111. Frey J, Kim S, Li Z, Wolfgang M, Riddle R. β-Catenin Directs Long-Chain Fatty Acid Catabolism in the Osteoblasts of Male Mice. Endocrinology. 2018;159:272-284 pubmed 出版商
  112. Caino M, Seo J, Wang Y, Rivadeneira D, Gabrilovich D, Kim E, et al. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. J Clin Invest. 2017;127:3755-3769 pubmed 出版商
  113. Wilhelm F, Böger C, Krüger S, Behrens H, Rocken C. Troy is expressed in human stomach mucosa and a novel putative prognostic marker of intestinal type gastric cancer. Oncotarget. 2017;8:50557-50569 pubmed 出版商
  114. McDonough E, Barrett C, Parang B, Mittal M, Smith J, Bradley A, et al. MTG16 is a tumor suppressor in colitis-associated carcinoma. JCI Insight. 2017;2: pubmed 出版商
  115. Wanet A, Caruso M, Domelevo Entfellner J, Najar M, Fattaccioli A, Demazy C, et al. The Transcription Factor 7-Like 2-Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Axis Connects Mitochondrial Biogenesis and Metabolic Shift with Stem Cell Commitment to Hepatic Differentiation. Stem Cells. 2017;35:2184-2197 pubmed 出版商
  116. Luo W, Tan P, Rodriguez M, He L, Tan K, Zeng L, et al. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition. J Biol Chem. 2017;292:15525-15537 pubmed 出版商
  117. Monteagudo S, Cornelis F, Aznar López C, Yibmantasiri P, Guns L, Carmeliet P, et al. DOT1L safeguards cartilage homeostasis and protects against osteoarthritis. Nat Commun. 2017;8:15889 pubmed 出版商
  118. Liang X, Yuan X, Yu J, Wu Y, Li K, Sun C, et al. Histone Chaperone ASF1A Predicts Poor Outcomes for Patients With Gastrointestinal Cancer and Drives Cancer Progression by Stimulating Transcription of β-Catenin Target Genes. EBioMedicine. 2017;21:104-116 pubmed 出版商
  119. Paul A, Chaker Z, Doetsch F. Hypothalamic regulation of regionally distinct adult neural stem cells and neurogenesis. Science. 2017;356:1383-1386 pubmed 出版商
  120. Li Q, Ye L, Zhang X, Wang M, Lin C, Huang S, et al. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling. Cancer Lett. 2017;402:166-176 pubmed 出版商
  121. Matsumoto Y, La Rose J, Lim M, Adissu H, Law N, Mao X, et al. Ubiquitin ligase RNF146 coordinates bone dynamics and energy metabolism. J Clin Invest. 2017;127:2612-2625 pubmed 出版商
  122. Logan C, Rajakaruna S, Bowen C, Radice G, Robinson M, Menko A. N-cadherin regulates signaling mechanisms required for lens fiber cell elongation and lens morphogenesis. Dev Biol. 2017;428:118-134 pubmed 出版商
  123. Lu J, Yang Y, Guo G, Liu Y, Zhang Z, Dong S, et al. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway. Oncotarget. 2017;8:49502-49514 pubmed 出版商
  124. Choi E, Jung B, Lee S, Yoo H, Shin E, Ko H, et al. A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer. Oncogene. 2017;36:5285-5295 pubmed 出版商
  125. Tammela T, Sanchez Rivera F, Cetinbas N, Wu K, Joshi N, Helenius K, et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature. 2017;545:355-359 pubmed 出版商
  126. Janda C, Dang L, You C, Chang J, de Lau W, Zhong Z, et al. Surrogate Wnt agonists that phenocopy canonical Wnt and ?-catenin signalling. Nature. 2017;545:234-237 pubmed 出版商
  127. Olvedy M, Tisserand J, Luciani F, Boeckx B, Wouters J, Lopez S, et al. Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma. J Clin Invest. 2017;127:2310-2325 pubmed 出版商
  128. Samson E, Tsao D, Zimak J, McLaughlin R, Trenton N, Mace E, et al. The coordinating role of IQGAP1 in the regulation of local, endosome-specific actin networks. Biol Open. 2017;6:785-799 pubmed 出版商
  129. Wu Y, Jhao Y, Cheng Y, Chen Y. 15-Deoxy-?12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction. Oncol Lett. 2017;13:2569-2576 pubmed 出版商
  130. Riemer P, Rydenfelt M, Marks M, van Eunen K, Thedieck K, Herrmann B, et al. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids. J Cell Biol. 2017;216:1567-1577 pubmed 出版商
  131. Jeong S, Lim S, Schevzov G, Gunning P, Helfman D. Loss of Tpm4.1 leads to disruption of cell-cell adhesions and invasive behavior in breast epithelial cells via increased Rac1 signaling. Oncotarget. 2017;8:33544-33559 pubmed 出版商
  132. Nag J, Kancharla A, Maoz M, Turm H, Agranovich D, Gupta C, et al. Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated ?-catenin stabilization. Oncotarget. 2017;8:38650-38667 pubmed 出版商
  133. Iglesia R, Prado M, Cruz L, Martins V, Santos T, Lopes M. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells. Stem Cell Res Ther. 2017;8:76 pubmed 出版商
  134. Yang X, Qi L, Lin F, Ou Z. The role of the chemokine receptor XCR1 in breast cancer cells. Breast Cancer (Dove Med Press). 2017;9:227-236 pubmed 出版商
  135. Yang S, Pei Y, Zhao A. iTRAQ-based Proteomic Analysis of Porcine Kidney Epithelial PK15 cells Infected with Pseudorabies virus. Sci Rep. 2017;7:45922 pubmed 出版商
  136. Kharfallah F, Guyot M, El Hassan A, Allache R, Merello E, De Marco P, et al. Scribble1 plays an important role in the pathogenesis of neural tube defects through its mediating effect of Par-3 and Vangl1/2 localization. Hum Mol Genet. 2017;26:2307-2320 pubmed 出版商
  137. Li Y, Urban A, Midura D, Simon H, Wang Q. Proteomic characterization of epicardial-myocardial signaling reveals novel regulatory networks including a role for NF-κB in epicardial EMT. PLoS ONE. 2017;12:e0174563 pubmed 出版商
  138. Hu X, Zhang Z, Liang Z, Xie D, Zhang T, Yu D, et al. Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma. Oncol Lett. 2017;13:686-694 pubmed 出版商
  139. Ojeh N, Akgul B, Tomic Canic M, Philpott M, Navsaria H. In vitro skin models to study epithelial regeneration from the hair follicle. PLoS ONE. 2017;12:e0174389 pubmed 出版商
  140. Wang X, Chen H, Tian R, Zhang Y, Drutskaya M, Wang C, et al. Macrophages induce AKT/β-catenin-dependent Lgr5+ stem cell activation and hair follicle regeneration through TNF. Nat Commun. 2017;8:14091 pubmed 出版商
  141. Keckesova Z, Donaher J, De Cock J, Freinkman E, Lingrell S, Bachovchin D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681-686 pubmed 出版商
  142. Lee H, Kim M, Baek M, Morales L, Jang I, Slaga T, et al. Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development. Sci Rep. 2017;7:45077 pubmed 出版商
  143. Chattopadhyay R, Raghavan S, Rao G. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function. Redox Biol. 2017;12:438-455 pubmed 出版商
  144. Riascos Bernal D, Chinnasamy P, Gross J, Almonte V, Egaña Gorroño L, Parikh D, et al. Inhibition of Smooth Muscle ?-Catenin Hinders Neointima Formation After Vascular Injury. Arterioscler Thromb Vasc Biol. 2017;37:879-888 pubmed 出版商
  145. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed 出版商
  146. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed 出版商
  147. Boutin A, Liao W, Wang M, Hwang S, Karpinets T, Cheung H, et al. Oncogenic Kras drives invasion and maintains metastases in colorectal cancer. Genes Dev. 2017;31:370-382 pubmed 出版商
  148. Ye S, Zhang T, Tong C, Zhou X, He K, Ban Q, et al. Depletion of Tcf3 and Lef1 maintains mouse embryonic stem cell self-renewal. Biol Open. 2017;6:511-517 pubmed 出版商
  149. Dogan A, Demirci S, Apdik H, Bayrak O, Gulluoglu S, Tuysuz E, et al. A new hope for obesity management: Boron inhibits adipogenesis in progenitor cells through the Wnt/β-catenin pathway. Metabolism. 2017;69:130-142 pubmed 出版商
  150. Domingues M, Martinez Sanz J, Papon L, Larue L, Mouawad L, Bonaventure J. Structure-based mutational analysis of ICAT residues mediating negative regulation of ?-catenin co-transcriptional activity. PLoS ONE. 2017;12:e0172603 pubmed 出版商
  151. Loo L, Bougen Zhukov N, Tan W. Early spatiotemporal-specific changes in intermediate signals are predictive of cytotoxic sensitivity to TNFα and co-treatments. Sci Rep. 2017;7:43541 pubmed 出版商
  152. Shi G, Zheng X, Zhu C, Li B, Wang Y, Jiang S, et al. Evidence of the Role of R-Spondin 1 and Its Receptor Lgr4 in the Transmission of Mechanical Stimuli to Biological Signals for Bone Formation. Int J Mol Sci. 2017;18: pubmed 出版商
  153. Fumagalli A, Drost J, Suijkerbuijk S, van Boxtel R, de Ligt J, Offerhaus G, et al. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc Natl Acad Sci U S A. 2017;114:E2357-E2364 pubmed 出版商
  154. Balashova O, Visina O, Borodinsky L. Folate receptor 1 is necessary for neural plate cell apical constriction during Xenopus neural tube formation. Development. 2017;144:1518-1530 pubmed 出版商
  155. Palma Vera S, Schoen J, Chen S. Periovulatory follicular fluid levels of estradiol trigger inflammatory and DNA damage responses in oviduct epithelial cells. PLoS ONE. 2017;12:e0172192 pubmed 出版商
  156. Tung K, Harakal J, Qiao H, Rival C, Li J, Paul A, et al. Egress of sperm autoantigen from seminiferous tubules maintains systemic tolerance. J Clin Invest. 2017;127:1046-1060 pubmed 出版商
  157. Subramaniam M, Cicek M, Pitel K, Bruinsma E, Nelson Holte M, Withers S, et al. TIEG1 modulates ?-catenin sub-cellular localization and enhances Wnt signaling in bone. Nucleic Acids Res. 2017;45:5170-5182 pubmed 出版商
  158. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed 出版商
  159. Tormos A, Rius Pérez S, Jorques M, Rada P, Ramírez L, Valverde A, et al. p38α regulates actin cytoskeleton and cytokinesis in hepatocytes during development and aging. PLoS ONE. 2017;12:e0171738 pubmed 出版商
  160. Genovese N, Domeier T, Telugu B, Roberts R. Enhanced Development of Skeletal Myotubes from Porcine Induced Pluripotent Stem Cells. Sci Rep. 2017;7:41833 pubmed 出版商
  161. Bakshi S, Taylor J, Strickson S, McCartney T, Cohen P. Identification of TBK1 complexes required for the phosphorylation of IRF3 and the production of interferon ?. Biochem J. 2017;474:1163-1174 pubmed 出版商
  162. Andersson Rolf A, Mustata R, Merenda A, Kim J, Perera S, Grego T, et al. One-step generation of conditional and reversible gene knockouts. Nat Methods. 2017;14:287-289 pubmed 出版商
  163. Melchionna R, Iapicca P, Di Modugno F, Trono P, Sperduti I, Fassan M, et al. The pattern of hMENA isoforms is regulated by TGF-?1 in pancreatic cancer and may predict patient outcome. Oncoimmunology. 2016;5:e1221556 pubmed 出版商
  164. Golden R, Chen B, Li T, Braun J, Manjunath H, Chen X, et al. An Argonaute phosphorylation cycle promotes microRNA-mediated silencing. Nature. 2017;542:197-202 pubmed 出版商
  165. Barnes L, Saurat J, Kaya G. Senescent Atrophic Epidermis Retains Lrig1+ Stem Cells and Loses Wnt Signaling, a Phenotype Shared with CD44KO Mice. PLoS ONE. 2017;12:e0169452 pubmed 出版商
  166. Mescher M, Jeong P, Knapp S, Rübsam M, Saynisch M, Kranen M, et al. The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma. J Exp Med. 2017;214:339-358 pubmed 出版商
  167. Kechele D, Blue R, Zwarycz B, Espenschied S, Mah A, Siegel M, et al. Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation. J Clin Invest. 2017;127:593-607 pubmed 出版商
  168. Yokoyama N, Ohta H, Kagawa Y, Leela Arporn R, Dermlim A, Nisa K, et al. Expression of apical junction complex proteins in colorectal mucosa of miniature dachshunds with inflammatory colorectal polyps. J Vet Med Sci. 2017;79:456-463 pubmed 出版商
  169. Zhu J, Wang P, Yu Z, Lai W, Cao Y, Huang P, et al. Advanced glycosylation end product promotes forkhead box O1 and inhibits Wnt pathway to suppress capacities of epidermal stem cells. Am J Transl Res. 2016;8:5569-5579 pubmed
  170. Li C, Chang L, Chen Z, Liu Z, Wang Y, Ye Q. The role of lncRNA MALAT1 in the regulation of hepatocyte proliferation during liver regeneration. Int J Mol Med. 2017;39:347-356 pubmed 出版商
  171. Shen X, Jia Z, D Alonzo D, Wang X, Bruder E, Emch F, et al. HECTD1 controls the protein level of IQGAP1 to regulate the dynamics of adhesive structures. Cell Commun Signal. 2017;15:2 pubmed 出版商
  172. Le Dour C, Macquart C, Sera F, Homma S, Bonne G, Morrow J, et al. Decreased WNT/?-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene. Hum Mol Genet. 2017;26:333-343 pubmed 出版商
  173. Bruurs L, Zwakenberg S, van der Net M, Zwartkruis F, Bos J. A Two-Tiered Mechanism Enables Localized Cdc42 Signaling during Enterocyte Polarization. Mol Cell Biol. 2017;37: pubmed 出版商
  174. Morandi L, Righi A, Maletta F, Rucci P, Pagni F, Gallo M, et al. Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. Endocr Relat Cancer. 2017;24:107-117 pubmed 出版商
  175. Boylan K, Buchanan P, Manion R, Shukla D, Braumberger K, Bruggemeyer C, et al. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate. Oncotarget. 2017;8:9717-9738 pubmed 出版商
  176. van Andel H, Ren Z, Koopmans I, Joosten S, Kocemba K, de Lau W, et al. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins. Proc Natl Acad Sci U S A. 2017;114:376-381 pubmed 出版商
  177. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed 出版商
  178. Lebensohn A, Dubey R, Neitzel L, Tacchelly Benites O, Yang E, Marceau C, et al. Comparative genetic screens in human cells reveal new regulatory mechanisms in WNT signaling. elife. 2016;5: pubmed 出版商
  179. Harper K, Sosa M, Entenberg D, Hosseini H, Cheung J, Nobre R, et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature. 2016;540:588-592 pubmed 出版商
  180. Karki R, Man S, Malireddi R, Kesavardhana S, Zhu Q, Burton A, et al. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature. 2016;540:583-587 pubmed 出版商
  181. Cao X, Shen L, Wu S, Yan C, Zhou Y, Xiong G, et al. Urban fine particulate matter exposure causes male reproductive injury through destroying blood-testis barrier (BTB) integrity. Toxicol Lett. 2017;266:1-12 pubmed 出版商
  182. Cao J, Tyburczy M, Moss J, Darling T, Widlund H, Kwiatkowski D. Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation. J Clin Invest. 2017;127:349-364 pubmed 出版商
  183. Xu D, Zhou P, Wang Y, Zhang Y, Zhang R, Zhang L, et al. miR-150 Suppresses the Proliferation and Tumorigenicity of Leukemia Stem Cells by Targeting the Nanog Signaling Pathway. Front Pharmacol. 2016;7:439 pubmed
  184. Xiao Y, Yang X, Miao Y, He X, Wang M, Sha W. Inhibition of cell proliferation and tumor growth of colorectal cancer by inhibitors of Wnt and Notch signaling pathways. Oncol Lett. 2016;12:3695-3700 pubmed
  185. Kung Y, Hung C, Chien K, Shih S. Control of the negative IRES trans-acting factor KHSRP by ubiquitination. Nucleic Acids Res. 2017;45:271-287 pubmed 出版商
  186. Chen Z, Tang C, Zhu Y, Xie M, He D, Pan Q, et al. TrpC5 regulates differentiation through the Ca2+/Wnt5a signalling pathway in colorectal cancer. Clin Sci (Lond). 2017;131:227-237 pubmed 出版商
  187. Kumazoe M, Takai M, Bae J, Hiroi S, Huang Y, Takamatsu K, et al. FOXO3 is essential for CD44 expression in pancreatic cancer cells. Oncogene. 2017;36:2643-2654 pubmed 出版商
  188. Kim W, Khan S, Gvozdenovic Jeremic J, Kim Y, Dahlman J, Kim H, et al. Hippo signaling interactions with Wnt/?-catenin and Notch signaling repress liver tumorigenesis. J Clin Invest. 2017;127:137-152 pubmed 出版商
  189. Wan H, Cai J, Chen F, Zhu J, Zhong J, Zhong H. SOX12: a novel potential target for acute myeloid leukaemia. Br J Haematol. 2017;176:421-430 pubmed 出版商
  190. Schiffmacher A, Xie V, Taneyhill L. Cadherin-6B proteolysis promotes the neural crest cell epithelial-to-mesenchymal transition through transcriptional regulation. J Cell Biol. 2016;215:735-747 pubmed
  191. Kim E, Davidson L, Zoh R, Hensel M, Salinas M, Patil B, et al. Rapidly cycling Lgr5+ stem cells are exquisitely sensitive to extrinsic dietary factors that modulate colon cancer risk. Cell Death Dis. 2016;7:e2460 pubmed 出版商
  192. Cao L, Riascos Bernal D, Chinnasamy P, Dunaway C, Hou R, Pujato M, et al. Control of mitochondrial function and cell growth by the atypical cadherin Fat1. Nature. 2016;539:575-578 pubmed 出版商
  193. Gao Y, Mruk D, Chen H, Lui W, Lee W, Cheng C. Regulation of the blood-testis barrier by a local axis in the testis: role of laminin ?2 in the basement membrane. FASEB J. 2017;31:584-597 pubmed 出版商
  194. Chu Q, Huang H, Huang T, Cao L, Peng L, Shi S, et al. Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis. Cell Death Dis. 2016;7:e2456 pubmed 出版商
  195. Salazar V, Ohte S, Capelo L, Gamer L, Rosen V. Specification of osteoblast cell fate by canonical Wnt signaling requires Bmp2. Development. 2016;143:4352-4367 pubmed
  196. Beyer S, Pontis J, Schirwis E, Battisti V, Rudolf A, Le Grand F, et al. Canonical Wnt signalling regulates nuclear export of Setdb1 during skeletal muscle terminal differentiation. Cell Discov. 2016;2:16037 pubmed
  197. Lian G, Dettenhofer M, Lu J, Downing M, Chenn A, Wong T, et al. Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway. Development. 2016;143:4509-4520 pubmed
  198. JENKINS L, Singh P, Varadaraj A, Lee N, Shah S, Flores H, et al. Altering the Proteoglycan State of Transforming Growth Factor ? Type III Receptor (T?RIII)/Betaglycan Modulates Canonical Wnt/?-Catenin Signaling. J Biol Chem. 2016;291:25716-25728 pubmed
  199. Lobato Álvarez J, Roldán M, López Murillo T, González Ramírez R, Bonilla Delgado J, Shoshani L. The Apical Localization of Na+, K+-ATPase in Cultured Human Retinal Pigment Epithelial Cells Depends on Expression of the ?2 Subunit. Front Physiol. 2016;7:450 pubmed
  200. Günther C, He G, Kremer A, Murphy J, Petrie E, Amann K, et al. The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis. J Clin Invest. 2016;126:4346-4360 pubmed 出版商
  201. Che D, Zhou T, Lan Y, Xie J, Gong H, Li C, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med. 2016;38:1815-1822 pubmed 出版商
  202. Gómez Salinero J, López Olañeta M, Ortiz Sánchez P, Larrasa Alonso J, Gatto A, Felkin L, et al. The Calcineurin Variant CnA?1 Controls Mouse Embryonic Stem Cell Differentiation by Directing mTORC2 Membrane Localization and Activation. Cell Chem Biol. 2016;23:1372-1382 pubmed 出版商
  203. Gammons M, Rutherford T, Steinhart Z, Angers S, Bienz M. Essential role of the Dishevelled DEP domain in a Wnt-dependent human-cell-based complementation assay. J Cell Sci. 2016;129:3892-3902 pubmed
  204. Saha S, Aranda E, Hayakawa Y, Bhanja P, Atay S, Brodin N, et al. Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injury. Nat Commun. 2016;7:13096 pubmed 出版商
  205. Mendonça M, Soares E, de Jesus M, Ceragioli H, Batista Ã, Nyúl Tóth Ã, et al. PEGylation of Reduced Graphene Oxide Induces Toxicity in Cells of the Blood-Brain Barrier: An in Vitro and in Vivo Study. Mol Pharm. 2016;13:3913-3924 pubmed
  206. Yi J, Manna A, Barr V, Hong J, Neuman K, Samelson L. madSTORM: a superresolution technique for large-scale multiplexing at single-molecule accuracy. Mol Biol Cell. 2016;27:3591-3600 pubmed
  207. Powis R, Karyka E, Boyd P, Côme J, Jones R, Zheng Y, et al. Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy. JCI Insight. 2016;1:e87908 pubmed 出版商
  208. Huang T, Alvarez A, Pangeni R, Horbinski C, Lu S, Kim S, et al. A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nat Commun. 2016;7:12885 pubmed 出版商
  209. Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed 出版商
  210. King B, Boccalatte F, Moran Crusio K, Wolf E, Wang J, Kayembe C, et al. The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells. Nat Immunol. 2016;17:1312-1321 pubmed 出版商
  211. Park S, Yoon S, Kim H, Kim K. 90K Glycoprotein Promotes Degradation of Mutant ?-Catenin Lacking the ISGylation or Phosphorylation Sites in the N-terminus. Neoplasia. 2016;18:618-625 pubmed 出版商
  212. Barth K, Blasche R, Neiser A, Bramke S, Frank J, Kasper M. P2X7R-dependent regulation of glycogen synthase kinase 3β and claudin-18 in alveolar epithelial type I cells of mice lung. Histochem Cell Biol. 2016;146:757-768 pubmed 出版商
  213. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed 出版商
  214. Kim M, Jeong J, Seo J, Kim H, Kim S, Jin W. Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer. Sci Rep. 2016;6:33899 pubmed 出版商
  215. Kikuchi I, Takahashi Kanemitsu A, Sakiyama N, Tang C, Tang P, Noda S, et al. Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways. Nat Commun. 2016;7:12887 pubmed 出版商
  216. Scotti L, Di Pietro M, Pascuali N, Irusta G, I de Zúñiga -, Gomez Peña M, et al. Sphingosine-1-phosphate restores endothelial barrier integrity in ovarian hyperstimulation syndrome. Mol Hum Reprod. 2016;22:852-866 pubmed
  217. Hubbs A, Fluharty K, Edwards R, Barnabei J, Grantham J, Palmer S, et al. Accumulation of Ubiquitin and Sequestosome-1 Implicate Protein Damage in Diacetyl-Induced Cytotoxicity. Am J Pathol. 2016;186:2887-2908 pubmed 出版商
  218. Gallego Delgado J, Basu Roy U, Ty M, Alique M, Fernandez Arias C, Movila A, et al. Angiotensin receptors and ?-catenin regulate brain endothelial integrity in malaria. J Clin Invest. 2016;126:4016-4029 pubmed 出版商
  219. Chang L, Chen T, Chen S, Chen C, Lee C, Wu S, et al. Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation. Oncotarget. 2016;7:67986-68001 pubmed 出版商
  220. Drelon C, Berthon A, Sahut Barnola I, Mathieu M, Dumontet T, Rodriguez S, et al. PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development. Nat Commun. 2016;7:12751 pubmed 出版商
  221. Wang M, Nagle R, Knudsen B, Rogers G, Cress A. A basal cell defect promotes budding of prostatic intraepithelial neoplasia. J Cell Sci. 2017;130:104-110 pubmed 出版商
  222. Wang H, Han X, Bretz C, Becker S, Gambhir D, Smith G, et al. Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization. Mol Ther Methods Clin Dev. 2016;3:16056 pubmed 出版商
  223. Kong X, Liu F, Gao J. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways. Oncotarget. 2016;7:66051-66060 pubmed 出版商
  224. Yao J, Qin L, Miao S, Wang X, Wu X. Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1. Oncol Lett. 2016;12:1840-1848 pubmed
  225. Sousa A, Rei M, Freitas R, Ricardo S, Caffrey T, David L, et al. Effect of MUC1/?-catenin interaction on the tumorigenic capacity of pancreatic CD133+ cells. Oncol Lett. 2016;12:1811-1817 pubmed
  226. Liu Z, Hui Y, Shi L, Chen Z, Xu X, Chi L, et al. Efficient CRISPR/Cas9-Mediated Versatile, Predictable, and Donor-Free Gene Knockout in Human Pluripotent Stem Cells. Stem Cell Reports. 2016;7:496-507 pubmed 出版商
  227. Vardaki I, Ceder S, Rutishauser D, Baltatzis G, Foukakis T, Panaretakis T. Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes. Oncotarget. 2016;7:74966-74978 pubmed 出版商
  228. Wegwitz F, Lenfert E, Gerstel D, von Ehrenstein L, Einhoff J, Schmidt G, et al. CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. Oncotarget. 2016;7:63730-63746 pubmed 出版商
  229. Ramazzotti G, Billi A, Manzoli L, Mazzetti C, Ruggeri A, Erneux C, et al. IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation. Oncotarget. 2016;7:84118-84127 pubmed 出版商
  230. Li N, Lee W, Cheng C. Overexpression of plastin 3 in Sertoli cells disrupts actin microfilament bundle homeostasis and perturbs the tight junction barrier. Spermatogenesis. 2016;6:e1206353 pubmed 出版商
  231. Jenny Zhou H, Qin L, Zhang H, Tang W, Ji W, He Y, et al. Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation. Nat Med. 2016;22:1033-1042 pubmed 出版商
  232. Hofbauer P, Jung J, McArdle T, Ogle B. Simple Monolayer Differentiation of Murine Cardiomyocytes via Nutrient Deprivation-Mediated Activation of β-Catenin. Stem Cell Rev. 2016;12:731-743 pubmed
  233. Li L, Liu H, Wang C, Liu X, Hu F, Xie N, et al. Overexpression of ?-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma. Biomed Res Int. 2016;2016:5378567 pubmed 出版商
  234. Arévalo Romero H, Meza I, Vallejo Flores G, Fuentes Panana E. Helicobacter pylori CagA and IL-1? Promote the Epithelial-to-Mesenchymal Transition in a Nontransformed Epithelial Cell Model. Gastroenterol Res Pract. 2016;2016:4969163 pubmed 出版商
  235. De Pauw A, Massion P, Sekkali B, André E, Dubroca C, Kmecova J, et al. Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/?-catenin inhibition. Cardiovasc Res. 2016;112:478-90 pubmed 出版商
  236. Gao S, Yang X, Wang M. Inhibitory effects of B?cell translocation gene 2 on skin cancer cells via the Wnt/??catenin signaling pathway. Mol Med Rep. 2016;14:3464-8 pubmed 出版商
  237. Dass R, Sarshad A, Carson B, Feenstra J, Kaur A, Obrdlik A, et al. Wnt5a Signals through DVL1 to Repress Ribosomal DNA Transcription by RNA Polymerase I. PLoS Genet. 2016;12:e1006217 pubmed 出版商
  238. Riascos Bernal D, Chinnasamy P, Cao L, Dunaway C, Valenta T, Basler K, et al. β-Catenin C-terminal signals suppress p53 and are essential for artery formation. Nat Commun. 2016;7:12389 pubmed 出版商
  239. Kim Y, Jin D, Lee B, Cho E, Han J, Shim Y, et al. Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA-IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy. J Thorac Oncol. 2016;11:2193-2201 pubmed 出版商
  240. Oh B, Kim S, Lee Y, Hong H, Kim T, Kim S, et al. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells. Oncotarget. 2016;7:57066-57076 pubmed 出版商
  241. Gerling M, Büller N, Kirn L, Joost S, Frings O, Englert B, et al. Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth. Nat Commun. 2016;7:12321 pubmed 出版商
  242. Hsu Y, Chang P, Ho C, Huang Y, Shih Y, Wang C, et al. Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling. Sci Rep. 2016;6:30575 pubmed 出版商
  243. Fang F, Qin Y, Hao F, Li Q, Zhang W, Zhao C, et al. CD147 modulates androgen receptor activity through the Akt/Gsk-3?/?-catenin/AR pathway in prostate cancer cells. Oncol Lett. 2016;12:1124-1128 pubmed
  244. Li N, Mruk D, Chen H, Wong C, Lee W, Cheng C. Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Sci Rep. 2016;6:29667 pubmed 出版商
  245. Pan B, Huang X, Deng C. Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in rats. Sci Rep. 2016;6:30040 pubmed 出版商
  246. Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, et al. Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway. Mol Med Rep. 2016;14:1891-900 pubmed 出版商
  247. Mihajlovic A, Bruce A. Rho-associated protein kinase regulates subcellular localisation of Angiomotin and Hippo-signalling during preimplantation mouse embryo development. Reprod Biomed Online. 2016;33:381-90 pubmed 出版商
  248. Dorland Y, Malinova T, van Stalborch A, Grieve A, van Geemen D, Jansen N, et al. The F-BAR protein pacsin2 inhibits asymmetric VE-cadherin internalization from tensile adherens junctions. Nat Commun. 2016;7:12210 pubmed 出版商
  249. Perdigoto C, Dauber K, Bar C, Tsai P, Valdes V, Cohen I, et al. Polycomb-Mediated Repression and Sonic Hedgehog Signaling Interact to Regulate Merkel Cell Specification during Skin Development. PLoS Genet. 2016;12:e1006151 pubmed 出版商
  250. Im J, Yoon S, Kim B, Ban H, Won K, Chung K, et al. DNA damage induced apoptosis suppressor (DDIAS) is upregulated via ERK5/MEF2B signaling and promotes ?-catenin-mediated invasion. Biochim Biophys Acta. 2016;1859:1449-1458 pubmed 出版商
  251. McClelland Descalzo D, Satoorian T, Walker L, Sparks N, Pulyanina P, zur Nieden N. Glucose-Induced Oxidative Stress Reduces Proliferation in Embryonic Stem Cells via FOXO3A/?-Catenin-Dependent Transcription of p21(cip1). Stem Cell Reports. 2016;7:55-68 pubmed 出版商
  252. Cantú A, Altshuler Keylin S, Laird D. Discrete somatic niches coordinate proliferation and migration of primordial germ cells via Wnt signaling. J Cell Biol. 2016;214:215-29 pubmed 出版商
  253. Chen H, Wei Z, Sun J, Bhattacharya A, Savage D, Serda R, et al. A recellularized human colon model identifies cancer driver genes. Nat Biotechnol. 2016;34:845-51 pubmed 出版商
  254. Zhang Q, Liu S, Parajuli K, Zhang W, Zhang K, Mo Z, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699 pubmed 出版商
  255. Gao Y, Lui W, Lee W, Cheng C. Polarity protein Crumbs homolog-3 (CRB3) regulates ectoplasmic specialization dynamics through its action on F-actin organization in Sertoli cells. Sci Rep. 2016;6:28589 pubmed 出版商
  256. Talar B, Gajos Michniewicz A, Talar M, Chouaib S, Czyz M. Pentoxifylline Inhibits WNT Signalling in ?-Cateninhigh Patient-Derived Melanoma Cell Populations. PLoS ONE. 2016;11:e0158275 pubmed 出版商
  257. Frohwitter G, Buerger H, van Diest P, Korsching E, Kleinheinz J, Fillies T. Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett. 2016;12:107-113 pubmed
  258. Eterno V, Zambelli A, Villani L, Tuscano A, Manera S, Spitaleri A, et al. AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128. Sci Rep. 2016;6:28436 pubmed 出版商
  259. Campos Y, Qiu X, Gomero E, Wakefield R, Horner L, Brutkowski W, et al. Alix-mediated assembly of the actomyosin-tight junction polarity complex preserves epithelial polarity and epithelial barrier. Nat Commun. 2016;7:11876 pubmed 出版商
  260. Shriver M, Marimuthu S, Paul C, Geist J, Seale T, Konstantopoulos K, et al. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit. Oncotarget. 2016;7:45414-45428 pubmed 出版商
  261. Li J, Bao Q, Chen S, Liu H, Feng J, Qin H, et al. Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/?-catenin signaling in mice. J Orthop Res. 2017;35:812-819 pubmed 出版商
  262. Fagnocchi L, Cherubini A, Hatsuda H, Fasciani A, Mazzoleni S, Poli V, et al. A Myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identity. Nat Commun. 2016;7:11903 pubmed 出版商
  263. Dianati E, Poiraud J, Weber Ouellette A, Plante I. Connexins, E-cadherin, Claudin-7 and ?-catenin transiently form junctional nexuses during the post-natal mammary gland development. Dev Biol. 2016;416:52-68 pubmed 出版商
  264. Horrillo A, Porras G, Ayuso M, González Manchón C. Loss of endothelial barrier integrity in mice with conditional ablation of podocalyxin (Podxl) in endothelial cells. Eur J Cell Biol. 2016;95:265-76 pubmed 出版商
  265. Guo Y, Wang L, Li B, Xu H, Yang J, Zheng L, et al. Wnt/?-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling. Oncotarget. 2016;7:42513-42526 pubmed 出版商
  266. Hey F, Giblett S, Forrest S, Herbert C, Pritchard C. Phosphorylations of Serines 21/9 in Glycogen Synthase Kinase 3α/β Are Not Required for Cell Lineage Commitment or WNT Signaling in the Normal Mouse Intestine. PLoS ONE. 2016;11:e0156877 pubmed 出版商
  267. Parang B, Bradley A, Mittal M, Short S, Thompson J, Barrett C, et al. Myeloid translocation genes differentially regulate colorectal cancer programs. Oncogene. 2016;35:6341-6349 pubmed 出版商
  268. De Cian M, Pauper E, Bandiera R, Vidal V, Sacco S, Gregoire E, et al. Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary. Oncogene. 2017;36:208-218 pubmed 出版商
  269. Lu B, Chen Q, Zhang X, Cheng L. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol. 2016;11:46 pubmed 出版商
  270. Kuang J, Li L, Guo L, Su Y, Wang Y, Xu Y, et al. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. J Exp Clin Cancer Res. 2016;35:88 pubmed 出版商
  271. Liu S, Barry E, Baron J, Rutherford R, Seabrook M, Bostick R. Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients. Mol Carcinog. 2017;56:412-424 pubmed 出版商
  272. Zhu P, Wang Y, Huang G, Ye B, Liu B, Wu J, et al. lnc-?-Catm elicits EZH2-dependent ?-catenin stabilization and sustains liver CSC self-renewal. Nat Struct Mol Biol. 2016;23:631-9 pubmed 出版商
  273. Park J, Kotani T, Konno T, Setiawan J, Kitamura Y, Imada S, et al. Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids. PLoS ONE. 2016;11:e0156334 pubmed 出版商
  274. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed 出版商
  275. Jacobsen A, Heijmans N, Verkaar F, Smit M, Heringa J, van Amerongen R, et al. Construction and Experimental Validation of a Petri Net Model of Wnt/β-Catenin Signaling. PLoS ONE. 2016;11:e0155743 pubmed 出版商
  276. He F, Wei L, Luo W, Liao Z, Li B, Zhou X, et al. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. Oncotarget. 2016;7:37000-37012 pubmed 出版商
  277. Lubeseder Martellato C, Hidalgo Sastre A, Hartmann C, Alexandrow K, Kamyabi Moghaddam Z, Sipos B, et al. Membranous CD24 drives the epithelial phenotype of pancreatic cancer. Oncotarget. 2016;7:49156-49168 pubmed 出版商
  278. Zeng L, Cai C, Li S, Wang W, Li Y, Chen J, et al. Essential Roles of Cyclin Y-Like 1 and Cyclin Y in Dividing Wnt-Responsive Mammary Stem/Progenitor Cells. PLoS Genet. 2016;12:e1006055 pubmed 出版商
  279. Jung J, Kang K, Kim J, Hong S, Park Y, Kim B. CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, ?-Catenin, and hTERT Activities. Stem Cells Dev. 2016;25:1006-19 pubmed 出版商
  280. de Jong P, Taniguchi K, Harris A, Bertin S, Takahashi N, Duong J, et al. ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nat Commun. 2016;7:11551 pubmed 出版商
  281. Allodi I, Comley L, Nichterwitz S, Nizzardo M, Simone C, Benitez J, et al. Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS. Sci Rep. 2016;6:25960 pubmed 出版商
  282. Simmers M, Cole B, Ogletree M, Chen Z, Xu Y, Kong L, et al. Hemodynamics associated with atrial fibrillation directly alters thrombotic potential of endothelial cells. Thromb Res. 2016;143:34-9 pubmed 出版商
  283. Morris J, Moseley V, Cabang A, Coleman K, Wei W, Garrett Mayer E, et al. Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXR? expression in human colon cancer cells. Oncotarget. 2016;7:35313-26 pubmed 出版商
  284. Payan Carreira R, Pires M, Santos C, Holst B, Colaco J, Rodriguez Martinez H. Immunolocalization of E-cadherin and ?-catenin in the cyclic and early pregnant canine endometrium. Theriogenology. 2016;86:1092-1101 pubmed 出版商
  285. Illich D, Zhang M, Ursu A, Osorno R, Kim K, Yoon J, et al. Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs. Cell Rep. 2016;15:787-800 pubmed 出版商
  286. Bie Q, Sun C, Gong A, Li C, Su Z, Zheng D, et al. Non-tumor tissue derived interleukin-17B activates IL-17RB/AKT/β-catenin pathway to enhance the stemness of gastric cancer. Sci Rep. 2016;6:25447 pubmed 出版商
  287. Nakagawa A, Naito A, Sumida T, Nomura S, Shibamoto M, Higo T, et al. Activation of endothelial β-catenin signaling induces heart failure. Sci Rep. 2016;6:25009 pubmed 出版商
  288. Marthandan S, Baumgart M, Priebe S, Groth M, Schaer J, Kaether C, et al. Conserved Senescence Associated Genes and Pathways in Primary Human Fibroblasts Detected by RNA-Seq. PLoS ONE. 2016;11:e0154531 pubmed 出版商
  289. Chen Y, Pan K, Wang P, Cao Z, Wang W, Wang S, et al. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis. J Biol Chem. 2016;291:12688-705 pubmed 出版商
  290. Chatterjee I, Baruah J, Lurie E, Wary K. Endothelial lipid phosphate phosphatase-3 deficiency that disrupts the endothelial barrier function is a modifier of cardiovascular development. Cardiovasc Res. 2016;111:105-18 pubmed 出版商
  291. Inada M, Izawa G, Kobayashi W, Ozawa M. 293 cells express both epithelial as well as mesenchymal cell adhesion molecules. Int J Mol Med. 2016;37:1521-7 pubmed 出版商
  292. Frank R, Komiyama N, Ryan T, Zhu F, O Dell T, Grant S. NMDA receptors are selectively partitioned into complexes and supercomplexes during synapse maturation. Nat Commun. 2016;7:11264 pubmed 出版商
  293. Rolo A, Savery D, Escuin S, de Castro S, Armer H, Munro P, et al. Regulation of cell protrusions by small GTPases during fusion of the neural folds. elife. 2016;5:e13273 pubmed 出版商
  294. Zhuang L, Yang Y, Ma X, Han B, Wang Z, Zhao Q, et al. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis. 2016;7:e2203 pubmed 出版商
  295. Stewart M, Plante I, Penuela S, Laird D. Loss of Panx1 Impairs Mammary Gland Development at Lactation: Implications for Breast Tumorigenesis. PLoS ONE. 2016;11:e0154162 pubmed 出版商
  296. Liu S, Zhou F, Shen Y, Zhang Y, Yin H, Zeng Y, et al. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells. Oncotarget. 2016;7:32876-92 pubmed 出版商
  297. Kumar A, Chalamalasetty R, Kennedy M, Thomas S, Inala S, Garriock R, et al. Zfp703 Is a Wnt/?-Catenin Feedback Suppressor Targeting the ?-Catenin/Tcf1 Complex. Mol Cell Biol. 2016;36:1793-802 pubmed 出版商
  298. Lu C, Thoeni C, Connor A, Kawabe H, Gallinger S, Rotin D. Intestinal knockout of Nedd4 enhances growth of Apcmin tumors. Oncogene. 2016;35:5839-5849 pubmed 出版商
  299. Zhou R, Yuan Z, Liu J, Liu J. Calcitonin gene-related peptide promotes the expression of osteoblastic genes and activates the WNT signal transduction pathway in bone marrow stromal stem cells. Mol Med Rep. 2016;13:4689-96 pubmed 出版商
  300. Conway A, Van Nostrand E, Pratt G, Aigner S, Wilbert M, Sundararaman B, et al. Enhanced CLIP Uncovers IMP Protein-RNA Targets in Human Pluripotent Stem Cells Important for Cell Adhesion and Survival. Cell Rep. 2016;15:666-679 pubmed 出版商
  301. Huang G, Yang X, Chen K, Xing J, Guo L, Zhu L, et al. Porf-2 Inhibits Neural Stem Cell Proliferation Through Wnt/?-Catenin Pathway by Its GAP Domain. Front Cell Neurosci. 2016;10:85 pubmed 出版商
  302. Zheng G, Li N, Jia X, Peng C, Luo L, Deng Y, et al. MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer. J Mol Med (Berl). 2016;94:1129-1141 pubmed
  303. Ren J, Li J, Liu X, Feng Y, Gui Y, Yang J, et al. Quercetin Inhibits Fibroblast Activation and Kidney Fibrosis Involving the Suppression of Mammalian Target of Rapamycin and β-catenin Signaling. Sci Rep. 2016;6:23968 pubmed 出版商
  304. Oudhoff M, Braam M, Freeman S, Wong D, Rattray D, Wang J, et al. SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/?-Catenin and Hippo/YAP Signaling. Dev Cell. 2016;37:47-57 pubmed 出版商
  305. Pan B, Huang X, Deng C. Aripiprazole and Haloperidol Activate GSK3?-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats. Int J Mol Sci. 2016;17:459 pubmed 出版商
  306. Kaur A, Webster M, Marchbank K, Behera R, Ndoye A, Kugel C, et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature. 2016;532:250-4 pubmed 出版商
  307. Yu J, Berga S, Johnston MacAnanny E, Sidell N, Bagchi I, Bagchi M, et al. Endometrial Stromal Decidualization Responds Reversibly to Hormone Stimulation and Withdrawal. Endocrinology. 2016;157:2432-46 pubmed 出版商
  308. Falcão V, Maschio D, de Fontes C, Oliveira R, Santos Silva J, Almeida A, et al. Reduced insulin secretion function is associated with pancreatic islet redistribution of cell adhesion molecules (CAMS) in diabetic mice after prolonged high-fat diet. Histochem Cell Biol. 2016;146:13-31 pubmed 出版商
  309. Holloway K, Sinha V, Bu W, Toneff M, Dong J, Peng Y, et al. Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype. Int J Biol Sci. 2016;12:381-8 pubmed 出版商
  310. Chou C, Fan C, Lin P, Liao P, Tung J, Hsieh C, et al. Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis. Oncotarget. 2016;7:25742-54 pubmed 出版商
  311. Jun S, Jung Y, Suh H, Wang W, Kim M, Oh Y, et al. LIG4 mediates Wnt signalling-induced radioresistance. Nat Commun. 2016;7:10994 pubmed 出版商
  312. Park S, Kim J, Kim N, Yang K, Shim J, Heo K. Estradiol, TGF-?1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration. Oncol Lett. 2016;11:1895-1902 pubmed
  313. Kim H, Kim J, Nam K, Kim W. Clinical significance of midkine expression in sporadic desmoid tumors. Oncol Lett. 2016;11:1677-1684 pubmed
  314. Pan Y, Deng Y, Xie S, Wang Z, Wang Y, Ren J, et al. Altered Wnt Signaling Pathway in Cognitive Impairment Caused by Chronic Intermittent Hypoxia: Focus on Glycogen Synthase Kinase-3? and ?-catenin. Chin Med J (Engl). 2016;129:838-45 pubmed 出版商
  315. Morgan E, Pittman J, DeGiacomo A, Cusher D, de Bakker C, Mroszczyk K, et al. BMPR1A antagonist differentially affects cartilage and bone formation during fracture healing. J Orthop Res. 2016;34:2096-2105 pubmed 出版商
  316. Chen H, Mruk D, Lee W, Cheng C. Planar Cell Polarity (PCP) Protein Vangl2 Regulates Ectoplasmic Specialization Dynamics via Its Effects on Actin Microfilaments in the Testes of Male Rats. Endocrinology. 2016;157:2140-59 pubmed 出版商
  317. Tögel L, Nightingale R, Chueh A, Jayachandran A, Tran H, Phesse T, et al. Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells. Mol Cancer Ther. 2016;15:1217-26 pubmed 出版商
  318. Kang R, Zhao S, Liu L, Li F, Li E, Luo L, et al. Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells. Cancer Cell Int. 2016;16:20 pubmed 出版商
  319. Ji X, Liu Y, Hurd R, Wang J, Fitzmaurice B, Nishina P, et al. Retinal Pigment Epithelium Atrophy 1 (rpea1): A New Mouse Model With Retinal Detachment Caused by a Disruption of Protein Kinase C, θ. Invest Ophthalmol Vis Sci. 2016;57:877-88 pubmed 出版商
  320. Xu X, Zhang Y, Jasper J, Lykken E, Alexander P, Markowitz G, et al. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. Oncotarget. 2016;7:20381-94 pubmed 出版商
  321. Kim J, Lee H, Park K, Choi Y, Nam J, Hong I. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment. Oncotarget. 2016;7:20395-409 pubmed 出版商
  322. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed 出版商
  323. Hirth S, Bühler A, Bührdel J, Rudeck S, Dahme T, Rottbauer W, et al. Paxillin and Focal Adhesion Kinase (FAK) Regulate Cardiac Contractility in the Zebrafish Heart. PLoS ONE. 2016;11:e0150323 pubmed 出版商
  324. Sobecki M, Mrouj K, Camasses A, Parisis N, Nicolas E, Llères D, et al. The cell proliferation antigen Ki-67 organises heterochromatin. elife. 2016;5:e13722 pubmed 出版商
  325. Clifford R, Maryon E, Kaplan J. Dynamic internalization and recycling of a metal ion transporter: Cu homeostasis and CTR1, the human Cu⁺ uptake system. J Cell Sci. 2016;129:1711-21 pubmed 出版商
  326. Li S, Wang F, Yang Y, Tiao M, Chuang J, Huang Y. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries. Int J Mol Sci. 2016;17:324 pubmed 出版商
  327. Huang L, Mokkapati S, Hu Q, Ruteshouser E, Hicks M, Huff V. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation. Neoplasia. 2016;18:71-81 pubmed 出版商
  328. Beyaz S, Mana M, Roper J, Kedrin D, Saadatpour A, Hong S, et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature. 2016;531:53-8 pubmed 出版商
  329. Gurnik S, Devraj K, Macas J, Yamaji M, Starke J, Scholz A, et al. Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling. Acta Neuropathol. 2016;131:753-73 pubmed 出版商
  330. Tepper S, Jeschke J, Böttcher K, Schmidt A, Davari K, Müller P, et al. PARP activation promotes nuclear AID accumulation in lymphoma cells. Oncotarget. 2016;7:13197-208 pubmed 出版商
  331. Zhang M, Linghu E, Zhan Q, He T, Cao B, Brock M, et al. Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling. Oncotarget. 2016;7:17957-69 pubmed 出版商
  332. Yang Z, Liu S, Zhu M, Zhang H, Wang J, Xu Q, et al. PS341 inhibits hepatocellular and colorectal cancer cells through the FOXO3/CTNNB1 signaling pathway. Sci Rep. 2016;6:22090 pubmed 出版商
  333. Ro S, Xue X, Ramakrishnan S, Cho C, Namkoong S, Jang I, et al. Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis. elife. 2016;5:e12204 pubmed 出版商
  334. Kabat A, Harrison O, Riffelmacher T, Moghaddam A, Pearson C, Laing A, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. elife. 2016;5:e12444 pubmed 出版商
  335. McCabe M, Tarulli G, Laven Law G, Matthiesson K, Meachem S, McLachlan R, et al. Gonadotropin suppression in men leads to a reduction in claudin-11 at the Sertoli cell tight junction. Hum Reprod. 2016;31:875-86 pubmed 出版商
  336. Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K, et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis. Sci Rep. 2016;6:21860 pubmed 出版商
  337. Katoh I, Fukunishi N, Fujimuro M, Kasai H, Moriishi K, Hata R, et al. Repression of Wnt/β-catenin response elements by p63 (TP63). Cell Cycle. 2016;15:699-710 pubmed 出版商
  338. Skardal A, Devarasetty M, Forsythe S, Atala A, Soker S. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Biotechnol Bioeng. 2016;113:2020-32 pubmed 出版商
  339. Hwang S, Lee H, Kim H, Lee H, Shin C, Yun S, et al. Ubiquitin-specific protease 4 controls metastatic potential through β-catenin stabilization in brain metastatic lung adenocarcinoma. Sci Rep. 2016;6:21596 pubmed 出版商
  340. Unzu C, Friedli M, Bosman A, Jaconi M, Wildhaber B, Rougemont A. Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues. Stem Cells Int. 2016;2016:4370142 pubmed 出版商
  341. Chojnacka K, Bilinska B, Mruk D. Interleukin 1alpha-induced disruption of the Sertoli cell cytoskeleton affects gap junctional communication. Cell Signal. 2016;28:469-480 pubmed 出版商
  342. Weyemi U, Redon C, Choudhuri R, Aziz T, Maeda D, Boufraqech M, et al. The histone variant H2A.X is a regulator of the epithelial-mesenchymal transition. Nat Commun. 2016;7:10711 pubmed 出版商
  343. Kim D, Helfman D. Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling. Oncogene. 2016;35:4495-508 pubmed 出版商
  344. Chang L, Lei X, Qin Y, Zeng G, Zhang X, Jin H, et al. Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastoma. Oncol Lett. 2016;11:69-74 pubmed
  345. Bleckmann A, Conradi L, Menck K, Schmick N, Schubert A, Rietkötter E, et al. β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases. Clin Exp Metastasis. 2016;33:309-23 pubmed 出版商
  346. Zhang J, Liu J, Li H, Wang J. β-Catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl. Mol Med Rep. 2016;13:2543-51 pubmed 出版商
  347. Zhao L, Li S, Gan L, Li C, Qiu Z, Feng Y, et al. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression. J Cell Mol Med. 2016;20:842-54 pubmed 出版商
  348. Bühler A, Kustermann M, Bummer T, Rottbauer W, Sandri M, Just S. Atrogin-1 Deficiency Leads to Myopathy and Heart Failure in Zebrafish. Int J Mol Sci. 2016;17: pubmed 出版商
  349. Lazarevic I, Engelhardt B. Modeling immune functions of the mouse blood-cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier. Fluids Barriers CNS. 2016;13:2 pubmed 出版商
  350. Ramasamy S, Saez B, Mukhopadhyay S, Ding D, Ahmed A, Chen X, et al. Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-κB inflammatory pathway. Proc Natl Acad Sci U S A. 2016;113:1871-6 pubmed 出版商
  351. Gao Y, Zhao Y, Zhang J, Lu Y, Liu X, Geng P, et al. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1. Sci Rep. 2016;6:19874 pubmed 出版商
  352. Liu S, Zhou P, Zhang Y. Abnormal expression of key genes and proteins in the canonical Wnt/β-catenin pathway of articular cartilage in a rat model of exercise-induced osteoarthritis. Mol Med Rep. 2016;13:1999-2006 pubmed 出版商
  353. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  354. Tien S, Lee H, Yang Y, Lin M, Chen Y, Chang Z. The Shp2-induced epithelial disorganization defect is reversed by HDAC6 inhibition independent of Cdc42. Nat Commun. 2016;7:10420 pubmed 出版商
  355. Avgustinova A, Iravani M, Robertson D, Fearns A, Gao Q, Klingbeil P, et al. Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness. Nat Commun. 2016;7:10305 pubmed 出版商
  356. Weilner S, Keider V, Winter M, Harreither E, Salzer B, Weiss F, et al. Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles. Aging (Albany NY). 2016;8:16-33 pubmed
  357. Sun Y, Zhu D, Chen F, Qian M, Wei H, Chen W, et al. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment. Oncogene. 2016;35:4321-34 pubmed 出版商
  358. Yang M, Xie X, Ding Y. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis. Oncol Rep. 2016;35:1796-806 pubmed 出版商
  359. Jimeno D, Gómez C, Calzada N, de la Villa P, Lillo C, Santos E. RASGRF2 controls nuclear migration in postnatal retinal cone photoreceptors. J Cell Sci. 2016;129:729-42 pubmed 出版商
  360. Chen Y, Statt S, Wu R, Chang H, Liao J, Wang C, et al. High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci Rep. 2016;6:18815 pubmed 出版商
  361. Maimets M, Rocchi C, Bron R, Pringle S, Kuipers J, Giepmans B, et al. Long-Term In Vitro Expansion of Salivary Gland Stem Cells Driven by Wnt Signals. Stem Cell Reports. 2016;6:150-62 pubmed 出版商
  362. Cui H, Wang S, Miao J, Fu Z, Feng F, Wu J, et al. CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling. Oncotarget. 2016;7:5613-29 pubmed 出版商
  363. Wang F, Feng Y, Li P, Wang K, Feng L, Liu Y, et al. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Oncotarget. 2016;7:4279-97 pubmed 出版商
  364. Zhang Y, Fan J, Ho J, Hu T, Kneeland S, Fan X, et al. Crim1 regulates integrin signaling in murine lens development. Development. 2016;143:356-66 pubmed 出版商
  365. Goodnough L, Dinuoscio G, ATIT R. Twist1 contributes to cranial bone initiation and dermal condensation by maintaining Wnt signaling responsiveness. Dev Dyn. 2016;245:144-56 pubmed 出版商
  366. Giampietro C, Disanza A, Bravi L, Barrios Rodiles M, Corada M, Frittoli E, et al. The actin-binding protein EPS8 binds VE-cadherin and modulates YAP localization and signaling. J Cell Biol. 2015;211:1177-92 pubmed 出版商
  367. Mills K, Brocardo M, Henderson B. APC binds the Miro/Milton motor complex to stimulate transport of mitochondria to the plasma membrane. Mol Biol Cell. 2016;27:466-82 pubmed 出版商
  368. Ou L, Fang L, Tang H, Qiao H, Zhang X, Wang Z. Dickkopf Wnt signaling pathway inhibitor 1 regulates the differentiation of mouse embryonic stem cells in vitro and in vivo. Mol Med Rep. 2016;13:720-30 pubmed 出版商
  369. Rafehi S, Ramos Valdes Y, Bertrand M, McGee J, Préfontaine M, Sugimoto A, et al. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Endocr Relat Cancer. 2016;23:147-59 pubmed 出版商
  370. Bowser J, Blackburn M, Shipley G, Molina J, Dunner K, Broaddus R. Loss of CD73-mediated actin polymerization promotes endometrial tumor progression. J Clin Invest. 2016;126:220-38 pubmed 出版商
  371. Kühne H, Hause G, Grundmann S, Schutkowski A, Brandsch C, Stangl G. Vitamin D receptor knockout mice exhibit elongated intestinal microvilli and increased ezrin expression. Nutr Res. 2016;36:184-92 pubmed 出版商
  372. Uribe R, Buzzi A, Bronner M, Strobl Mazzulla P. Histone demethylase KDM4B regulates otic vesicle invagination via epigenetic control of Dlx3 expression. J Cell Biol. 2015;211:815-27 pubmed 出版商
  373. Ye S, Zhang D, Cheng F, Wilson D, Mackay J, He K, et al. Wnt/β-catenin and LIF-Stat3 signaling pathways converge on Sp5 to promote mouse embryonic stem cell self-renewal. J Cell Sci. 2016;129:269-76 pubmed 出版商
  374. Zhou R, Zhou X, Yin Z, Guo J, Hu T, Jiang S, et al. Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer. Oncotarget. 2015;6:44609-22 pubmed 出版商
  375. McCabe M, Foo C, Dinger M, Smooker P, Stanton P. Claudin-11 and occludin are major contributors to Sertoli cell tight junction function, in vitro. Asian J Androl. 2016;18:620-6 pubmed 出版商
  376. Koudelkova P, Weber G, Mikulits W. Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF. PLoS ONE. 2015;10:e0142134 pubmed 出版商
  377. Pai P, Rachagani S, Lakshmanan I, Macha M, Sheinin Y, Smith L, et al. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Mol Oncol. 2016;10:224-39 pubmed 出版商
  378. Leal L, Bueno A, Gomes D, Abduch R, de Castro M, Antonini S. Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis. Oncotarget. 2015;6:43016-32 pubmed 出版商
  379. McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed 出版商
  380. Abshagen K, Senne M, Genz B, Thomas M, Vollmar B. Differential Effects of Axin2 Deficiency on the Fibrogenic and Regenerative Response in Livers of Bile Duct-Ligated Mice. Eur Surg Res. 2015;55:328-340 pubmed
  381. Ma S, Yang L, Niu T, Cheng C, Zhong L, Zheng M, et al. SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML. Sci Rep. 2015;5:15646 pubmed 出版商
  382. Bizet A, Becker Heck A, Ryan R, Weber K, Filhol E, Krug P, et al. Mutations in TRAF3IP1/IFT54 reveal a new role for IFT proteins in microtubule stabilization. Nat Commun. 2015;6:8666 pubmed 出版商
  383. Chakedis J, French R, Babicky M, Jaquish D, Howard H, Mose E, et al. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells. Oncogene. 2016;35:3249-59 pubmed 出版商
  384. Eisses J, Criscimanna A, Dionise Z, Orabi A, Javed T, Sarwar S, et al. Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation Programs. Am J Pathol. 2015;185:3304-15 pubmed 出版商
  385. Arya P, Rainey M, Bhattacharyya S, Mohapatra B, George M, Kuracha M, et al. The endocytic recycling regulatory protein EHD1 Is required for ocular lens development. Dev Biol. 2015;408:41-55 pubmed 出版商
  386. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed 出版商
  387. Akhade V, Dighe S, Kataruka S, Rao M. Mechanism of Wnt signaling induced down regulation of mrhl long non-coding RNA in mouse spermatogonial cells. Nucleic Acids Res. 2016;44:387-401 pubmed 出版商
  388. Stewart M, Bechberger J, Welch I, Naus C, Laird D. Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancer. Oncotarget. 2015;6:37185-99 pubmed 出版商
  389. Xiong W, Zhang L, Yu L, Xie W, Man Y, Xiong Y, et al. Estradiol promotes cells invasion by activating β-catenin signaling pathway in endometriosis. Reproduction. 2015;150:507-16 pubmed 出版商
  390. Hwang J, Sung W, Tu H, Hsieh K, Yeh C, Chen C, et al. The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma. PLoS ONE. 2015;10:e0139435 pubmed 出版商
  391. Basu S, Combe K, Kwiatkowski F, Caldefie Chézet F, Penault Llorca F, Bignon Y, et al. Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen. PLoS ONE. 2015;10:e0138443 pubmed 出版商
  392. Konzack A, Jakupovic M, Kubaichuk K, Görlach A, Dombrowski F, Miinalainen I, et al. Mitochondrial Dysfunction Due to Lack of Manganese Superoxide Dismutase Promotes Hepatocarcinogenesis. Antioxid Redox Signal. 2015;23:1059-75 pubmed 出版商
  393. Leve F, Peres Moreira R, Binato R, Abdelhay E, Morgado Díaz J. LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways. PLoS ONE. 2015;10:e0139094 pubmed 出版商
  394. Jamieson C, Lui C, Brocardo M, Martino Echarri E, Henderson B. Rac1 augments Wnt signaling by stimulating β-catenin-lymphoid enhancer factor-1 complex assembly independent of β-catenin nuclear import. J Cell Sci. 2015;128:3933-46 pubmed 出版商
  395. Mazur P, Herner A, Mello S, Wirth M, Hausmann S, Sánchez Rivera F, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat Med. 2015;21:1163-71 pubmed 出版商
  396. Yokdang N, Hatakeyama J, Wald J, Simion C, Tellez J, Chang D, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35:2932-47 pubmed 出版商
  397. Nemazanyy I, Montagnac G, Russell R, Morzyglod L, Burnol A, Guan K, et al. Class III PI3K regulates organismal glucose homeostasis by providing negative feedback on hepatic insulin signalling. Nat Commun. 2015;6:8283 pubmed 出版商
  398. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed 出版商
  399. Basak P, Dillon R, Leslie H, Raouf A, Mowat M. The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity. BMC Cancer. 2015;15:630 pubmed 出版商
  400. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed 出版商
  401. Chen B, Tao J, Lin Y, Lin R, Liu W, Chen L. Electro-acupuncture exerts beneficial effects against cerebral ischemia and promotes the proliferation of neural progenitor cells in the cortical peri-infarct area through the Wnt/β-catenin signaling pathway. Int J Mol Med. 2015;36:1215-22 pubmed 出版商
  402. Conde Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, et al. A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity. Nat Commun. 2015;6:8093 pubmed 出版商
  403. Zhang Y, Dai Q, Chen W, Jiang S, Chen S, Zhang Y, et al. Effects of acupuncture on cortical expression of Wnt3a, β-catenin and Sox2 in a rat model of traumatic brain injury. Acupunct Med. 2016;34:48-54 pubmed 出版商
  404. Ozgüven B, Tuncel D, Polat N, Sakiz D, Kabukcuoglu F, Köksal H, et al. Solid-pseudopapillary neoplasm of the pancreas: Clinicopathologic and immunohistochemical analysis of nine cases. Indian J Pathol Microbiol. 2015;58:292-5 pubmed 出版商
  405. Sivaraj K, Li R, Albarrán Juárez J, Wang S, Tischner D, Grimm M, et al. Endothelial Gαq/11 is required for VEGF-induced vascular permeability and angiogenesis. Cardiovasc Res. 2015;108:171-80 pubmed 出版商
  406. Ohata S, Herranz Pérez V, Nakatani J, Boletta A, García Verdugo J, Álvarez Buylla A. Mechanosensory Genes Pkd1 and Pkd2 Contribute to the Planar Polarization of Brain Ventricular Epithelium. J Neurosci. 2015;35:11153-68 pubmed 出版商
  407. Madison B, Jeganathan A, Mizuno R, Winslow M, Castells A, Cuatrecasas M, et al. Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2. PLoS Genet. 2015;11:e1005408 pubmed 出版商
  408. Yang G, Xu Z, Lu W, Li X, Sun C, Guo J, et al. Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method. PLoS ONE. 2015;10:e0134727 pubmed 出版商
  409. Hamazaki J, Hirayama S, Murata S. Redundant Roles of Rpn10 and Rpn13 in Recognition of Ubiquitinated Proteins and Cellular Homeostasis. PLoS Genet. 2015;11:e1005401 pubmed 出版商
  410. Piccolo E, Tinari N, D Addario D, Rossi C, Iacobelli V, La Sorda R, et al. Prognostic relevance of LGALS3BP in human colorectal carcinoma. J Transl Med. 2015;13:248 pubmed 出版商
  411. Takahashi S, Kohashi K, Yamamoto H, Hirahashi M, Kumagai R, Takizawa N, et al. Expression of adhesion molecules and epithelial-mesenchymal transition factors in medullary carcinoma of the colorectum. Hum Pathol. 2015;46:1257-66 pubmed 出版商
  412. Eiring A, Khorashad J, Anderson D, Yu F, Redwine H, Mason C, et al. β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia. Leukemia. 2015;29:2328-37 pubmed 出版商
  413. Cartón García F, Overeem A, Nieto R, Bazzocco S, Dopeso H, Macaya I, et al. Myo5b knockout mice as a model of microvillus inclusion disease. Sci Rep. 2015;5:12312 pubmed 出版商
  414. Riordan D, Varma S, West R, Brown P. Automated Analysis and Classification of Histological Tissue Features by Multi-Dimensional Microscopic Molecular Profiling. PLoS ONE. 2015;10:e0128975 pubmed 出版商
  415. Yoshida N, Kinugasa T, Ohshima K, Yuge K, Ohchi T, Fujino S, et al. Analysis of Wnt and β-catenin Expression in Advanced Colorectal Cancer. Anticancer Res. 2015;35:4403-10 pubmed
  416. Kontro H, Cannino G, Rustin P, Dufour E, Kainulainen H. DAPIT Over-Expression Modulates Glucose Metabolism and Cell Behaviour in HEK293T Cells. PLoS ONE. 2015;10:e0131990 pubmed 出版商
  417. Maggiorani D, Dissard R, Belloy M, Saulnier Blache J, Casemayou A, Ducassé L, et al. Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells. PLoS ONE. 2015;10:e0131416 pubmed 出版商
  418. Wainwright E, Wilhelm D, Combes A, Little M, Koopman P. ROBO2 restricts the nephrogenic field and regulates Wolffian duct-nephrogenic cord separation. Dev Biol. 2015;404:88-102 pubmed 出版商
  419. Sugiyama Y, Shelley E, Badouel C, McNeill H, McAvoy J. Atypical Cadherin Fat1 Is Required for Lens Epithelial Cell Polarity and Proliferation but Not for Fiber Differentiation. Invest Ophthalmol Vis Sci. 2015;56:4099-107 pubmed 出版商
  420. Zhang J, Li L, Baldwin A, Friedman A, Paz Priel I. Loss of IKKβ but Not NF-κB p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells. PLoS ONE. 2015;10:e0130441 pubmed 出版商
  421. Xu N, Zhou X, Wang S, Xu L, Zhou H, Liu X. Artesunate Induces SKM-1 Cells Apoptosis by Inhibiting Hyperactive β-catenin Signaling Pathway. Int J Med Sci. 2015;12:524-9 pubmed 出版商
  422. Kim D, Yeom J, Lee B, Lee K, Bae J, Rhee S. Inhibition of discoidin domain receptor 2-mediated lung cancer cells progression by gold nanoparticle-aptamer-assisted delivery of peptides containing transmembrane-juxtamembrane 1/2 domain. Biochem Biophys Res Commun. 2015;464:392-5 pubmed 出版商
  423. Scalia C, Gendusa R, Cattoretti G. A 2-Step Laemmli and Antigen Retrieval Method Improves Immunodetection. Appl Immunohistochem Mol Morphol. 2016;24:436-46 pubmed 出版商
  424. Tong T, Kim N, Park T. Topical Application of Oleuropein Induces Anagen Hair Growth in Telogen Mouse Skin. PLoS ONE. 2015;10:e0129578 pubmed 出版商
  425. Wang J, Zhang K, Wang J, Wu X, Liu X, Li B, et al. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma. Oncotarget. 2015;6:18905-20 pubmed
  426. Zhang H, Jing X, Wu X, Hu J, Zhang X, Wang X, et al. Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes. Anticancer Drugs. 2015;26:706-15 pubmed 出版商
  427. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed 出版商
  428. Li N, Mruk D, Wong C, Lee W, Han D, Cheng C. Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis. FASEB J. 2015;29:3788-805 pubmed 出版商
  429. Ayadi M, Bouygues A, Ouaret D, Ferrand N, Chouaib S, Thiery J, et al. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors. Oncotarget. 2015;6:18518-33 pubmed
  430. Bag S, Pal M, Chaudhary A, Das R, Paul R, Sengupta S, et al. Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer. J Clin Pathol. 2015;68:605-13 pubmed 出版商
  431. Tréhoux S, Lahdaoui F, Delpu Y, Renaud F, Leteurtre E, Torrisani J, et al. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochim Biophys Acta. 2015;1853:2392-403 pubmed 出版商
  432. Williams B, Tebbutt N, Buchert M, Putoczki T, Doggett K, Bao S, et al. Glycoprotein A33 deficiency: a new mouse model of impaired intestinal epithelial barrier function and inflammatory disease. Dis Model Mech. 2015;8:805-15 pubmed 出版商
  433. Figueira A, Gomes C, Vilhena H, Miranda S, Carvalheira J, de Matos A, et al. Characterization of α-, β- and p120-Catenin Expression in Feline Mammary Tissues and their Relation with E- and P-Cadherin. Anticancer Res. 2015;35:3361-9 pubmed
  434. Kim S, Lee E, Kuh H. Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro. Exp Cell Res. 2015;335:187-96 pubmed 出版商
  435. Zhu D, Wang Z, Zhao J, Calimeri T, Meng J, Hideshima T, et al. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat Med. 2015;21:572-80 pubmed 出版商
  436. Cheung C, Bendris N, Paul C, Hamieh A, Anouar Y, Hahne M, et al. Cyclin A2 modulates EMT via β-catenin and phospholipase C pathways. Carcinogenesis. 2015;36:914-24 pubmed 出版商
  437. Duvall Noelle N, Karwandyar A, Richmond A, Raman D. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. Oncogene. 2016;35:1122-33 pubmed 出版商
  438. Grzesiak M, Mitan A, Janik M, Knapczyk Stwora K, Slomczynska M. Flutamide alters β-catenin expression and distribution, and its interactions with E-cadherin in the porcine corpus luteum of mid- and late pregnancy. Histol Histopathol. 2015;30:1341-52 pubmed 出版商
  439. Grikscheit K, Frank T, Wang Y, Grosse R. Junctional actin assembly is mediated by Formin-like 2 downstream of Rac1. J Cell Biol. 2015;209:367-76 pubmed 出版商
  440. Cuevas C, Tapia Rojas C, Cespedes C, Inestrosa N, Vio C. β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats. Biomed Res Int. 2015;2015:726012 pubmed 出版商
  441. Brunner S, Weber F, Werner J, Agha A, Farkas S, Schlitt H, et al. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification. BMC Surg. 2015;15:49 pubmed 出版商
  442. Isogai T, van der Kammen R, Innocenti M. SMIFH2 has effects on Formins and p53 that perturb the cell cytoskeleton. Sci Rep. 2015;5:9802 pubmed 出版商
  443. VaÅ¡kovičová K, Szabadosová E, ÄŒermák V, Gandalovičová A, Kasalová L, Rösel D, et al. PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness. BMC Cancer. 2015;15:326 pubmed 出版商
  444. Teasley D, Parajuli S, Nguyen M, Moore H, Alspach E, Lock Y, et al. Flap Endonuclease 1 Limits Telomere Fragility on the Leading Strand. J Biol Chem. 2015;290:15133-45 pubmed 出版商
  445. Shaikh L, Zhou J, Teo A, Garg S, Neogi S, Figg N, et al. LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal. J Clin Endocrinol Metab. 2015;100:E836-44 pubmed 出版商
  446. Caruso M, Ferranti F, Corano Scheri K, Dobrowolny G, Ciccarone F, Grammatico P, et al. R-spondin 1/dickkopf-1/beta-catenin machinery is involved in testicular embryonic angiogenesis. PLoS ONE. 2015;10:e0124213 pubmed 出版商
  447. Lin X, Xu W, Shao M, Fan Q, Wen G, Li C, et al. Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration. BMC Complement Altern Med. 2015;15:126 pubmed 出版商
  448. Overgaard C, Schlingmann B, Dorsainvil White S, Ward C, Fan X, Swarnakar S, et al. The relative balance of GM-CSF and TGF-β1 regulates lung epithelial barrier function. Am J Physiol Lung Cell Mol Physiol. 2015;308:L1212-23 pubmed 出版商
  449. Gay M, Valenta T, Herr P, Paratore Hari L, Basler K, Sommer L. Distinct adhesion-independent functions of β-catenin control stage-specific sensory neurogenesis and proliferation. BMC Biol. 2015;13:24 pubmed 出版商
  450. Zarzycka M, Chojnacka K, Mruk D, Górowska E, Hejmej A, Kotula Balak M, et al. Flutamide alters the distribution of c-Src and affects the N-cadherin-β-catenin complex in the seminiferous epithelium of adult rat. Andrology. 2015;3:569-81 pubmed 出版商
  451. Figeac N, Zammit P. Coordinated action of Axin1 and Axin2 suppresses β-catenin to regulate muscle stem cell function. Cell Signal. 2015;27:1652-65 pubmed 出版商
  452. Lund K, Dembinski J, Solberg N, Urbanucci A, Mills I, Krauss S. Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment. PLoS ONE. 2015;10:e0123684 pubmed 出版商
  453. Hsiao C, Wu Y, Nan F, Huang S, Chen L, Chen S. Immunomodulator 'mushroom beta glucan' induces Wnt/β catenin signalling and improves wound recovery in tilapia and rat skin: a histopathological study. Int Wound J. 2016;13:1116-1128 pubmed 出版商
  454. Janes K. An analysis of critical factors for quantitative immunoblotting. Sci Signal. 2015;8:rs2 pubmed 出版商
  455. Fu Q, Chen Z, Gong X, Cai Y, Chen Y, Ma X, et al. β-Catenin expression is regulated by an IRES-dependent mechanism and stimulated by paclitaxel in human ovarian cancer cells. Biochem Biophys Res Commun. 2015;461:21-7 pubmed 出版商
  456. Kubelt C, Hattermann K, Sebens S, Mehdorn H, Held Feindt J. Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas. Int J Oncol. 2015;46:2515-25 pubmed 出版商
  457. Malchenko S, Sredni S, Hashimoto H, Kasai A, Nagayasu K, Xie J, et al. A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells. PLoS ONE. 2015;10:e0121707 pubmed 出版商
  458. Tsukiyama T, Fukui A, Terai S, Fujioka Y, Shinada K, Takahashi H, et al. Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling. Mol Cell Biol. 2015;35:2007-23 pubmed 出版商
  459. Cho J, Lee S, Oh A, Yoon M, Woo T, Park B. NF2 blocks Snail-mediated p53 suppression in mesothelioma. Oncotarget. 2015;6:10073-85 pubmed
  460. Lee J, Garbe J, Vrba L, Miyano M, Futscher B, Stampfer M, et al. Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol. 2015;3:13 pubmed 出版商
  461. Bazellières E, Conte V, Elosegui Artola A, Serra Picamal X, Bintanel Morcillo M, Roca Cusachs P, et al. Control of cell-cell forces and collective cell dynamics by the intercellular adhesome. Nat Cell Biol. 2015;17:409-20 pubmed 出版商
  462. Kim Y, Jin D, Lee B, Cho E, Han J, Shim Y, et al. RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung. Clin Epigenetics. 2015;7:32 pubmed 出版商
  463. Boersma V, Moatti N, Segura Bayona S, Peuscher M, van der Torre J, Wevers B, et al. MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5' end resection. Nature. 2015;521:537-540 pubmed 出版商
  464. Iervolino A, Trepiccione F, Petrillo F, Spagnuolo M, Scarfò M, Frezzetti D, et al. Selective dicer suppression in the kidney alters GSK3β/β-catenin pathways promoting a glomerulocystic disease. PLoS ONE. 2015;10:e0119142 pubmed 出版商
  465. Chen X, Liu X, Lang H, Zhang S, Luo Y, Zhang J. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line. PLoS ONE. 2015;10:e0121319 pubmed 出版商
  466. Melo E, Kasper J, Unger R, Farré R, Kirkpatrick C. Development of a Bronchial Wall Model: Triple Culture on a Decellularized Porcine Trachea. Tissue Eng Part C Methods. 2015;21:909-21 pubmed 出版商
  467. Skardal A, Devarasetty M, Rodman C, Atala A, Soker S. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro. Ann Biomed Eng. 2015;43:2361-73 pubmed 出版商
  468. Geels Y, van der Putten L, van Tilborg A, Lurkin I, Zwarthoff E, Pijnenborg J, et al. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecol Oncol. 2015;137:245-51 pubmed 出版商
  469. Furihata T, Kawamatsu S, Ito R, Saito K, Suzuki S, Kishida S, et al. Hydrocortisone enhances the barrier properties of HBMEC/ciβ, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects. Fluids Barriers CNS. 2015;12:7 pubmed 出版商
  470. Tennakoon A, Izawa T, Wijesundera K, Katou Ichikawa C, Tanaka M, Golbar H, et al. Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Exp Mol Pathol. 2015;98:476-85 pubmed 出版商
  471. Whish S, Dziegielewska K, MøllgÃ¥rd K, Noor N, Liddelow S, Habgood M, et al. The inner CSF-brain barrier: developmentally controlled access to the brain via intercellular junctions. Front Neurosci. 2015;9:16 pubmed 出版商
  472. Zheng L, Sun D, Fan W, Zhang Z, Li Q, Jiang T. Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer. PLoS ONE. 2015;10:e0118276 pubmed 出版商
  473. ErLin S, WenJie W, LiNing W, BingXin L, MingDe L, Yan S, et al. Musashi-1 maintains blood-testis barrier structure during spermatogenesis and regulates stress granule formation upon heat stress. Mol Biol Cell. 2015;26:1947-56 pubmed 出版商
  474. Song E, Yu W, Xiong X, Kuang X, Ai Y, Xiong X. Astrocyte elevated gene-1 promotes progression of cervical squamous cell carcinoma by inducing epithelial-mesenchymal transition via Wnt signaling. Int J Gynecol Cancer. 2015;25:345-55 pubmed 出版商
  475. Dow L, Fisher J, O Rourke K, Muley A, Kastenhuber E, Livshits G, et al. Inducible in vivo genome editing with CRISPR-Cas9. Nat Biotechnol. 2015;33:390-394 pubmed 出版商
  476. Riise J, Plath N, Pakkenberg B, Parachikova A. Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease. J Neural Transm (Vienna). 2015;122:1303-18 pubmed 出版商
  477. Kang Y, Cho C, Kwon S. Microcystic stromal tumor of the ovary with mutation in exon 3 of β-catenin: a case report. Int J Gynecol Pathol. 2015;34:121-5 pubmed 出版商
  478. Walker M, Stopford C, Cederlund M, Fang F, Jahn C, Rabinowitz A, et al. FOXP1 potentiates Wnt/β-catenin signaling in diffuse large B cell lymphoma. Sci Signal. 2015;8:ra12 pubmed 出版商
  479. Xue J, Chen Y, Wu Y, Wang Z, Zhou A, Zhang S, et al. Tumour suppressor TRIM33 targets nuclear β-catenin degradation. Nat Commun. 2015;6:6156 pubmed 出版商
  480. Wagner R, Luciani F, Cario André M, Rubod A, Petit V, Benzekri L, et al. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. J Invest Dermatol. 2015;135:1810-1819 pubmed 出版商
  481. Cai K, Wang Y, Smith E, Smedberg J, Yang D, Yang W, et al. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice. Neoplasia. 2015;17:89-100 pubmed 出版商
  482. Banach Orlowska M, Szymańska E, Miaczynska M. APPL1 endocytic adaptor as a fine tuner of Dvl2-induced transcription. FEBS Lett. 2015;589:532-9 pubmed 出版商
  483. Wei Y, Backlund L, Wegener G, Mathé A, Lavebratt C. Telomerase dysregulation in the hippocampus of a rat model of depression: normalization by lithium. Int J Neuropsychopharmacol. 2015;18:pyv002 pubmed 出版商
  484. Chow H, Dong B, Duron S, Campbell D, Ong C, Hoeflich K, et al. Group I Paks as therapeutic targets in NF2-deficient meningioma. Oncotarget. 2015;6:1981-94 pubmed
  485. Traenkle B, Emele F, Anton R, Poetz O, Haeussler R, Maier J, et al. Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells. Mol Cell Proteomics. 2015;14:707-23 pubmed 出版商
  486. Chong K, Hsu C, Hung T, Hu H, Huang T, Wang T, et al. Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells. Cancer Biol Ther. 2015;16:149-59 pubmed 出版商
  487. Gao B, Huang Q, Jie Q, Wang L, Zhang H, Liu J, et al. Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs. Biochimie. 2015;110:36-44 pubmed 出版商
  488. Xu X, Kim J, Sun P, Yoo S, Kim H, Jin Y, et al. Immunohistochemical demonstration of alteration of β-catenin during tumor metastasis by different mechanisms according to histology in lung cancer. Exp Ther Med. 2015;9:311-318 pubmed
  489. López Escobar B, Cano D, Rojas A, De Felipe B, Palma F, Sánchez Alcázar J, et al. The effect of maternal diabetes on the Wnt-PCP pathway during embryogenesis as reflected in the developing mouse eye. Dis Model Mech. 2015;8:157-68 pubmed 出版商
  490. Olsen P, Solberg N, Lund K, Vehus T, Gelazauskaite M, Wilson S, et al. Implications of targeted genomic disruption of β-catenin in BxPC-3 pancreatic adenocarcinoma cells. PLoS ONE. 2014;9:e115496 pubmed 出版商
  491. Kim Y, Han D, Min H, Jin J, Yi E, Kim Y. Comparative proteomic profiling of pancreatic ductal adenocarcinoma cell lines. Mol Cells. 2014;37:888-98 pubmed 出版商
  492. Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman M, et al. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015;21:899-906 pubmed 出版商
  493. Ulanet D, Couto K, Jha A, Choe S, Wang A, Woo H, et al. Mesenchymal phenotype predisposes lung cancer cells to impaired proliferation and redox stress in response to glutaminase inhibition. PLoS ONE. 2014;9:e115144 pubmed 出版商
  494. Yokoi N, Fukata Y, Kase D, Miyazaki T, Jaegle M, Ohkawa T, et al. Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy. Nat Med. 2015;21:19-26 pubmed 出版商
  495. Scotti L, Abramovich D, Pascuali N, Durand L, Irusta G, de Zúñiga I, et al. Inhibition of angiopoietin-1 (ANGPT1) affects vascular integrity in ovarian hyperstimulation syndrome (OHSS). Reprod Fertil Dev. 2016;28:690-9 pubmed 出版商
  496. Bisson J, Mills B, Paul Helt J, Zwaka T, Cohen E. Wnt5a and Wnt11 inhibit the canonical Wnt pathway and promote cardiac progenitor development via the Caspase-dependent degradation of AKT. Dev Biol. 2015;398:80-96 pubmed 出版商
  497. Fine J, Renner D, Forsberg A, Cameron R, Galick B, Le C, et al. Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. Neurosci Lett. 2015;584:362-7 pubmed 出版商
  498. da Silva S, Morand G, Alobaid F, Hier M, Mlynarek A, Alaoui Jamali M, et al. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clin Exp Metastasis. 2015;32:55-63 pubmed 出版商
  499. Davis H, Irshad S, Bansal M, Rafferty H, Boitsova T, Bardella C, et al. Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche. Nat Med. 2015;21:62-70 pubmed 出版商
  500. Jones R, Abedalthagafi M, Brahmandam M, Greenfield E, Hoang M, Louis D, et al. Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia. Mod Pathol. 2015;28:596-606 pubmed 出版商
  501. Isobe T, Hisamori S, Hogan D, Zabala M, Hendrickson D, Dalerba P, et al. miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. elife. 2014;3: pubmed 出版商
  502. Wang T, Chen Z, Zhu Y, Pan Q, Liu Y, Qi X, et al. Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells. J Biol Chem. 2015;290:448-56 pubmed 出版商
  503. Hung T, Hsu S, Cheng C, Choo K, Tseng C, Chen T, et al. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Oncotarget. 2014;5:12273-90 pubmed
  504. Voorneveld P, Kodach L, Jacobs R, van Noesel C, Peppelenbosch M, Korkmaz K, et al. The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC. Br J Cancer. 2015;112:122-30 pubmed 出版商
  505. Raiko L, Leinonen P, Hägg P, Peltonen J, Oikarinen A, Peltonen S. Tight junctions in Hailey-Hailey and Darier's diseases. Dermatol Reports. 2009;1:e1 pubmed 出版商
  506. Shriver M, Stroka K, Vitolo M, Martin S, Huso D, Konstantopoulos K, et al. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis. Oncogene. 2015;34:4248-59 pubmed 出版商
  507. Pérez Alvarez M, Mateos L, Alonso A, Wandosell F. Estradiol and Progesterone Administration After pMCAO Stimulates the Neurological Recovery and Reduces the Detrimental Effect of Ischemia Mainly in Hippocampus. Mol Neurobiol. 2015;52:1690-1703 pubmed 出版商
  508. Li F, Song N, Tombran Tink J, Niyibizi C. Pigment epithelium derived factor suppresses expression of Sost/Sclerostin by osteocytes: implication for its role in bone matrix mineralization. J Cell Physiol. 2015;230:1243-9 pubmed 出版商
  509. Raap M, Antonopoulos W, Dämmrich M, Christgen H, Steinmann D, Länger F, et al. High frequency of lobular breast cancer in distant metastases to the orbit. Cancer Med. 2015;4:104-11 pubmed 出版商
  510. de Andrade G, Kunzelman L, Merrill M, Fuerst P. Developmentally dynamic colocalization patterns of DSCAM with adhesion and synaptic proteins in the mouse retina. Mol Vis. 2014;20:1422-33 pubmed
  511. Kim H, Park J, Won H, Lee J, Kong G. CBX7 inhibits breast tumorigenicity through DKK-1-mediated suppression of the Wnt/β-catenin pathway. FASEB J. 2015;29:300-13 pubmed 出版商
  512. Ibrahem S, Al Ghamdi S, Baloch K, Muhammad B, Fadhil W, Jackson D, et al. STAT3 paradoxically stimulates β-catenin expression but inhibits β-catenin function. Int J Exp Pathol. 2014;95:392-400 pubmed 出版商
  513. Yu J, Kong C, Zhang Z, Zhan B, Jiang Z. Aplasia Ras homolog member I expression induces apoptosis in renal cancer cells via the β-catenin signaling pathway. Mol Med Rep. 2015;11:475-81 pubmed 出版商
  514. Vestergaard M, Awan A, Warzecha C, Christensen S, Andersen C. Immunofluorescence Microscopy and mRNA Analysis of Human Embryonic Stem Cells (hESCs) Including Primary Cilia Associated Signaling Pathways. Methods Mol Biol. 2016;1307:123-40 pubmed 出版商
  515. Jansen S, Holman R, Hedemann I, Frankes E, Elzinga C, Timens W, et al. Prostaglandin E2 promotes MYCN non-amplified neuroblastoma cell survival via β-catenin stabilization. J Cell Mol Med. 2015;19:210-26 pubmed 出版商
  516. O Shea C, Fitzpatrick J, Koch P. Desmosomal defects in acantholytic squamous cell carcinomas. J Cutan Pathol. 2014;41:873-9 pubmed 出版商
  517. Fan C, Jiang G, Zhang X, Miao Y, Lin X, Luan L, et al. Zbed3 contributes to malignant phenotype of lung cancer via regulating β-catenin and P120-catenin 1. Mol Carcinog. 2015;54 Suppl 1:E138-47 pubmed 出版商
  518. Jia D, Yang W, Li L, Liu H, Tan Y, Ooi S, et al. β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer. Cell Death Differ. 2015;22:298-310 pubmed 出版商
  519. Matsuyama M, Nomori A, Nakakuni K, Shimono A, Fukushima M. Secreted Frizzled-related protein 1 (Sfrp1) regulates the progression of renal fibrosis in a mouse model of obstructive nephropathy. J Biol Chem. 2014;289:31526-33 pubmed 出版商
  520. Mendonça M, Soares E, Stávale L, Kalapothakis E, Cruz Höfling M. Vascular endothelial growth factor increases during blood-brain barrier-enhanced permeability caused by Phoneutria nigriventer spider venom. Biomed Res Int. 2014;2014:721968 pubmed 出版商
  521. Milara J, Peiró T, Serrano A, Artigues E, Aparicio J, Tenor H, et al. Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro. COPD. 2015;12:320-31 pubmed 出版商
  522. Liu C, Lin C, Gao C, May Simera H, Swaroop A, Li T. Null and hypomorph Prickle1 alleles in mice phenocopy human Robinow syndrome and disrupt signaling downstream of Wnt5a. Biol Open. 2014;3:861-70 pubmed 出版商
  523. Rubashkin M, Cassereau L, Bainer R, DuFort C, Yui Y, Ou G, et al. Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate. Cancer Res. 2014;74:4597-611 pubmed 出版商
  524. Valkenburg K, Yu X, De Marzo A, Spiering T, Matusik R, Williams B. Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia. Prostate. 2014;74:1506-20 pubmed 出版商
  525. Hagos Y, Wegner W, Kuehne A, Floerl S, Marada V, Burckhardt G, et al. HNF4α induced chemosensitivity to oxaliplatin and 5-FU mediated by OCT1 and CNT3 in renal cell carcinoma. J Pharm Sci. 2014;103:3326-34 pubmed 出版商
  526. Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T, et al. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014;26:222-34 pubmed 出版商
  527. Ihara K, Asanuma K, Fukuda T, Ohwada S, Yoshida M, Nishimori K. MAGI-2 is critical for the formation and maintenance of the glomerular filtration barrier in mouse kidney. Am J Pathol. 2014;184:2699-708 pubmed 出版商
  528. Van Brocklyn J, Wojton J, Meisen W, Kellough D, Ecsedy J, Kaur B, et al. Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Res. 2014;74:5364-70 pubmed 出版商
  529. Xie Y, Lu W, Liu S, Yang Q, Carver B, Li E, et al. Crosstalk between nuclear MET and SOX9/?-catenin correlates with castration-resistant prostate cancer. Mol Endocrinol. 2014;28:1629-39 pubmed 出版商
  530. Willis C, Klüppel M. Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells. PLoS ONE. 2014;9:e103966 pubmed 出版商
  531. Wanet A, Remacle N, Najar M, Sokal E, Arnould T, Najimi M, et al. Mitochondrial remodeling in hepatic differentiation and dedifferentiation. Int J Biochem Cell Biol. 2014;54:174-85 pubmed 出版商
  532. Crespi A, Bertoni A, Ferrari I, Padovano V, Della Mina P, Berti E, et al. POF1B localizes to desmosomes and regulates cell adhesion in human intestinal and keratinocyte cell lines. J Invest Dermatol. 2015;135:192-201 pubmed 出版商
  533. Zhang S, Li L, Kendrick S, Gerard R, Zhu H. TALEN-mediated somatic mutagenesis in murine models of cancer. Cancer Res. 2014;74:5311-21 pubmed 出版商
  534. Ohta H, Sunden Y, Yokoyama N, Osuga T, Lim S, Tamura Y, et al. Expression of apical junction complex proteins in duodenal mucosa of dogs with inflammatory bowel disease. Am J Vet Res. 2014;75:746-51 pubmed 出版商
  535. Ostapoff K, Cenik B, Wang M, Ye R, Xu X, Nugent D, et al. Neutralizing murine TGF?R2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis. Cancer Res. 2014;74:4996-5007 pubmed 出版商
  536. Hsu H, Liu Y, Tseng K, Yang T, Yeh C, You J, et al. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression. J Cancer Res Clin Oncol. 2015;141:11-21 pubmed 出版商
  537. Coulson Thomas V, Gesteira T, Esko J, KAO W. Heparan sulfate regulates hair follicle and sebaceous gland morphogenesis and homeostasis. J Biol Chem. 2014;289:25211-26 pubmed 出版商
  538. Hsu H, Liu Y, Tseng K, Tan B, Chen S, Chen H. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/?-catenin signaling pathway in colorectal cancer cells. Cell Signal. 2014;26:2333-42 pubmed 出版商
  539. Azzolin L, Panciera T, Soligo S, Enzo E, Bicciato S, Dupont S, et al. YAP/TAZ incorporation in the ?-catenin destruction complex orchestrates the Wnt response. Cell. 2014;158:157-70 pubmed 出版商
  540. Jin G, Liu B, You Z, Bambakidis T, Dekker S, Maxwell J, et al. Development of a novel neuroprotective strategy: combined treatment with hypothermia and valproic acid improves survival in hypoxic hippocampal cells. Surgery. 2014;156:221-8 pubmed 出版商
  541. Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, et al. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. J Pathol. 2014;234:302-15 pubmed 出版商
  542. Ohkawa T, Satake S, Yokoi N, Miyazaki Y, Ohshita T, Sobue G, et al. Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis. J Neurosci. 2014;34:8151-63 pubmed 出版商
  543. Moody S, Schinzel A, Singh S, Izzo F, Strickland M, Luo L, et al. PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling. Oncogene. 2015;34:2061-71 pubmed 出版商
  544. Oishi N, Kondo T, Nakazawa T, Mochizuki K, Kasai K, Inoue T, et al. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case report and literature review. Pathol Res Pract. 2014;210:1142-5 pubmed 出版商
  545. Zhu Z, Liu Y, Li K, Liu J, Wang H, Sun B, et al. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility. Carcinogenesis. 2014;35:1901-10 pubmed 出版商
  546. Godde N, Sheridan J, Smith L, Pearson H, Britt K, Galea R, et al. Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland. PLoS Genet. 2014;10:e1004323 pubmed 出版商
  547. Powell A, Vlacich G, Zhao Z, McKinley E, Washington M, Manning H, et al. Inducible loss of one Apc allele in Lrig1-expressing progenitor cells results in multiple distal colonic tumors with features of familial adenomatous polyposis. Am J Physiol Gastrointest Liver Physiol. 2014;307:G16-23 pubmed 出版商
  548. Elliott V, Rychahou P, Zaytseva Y, Evers B. Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model. PLoS ONE. 2014;9:e97432 pubmed 出版商
  549. Durak O, de Anda F, Singh K, Leussis M, Petryshen T, Sklar P, et al. Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of ?-catenin. Mol Psychiatry. 2015;20:388-97 pubmed 出版商
  550. Hatakeyama J, Wakamatsu Y, Nagafuchi A, Kageyama R, Shigemoto R, Shimamura K. Cadherin-based adhesions in the apical endfoot are required for active Notch signaling to control neurogenesis in vertebrates. Development. 2014;141:1671-82 pubmed 出版商
  551. Zhao C, Zhang J, Li K, Yang J, Yu H, Duan S, et al. ?-Catenin regulates membrane potential in muscle cells by regulating the ?2 subunit of Na,K-ATPase. Eur J Neurosci. 2014;40:2216-24 pubmed 出版商
  552. Villarreal Calderon R, Luévano González A, Aragón Flores M, Zhu H, Yuan Y, Xiang Q, et al. Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis. Ann Diagn Pathol. 2014;18:129-35 pubmed 出版商
  553. Li J, Bai X, Zou Y, Hao Y, Xu X. Aberration of the Wnt signaling pathway in pulmonary fatal adenocarcinoma: a case report. Chin J Cancer Res. 2014;26:E13-6 pubmed 出版商
  554. Alfaro Cervello C, Cebrian Silla A, Soriano Navarro M, García Tárraga P, Matías Guiu J, Gomez Pinedo U, et al. The adult macaque spinal cord central canal zone contains proliferative cells and closely resembles the human. J Comp Neurol. 2014;522:1800-17 pubmed 出版商
  555. Wang H, Sun W, Ma J, Pan Y, Wang L, Zhang W. Polycystin-1 mediates mechanical strain-induced osteoblastic mechanoresponses via potentiation of intracellular calcium and Akt/?-catenin pathway. PLoS ONE. 2014;9:e91730 pubmed 出版商
  556. Ramaiahgari S, den Braver M, Herpers B, Terpstra V, Commandeur J, van de Water B, et al. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Arch Toxicol. 2014;88:1083-95 pubmed 出版商
  557. Konsavage W, Yochum G. The myc 3' wnt-responsive element suppresses colonic tumorigenesis. Mol Cell Biol. 2014;34:1659-69 pubmed 出版商
  558. Hwang W, Jiang J, Yang S, Huang T, Lan H, Teng H, et al. MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol. 2014;16:268-80 pubmed 出版商
  559. Boin A, Couvelard A, Couderc C, Brito I, Filipescu D, Kalamarides M, et al. Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas. Neuro Oncol. 2014;16:1196-209 pubmed 出版商
  560. Rodrigues M, Rema A, Gartner M, Laufer Amorim R. Role of adhesion molecules and proliferation hyperplasic, pre neoplastic and neoplastic lesions in canine prostate. Pak J Biol Sci. 2013;16:1324-9 pubmed
  561. Piao H, Yuan Y, Wang M, Sun Y, Liang H, Ma L. ?-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-?B signalling. Nat Cell Biol. 2014;16:245-54 pubmed 出版商
  562. Martianov I, Cler E, Duluc I, Vicaire S, Philipps M, Freund J, et al. TAF4 inactivation reveals the 3 dimensional growth promoting activities of collagen 6A3. PLoS ONE. 2014;9:e87365 pubmed 出版商
  563. Kohler E, Baruah J, Urao N, Ushio Fukai M, Fukai T, Chatterjee I, et al. Low-dose 6-bromoindirubin-3'-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularization. Stem Cells. 2014;32:1538-52 pubmed 出版商
  564. Grünberg J, Hammarstedt A, Hedjazifar S, Smith U. The Novel Secreted Adipokine WNT1-inducible Signaling Pathway Protein 2 (WISP2) Is a Mesenchymal Cell Activator of Canonical WNT. J Biol Chem. 2014;289:6899-907 pubmed 出版商
  565. Hilliard S, Yao X, El Dahr S. Mdm2 is required for maintenance of the nephrogenic niche. Dev Biol. 2014;387:1-14 pubmed 出版商
  566. Byron A, Randles M, Humphries J, Mironov A, Hamidi H, Harris S, et al. Glomerular cell cross-talk influences composition and assembly of extracellular matrix. J Am Soc Nephrol. 2014;25:953-66 pubmed 出版商
  567. D Anselmi F, Masiello M, Cucina A, Proietti S, Dinicola S, Pasqualato A, et al. Microenvironment promotes tumor cell reprogramming in human breast cancer cell lines. PLoS ONE. 2013;8:e83770 pubmed 出版商
  568. McGuire D, Rowse A, Li H, Peng B, Sestero C, Cashman K, et al. CD5 enhances Th17-cell differentiation by regulating IFN-? response and ROR?t localization. Eur J Immunol. 2014;44:1137-42 pubmed 出版商
  569. Metcalfe C, Kljavin N, Ybarra R, De Sauvage F. Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell. 2014;14:149-59 pubmed 出版商
  570. Kim S, Kim M, Kim M, Kim S, Choi J, Yu E, et al. Pleomorphic solid pseudopapillary neoplasm of the pancreas: degenerative change rather than high-grade malignant potential. Hum Pathol. 2014;45:166-74 pubmed 出版商
  571. Rennoll S, Konsavage W, Yochum G. Nuclear AXIN2 represses MYC gene expression. Biochem Biophys Res Commun. 2014;443:217-22 pubmed 出版商
  572. Krabbe L, Westerman M, Bagrodia A, Gayed B, Darwish O, Haddad A, et al. Dysregulation of ?-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma. J Urol. 2014;191:1671-7 pubmed 出版商
  573. Kriz V, Pospichalova V, Masek J, Kilander M, Slavík J, Tanneberger K, et al. ?-arrestin promotes Wnt-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation via increased membrane recruitment of Amer1 protein. J Biol Chem. 2014;289:1128-41 pubmed 出版商
  574. Dawes L, Sugiyama Y, Lovicu F, Harris C, Shelley E, McAvoy J. Interactions between lens epithelial and fiber cells reveal an intrinsic self-assembly mechanism. Dev Biol. 2014;385:291-303 pubmed 出版商
  575. Whiteman E, Fan S, Harder J, Walton K, Liu C, Soofi A, et al. Crumbs3 is essential for proper epithelial development and viability. Mol Cell Biol. 2014;34:43-56 pubmed 出版商
  576. Thrasivoulou C, Millar M, Ahmed A. Activation of intracellular calcium by multiple Wnt ligands and translocation of ?-catenin into the nucleus: a convergent model of Wnt/Ca2+ and Wnt/?-catenin pathways. J Biol Chem. 2013;288:35651-9 pubmed 出版商
  577. Liu H, Zhang W, Jia Y, Yu Q, Grau G, Peng L, et al. Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells. Cell Death Dis. 2013;4:e857 pubmed 出版商
  578. Kazantseva J, Kivil A, Tints K, Kazantseva A, Neuman T, Palm K. Alternative splicing targeting the hTAF4-TAFH domain of TAF4 represses proliferation and accelerates chondrogenic differentiation of human mesenchymal stem cells. PLoS ONE. 2013;8:e74799 pubmed 出版商
  579. Xavier C, Melikova M, Chuman Y, Uren A, Baljinnyam B, Rubin J. Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/?-catenin signaling. Cell Signal. 2014;26:94-101 pubmed 出版商
  580. Yu L, Cheng H, Yang S. Clinicopathological and extensive immunohistochemical study of a type II pleuropulmonary blastoma. Fetal Pediatr Pathol. 2014;33:1-8 pubmed 出版商
  581. Linch M, Sanz Garcia M, Rosse C, Riou P, Peel N, Madsen C, et al. Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids. Carcinogenesis. 2014;35:396-406 pubmed 出版商
  582. Gu M, Choi J. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma. J Clin Pathol. 2014;67:229-34 pubmed 出版商
  583. Müller M, Florian S, Pommer S, Osterhoff M, Esworthy R, Chu F, et al. Deletion of glutathione peroxidase-2 inhibits azoxymethane-induced colon cancer development. PLoS ONE. 2013;8:e72055 pubmed 出版商
  584. Knoblich K, Wang H, Sharma C, Fletcher A, Turley S, Hemler M. Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits ?-catenin degradation. Cell Mol Life Sci. 2014;71:1305-14 pubmed 出版商
  585. Siljamäki E, Raiko L, Toriseva M, Nissinen L, Näreoja T, Peltonen J, et al. p38? mitogen-activated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes. Arch Dermatol Res. 2014;306:131-41 pubmed 出版商
  586. Lu H, Hu L, Yu L, Wang X, Urvalek A, Li T, et al. KLF8 and FAK cooperatively enrich the active MMP14 on the cell surface required for the metastatic progression of breast cancer. Oncogene. 2014;33:2909-17 pubmed 出版商
  587. Lee P, Yau D, Lau P, Chan J. Plexiform fibromyxoma (plexiform angiomyxoid myofibroblastic tumor) of stomach: an unusual presentation as a fistulating abscess. Int J Surg Pathol. 2014;22:286-90 pubmed 出版商
  588. Nakamura I, Fernández Barrena M, Ortiz Ruiz M, Almada L, Hu C, Elsawa S, et al. Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regeneration. J Biol Chem. 2013;288:21389-98 pubmed 出版商
  589. Lee S, Kim H, Kim W, Han H, Lim S, Kim W, et al. Genetic alteration and immunohistochemical staining patterns of ovarian high-grade serous adenocarcinoma with special emphasis on p53 immnnostaining pattern. Pathol Int. 2013;63:252-9 pubmed 出版商
  590. Shi Y, Wu H, Zhang M, Ding L, Meng F, Fan X. Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol. 2013;8:89 pubmed 出版商
  591. King S, Mohiuddin J, Dekaney C. Paneth cells expand from newly created and preexisting cells during repair after doxorubicin-induced damage. Am J Physiol Gastrointest Liver Physiol. 2013;305:G151-62 pubmed 出版商
  592. Boehlke C, Kotsis F, Buchholz B, Powelske C, Eckardt K, Walz G, et al. Kif3a guides microtubular dynamics, migration and lumen formation of MDCK cells. PLoS ONE. 2013;8:e62165 pubmed 出版商
  593. Colli L, Saggioro F, Serafini L, Camargo R, Machado H, Moreira A, et al. Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors. PLoS ONE. 2013;8:e62424 pubmed 出版商
  594. Min H, Lee C, Jung K. Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population. J Korean Med Sci. 2013;28:534-41 pubmed 出版商
  595. Qiu H, Zhang L, Ren C, Zeng Z, Wu W, Luo H, et al. Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling. PLoS ONE. 2013;8:e56959 pubmed 出版商
  596. Vasconcelos Nóbrega C, Costa C, Vala H, Colaco A, Santos L, Lopes C, et al. E-cadherin and ?-catenin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in mice. Urol Int. 2013;91:462-6 pubmed 出版商
  597. Zhang J, Twelvetrees A, Lazarus J, Blasier K, Yao X, Inamdar N, et al. Establishing a novel knock-in mouse line for studying neuronal cytoplasmic dynein under normal and pathologic conditions. Cytoskeleton (Hoboken). 2013;70:215-27 pubmed 出版商
  598. Li Y, Zheng Y, Izumi K, Ishiguro H, Ye B, Li F, et al. Androgen activates ?-catenin signaling in bladder cancer cells. Endocr Relat Cancer. 2013;20:293-304 pubmed 出版商
  599. Souazé F, Bou Hanna C, Kandel C, Leclair F, Devalliere J, Charreau B, et al. Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: a translational study. PLoS ONE. 2013;8:e55904 pubmed 出版商
  600. Lang J, Maeda Y, Bannerman P, Xu J, Horiuchi M, Pleasure D, et al. Adenomatous polyposis coli regulates oligodendroglial development. J Neurosci. 2013;33:3113-30 pubmed 出版商
  601. Dawes L, Sugiyama Y, Tanedo A, Lovicu F, McAvoy J. Wnt-frizzled signaling is part of an FGF-induced cascade that promotes lens fiber differentiation. Invest Ophthalmol Vis Sci. 2013;54:1582-90 pubmed 出版商
  602. Femia A, Dolara P, Salvadori M, Caderni G. Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazine-induced rat colon carcinogenesis: correlation with nuclear ?-catenin. BMC Cancer. 2013;13:48 pubmed 出版商
  603. Han J, Soletti R, Sadarangani A, Sridevi P, Ramirez M, Eckmann L, et al. Nuclear expression of ?-catenin promotes RB stability and resistance to TNF-induced apoptosis in colon cancer cells. Mol Cancer Res. 2013;11:207-18 pubmed 出版商
  604. Avoranta S, Korkeila E, Ristamäki R, Syrjanen K, Carpén O, Pyrhönen S, et al. ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer. Hum Pathol. 2013;44:966-74 pubmed 出版商
  605. Ford C, Jary E, Ma S, Nixdorf S, Heinzelmann Schwarz V, Ward R. The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells. PLoS ONE. 2013;8:e54362 pubmed 出版商
  606. Latasa M, Salis F, Urtasun R, Garcia Irigoyen O, Elizalde M, Uriarte I, et al. Regulation of amphiregulin gene expression by ?-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system. PLoS ONE. 2012;7:e52711 pubmed 出版商
  607. Wang Q, Lin J, Chan S, Lin J. The Xin repeat-containing protein, mXinβ, initiates the maturation of the intercalated discs during postnatal heart development. Dev Biol. 2013;374:264-80 pubmed 出版商
  608. Styner M, Meyer M, Galior K, Case N, Xie Z, Sen B, et al. Mechanical strain downregulates C/EBP? in MSC and decreases endoplasmic reticulum stress. PLoS ONE. 2012;7:e51613 pubmed 出版商
  609. Nakanishi Y, Seno H, Fukuoka A, Ueo T, Yamaga Y, Maruno T, et al. Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet. 2013;45:98-103 pubmed 出版商
  610. McClain C, Sim F, Goldman S. Pleiotrophin suppression of receptor protein tyrosine phosphatase-?/? maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells. J Neurosci. 2012;32:15066-75 pubmed 出版商
  611. Carlsson E, Krohn K, Ovaska K, Lindberg P, Häyry V, Maliniemi P, et al. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis. Genes Chromosomes Cancer. 2013;52:191-201 pubmed 出版商
  612. Li Y, Wu C, Chen W, Huang Y, Chai C. The expression and significance of WWOX and ?-catenin in hepatocellular carcinoma. APMIS. 2013;121:120-6 pubmed 出版商
  613. Langer M, Duggan E, Booth J, Patel V, Zander R, Silasi Mansat R, et al. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function. Infect Immun. 2012;80:4374-87 pubmed 出版商
  614. Wallmen B, Schrempp M, Hecht A. Intrinsic properties of Tcf1 and Tcf4 splice variants determine cell-type-specific Wnt/?-catenin target gene expression. Nucleic Acids Res. 2012;40:9455-69 pubmed 出版商
  615. Gil da Costa R, Oliveira P, Bastos M, Lopes C, Lopes C. Ptaquiloside-induced early-stage urothelial lesions show increased cell proliferation and intact ?-catenin and E-cadherin expression. Environ Toxicol. 2014;29:763-9 pubmed 出版商
  616. Raposo C, Odorissi P, Oliveira A, Aoyama H, Ferreira C, Verinaud L, et al. Effect of Phoneutria nigriventer venom on the expression of junctional protein and P-gp efflux pump function in the blood-brain barrier. Neurochem Res. 2012;37:1967-81 pubmed 出版商
  617. Curtis C, Griffin C. The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling. Mol Cell Biol. 2012;32:1312-20 pubmed 出版商
  618. Baljinnyam B, Klauzinska M, Saffo S, Callahan R, Rubin J. Recombinant R-spondin2 and Wnt3a up- and down-regulate novel target genes in C57MG mouse mammary epithelial cells. PLoS ONE. 2012;7:e29455 pubmed 出版商
  619. Zhang J, Liang Z, Gao J, Luo Y, Liu T. Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis. Histopathology. 2011;59:1204-14 pubmed 出版商
  620. Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y. Characterization of hepatocellular adenoma based on the phenotypic classification: The Kanazawa experience. Hepatol Res. 2011;41:982-8 pubmed 出版商
  621. Jin G, Bausch D, Knightly T, Liu Z, Li Y, Liu B, et al. Histone deacetylase inhibitors enhance endothelial cell sprouting angiogenesis in vitro. Surgery. 2011;150:429-35 pubmed 出版商
  622. Ohta H, Yamaguchi T, Rajapakshage B, Murakami M, Sasaki N, Nakamura K, et al. Expression and subcellular localization of apical junction proteins in canine duodenal and colonic mucosa. Am J Vet Res. 2011;72:1046-51 pubmed 出版商
  623. Kolegraff K, Nava P, Laur O, Parkos C, Nusrat A. Characterization of full-length and proteolytic cleavage fragments of desmoglein-2 in native human colon and colonic epithelial cell lines. Cell Adh Migr. 2011;5:306-14 pubmed
  624. Hirt B, Gleiser C, Eckhard A, Mack A, Muller M, Wolburg H, et al. All functional aquaporin-4 isoforms are expressed in the rat cochlea and contribute to the formation of orthogonal arrays of particles. Neuroscience. 2011;189:79-92 pubmed 出版商
  625. MARCIANO D, BRAKEMAN P, Lee C, Spivak N, Eastburn D, Bryant D, et al. p120 catenin is required for normal renal tubulogenesis and glomerulogenesis. Development. 2011;138:2099-109 pubmed 出版商
  626. Im M, Kim D, Park J, Chung H, Lee Y, Kim C, et al. Alteration of the ?-catenin pathway in spiradenoma. J Cutan Pathol. 2011;38:657-62 pubmed 出版商
  627. Li J, Swope D, Raess N, Cheng L, Muller E, Radice G. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling. Mol Cell Biol. 2011;31:1134-44 pubmed 出版商
  628. Gladden A, Hebert A, Schneeberger E, McClatchey A. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev Cell. 2010;19:727-39 pubmed 出版商
  629. Yong Jiang -, Huawei Liu -, Hu Long -, Yingying Yang -, Dianying Liao -, Xiuhui Zhang -. Goblet cell carcinoid of the appendix: a clinicopathological and immunohistochemical study of 26 cases from southwest china. Int J Surg Pathol. 2010;18:488-92 pubmed 出版商
  630. Tonge P, Andrews P. Retinoic acid directs neuronal differentiation of human pluripotent stem cell lines in a non-cell-autonomous manner. Differentiation. 2010;80:20-30 pubmed 出版商
  631. Huvila J, Brandt A, Rojas C, Pasanen S, Talve L, Hirsimäki P, et al. Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors. Int J Gynecol Cancer. 2009;19:1226-31 pubmed 出版商
  632. Revet I, Huizenga G, Koster J, Volckmann R, van Sluis P, Versteeg R, et al. MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3. Cancer Lett. 2010;289:195-207 pubmed 出版商
  633. Martinez G, Wijesinghe M, Turner K, Abud H, Taketo M, Noda T, et al. Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation. Invest Ophthalmol Vis Sci. 2009;50:4794-806 pubmed 出版商
  634. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed 出版商
  635. Patriarca C, Colombo P, Pio Taronna A, Wesseling J, Franchi G, Guddo F, et al. Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1). Int J Surg Pathol. 2009;17:99-106 pubmed 出版商
  636. Elzagheid A, Buhmeida A, Korkeila E, Collan Y, Syrjanen K, Pyrhonen S. Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma. World J Gastroenterol. 2008;14:3866-71 pubmed
  637. Buhmeida A, Elzagheid A, Algars A, Collan Y, Syrjanen K, Pyrhonen S. Expression of the cell-cell adhesion molecule beta-catenin in colorectal carcinomas and their metastases. APMIS. 2008;116:1-9 pubmed 出版商
  638. Hervieu V, Lombard Bohas C, Dumortier J, Boillot O, Scoazec J. Primary acinar cell carcinoma of the liver. Virchows Arch. 2008;452:337-41 pubmed 出版商
  639. Reichel O, Mayr D, Durst F, Berghaus A. E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. 2008;265:937-42 pubmed 出版商
  640. Lim S, Lim K, Giuliano R, Federoff H. Temporal and spatial localization of nectin-1 and l-afadin during synaptogenesis in hippocampal neurons. J Comp Neurol. 2008;507:1228-44 pubmed 出版商
  641. Thompson J, Wong L, Lau P, Bannigan J. Adherens junction breakdown in the periderm following cadmium administration in the chick embryo: distribution of cadherins and associated molecules. Reprod Toxicol. 2008;25:39-46 pubmed
  642. Gama A, Paredes J, Gartner F, Alves A, Schmitt F. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival. Vet J. 2008;177:45-53 pubmed
  643. Huang D, Casale G, Tian J, Wehbi N, Abrahams N, Kaleem Z, et al. Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens. Cancer Epidemiol Biomarkers Prev. 2007;16:1371-81 pubmed
  644. Mahomed F, Altini M, Meer S. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Oral Dis. 2007;13:386-92 pubmed
  645. Canavese G, Bernardi A, Candelaresi G, Lovadina P, Amerio S, Rossetti V, et al. Expression of the E-cadherin-catenins complex in sentinel node is related to tumor morphology but not to spread to nonsentinel nodes. Pathol Res Pract. 2007;203:517-23 pubmed
  646. De Matos A, Lopes C, Faustino A, Carvalheira J, Rutteman G, Gärtner M. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours. APMIS. 2007;115:327-34 pubmed
  647. Chang M, Boulden J, Sutanto Ward E, DuHadaway J, Soler A, Muller A, et al. Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression. Cancer Res. 2007;67:100-7 pubmed
  648. Gritli Linde A, Hallberg K, Harfe B, Reyahi A, Kannius Janson M, Nilsson J, et al. Abnormal hair development and apparent follicular transformation to mammary gland in the absence of hedgehog signaling. Dev Cell. 2007;12:99-112 pubmed
  649. Kurek D, Garinis G, van Doorninck J, van der Wees J, Grosveld F. Transcriptome and phenotypic analysis reveals Gata3-dependent signalling pathways in murine hair follicles. Development. 2007;134:261-72 pubmed
  650. Akins M, Greer C. Axon behavior in the olfactory nerve reflects the involvement of catenin-cadherin mediated adhesion. J Comp Neurol. 2006;499:979-89 pubmed
  651. Tiemann K, Kosmahl M, Ohlendorf J, Krams M, Kloppel G. Solid pseudopapillary neoplasms of the pancreas are associated with FLI-1 expression, but not with EWS/FLI-1 translocation. Mod Pathol. 2006;19:1409-13 pubmed
  652. Larre I, Ponce A, Fiorentino R, Shoshani L, Contreras R, Cereijido M. Contacts and cooperation between cells depend on the hormone ouabain. Proc Natl Acad Sci U S A. 2006;103:10911-6 pubmed
  653. Goldstein N. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol. 2006;125:132-45 pubmed
  654. Lee J, Choi K, Lee S, Gye M. Expression of beta-catenin in human testes with spermatogenic defects. Arch Androl. 2005;51:271-6 pubmed
  655. Kaplan S, Gard J, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, et al. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm. 2004;1:3-11 pubmed
  656. Knudsen K, Sauer C, Johnson K, Wheelock M. Effect of N-cadherin misexpression by the mammary epithelium in mice. J Cell Biochem. 2005;95:1093-107 pubmed
  657. Modarresi R, Lafond T, Roman Blas J, Danielson K, Tuan R, Seghatoleslami M. N-cadherin mediated distribution of beta-catenin alters MAP kinase and BMP-2 signaling on chondrogenesis-related gene expression. J Cell Biochem. 2005;95:53-63 pubmed
  658. Ramburan A, Oladiran F, Smith C, Hadley G, Govender D. Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy. J Clin Pathol. 2005;58:44-50 pubmed
  659. Sedivy R, Peters K, Kloppel G. Osteopontin expression in ductal adenocarcinomas and undifferentiated carcinomas of the pancreas. Virchows Arch. 2005;446:41-5 pubmed
  660. Honecker F, Kersemaekers A, Molier M, Van Weeren P, Stoop H, de Krijger R, et al. Involvement of E-cadherin and beta-catenin in germ cell tumours and in normal male fetal germ cell development. J Pathol. 2004;204:167-74 pubmed
  661. Lyakhovitsky A, Barzilai A, Fogel M, Trau H, Huszar M. Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors. Am J Dermatopathol. 2004;26:372-8 pubmed
  662. Marques F, Fonsechi Carvasan G, de Angelo Andrade L, Bottcher Luiz F. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Gynecol Oncol. 2004;94:16-24 pubmed
  663. Zhang P, Furth E, Cai X, Goldblum J, Pasha T, Min K. The role of beta-catenin, TGF beta 3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids. Hum Pathol. 2004;35:670-4 pubmed
  664. Zhu P, Martin E, Mengwasser J, Schlag P, Janssen K, Göttlicher M. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell. 2004;5:455-63 pubmed
  665. Song S, Kim S, Kim D, Son H, Rhee J, Kim Y. Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta. J Clin Gastroenterol. 2004;38:252-9 pubmed
  666. Fidder H, Barshack I, Chen Shtoyerman R, Onaca N, Goldberg I, Rath P, et al. Immunohistochemical analyses of colon cancer in I1307K APC mutation carriers compared with noncarriers. Dig Dis Sci. 2003;48:1102-5 pubmed
  667. Luo Y, Radice G. Cadherin-mediated adhesion is essential for myofibril continuity across the plasma membrane but not for assembly of the contractile apparatus. J Cell Sci. 2003;116:1471-9 pubmed
  668. Wu S, Morin P, Maouyo D, Sears C. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124:392-400 pubmed
  669. Swinney D, Xu Y, Scarafia L, Lee I, Mak A, Gan Q, et al. A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem. 2002;277:23573-81 pubmed
  670. Warchol M. Cell density and N-cadherin interactions regulate cell proliferation in the sensory epithelia of the inner ear. J Neurosci. 2002;22:2607-16 pubmed
  671. Wheelock M, Soler A, Knudsen K. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia. 2001;6:275-85 pubmed
  672. Barshack I, Goldberg I, Chowers Y, Weiss B, Horowitz A, Kopolovic J. Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue. J Clin Pathol. 2001;54:684-8 pubmed
  673. Rahn J, Dabbagh L, Pasdar M, Hugh J. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Cancer. 2001;91:1973-82 pubmed
  674. Rashid M, Sanda M, Vallorosi C, Rios Doria J, Rubin M, Day M. Posttranslational truncation and inactivation of human E-cadherin distinguishes prostate cancer from matched normal prostate. Cancer Res. 2001;61:489-92 pubmed
  675. Han A, Soler A, Tang C, Knudsen K, Salazar H. Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch Pathol Lab Med. 2000;124:1147-51 pubmed
  676. Carbajal J, Gratrix M, Yu C, Schaeffer R. ROCK mediates thrombin's endothelial barrier dysfunction. Am J Physiol Cell Physiol. 2000;279:C195-204 pubmed
  677. Elliott D, Clark D. Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface. Infect Immun. 2000;68:2315-22 pubmed
  678. Vallorosi C, Day K, Zhao X, Rashid M, Rubin M, Johnson K, et al. Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem. 2000;275:3328-34 pubmed
  679. Peralta Soler A, Knudsen K, Salazar H, Han A, Keshgegian A. P-cadherin expression in breast carcinoma indicates poor survival. Cancer. 1999;86:1263-72 pubmed